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Preamble
Mostly out of habit and to honour the fact that research is rarely an entirely solitary
process I will mostly rely on the use of we in the text.
v

Zusammenfassung
Der menschliche Organismus verfügt als erste Verteidigung gegen Pathogene über Zellen
des Immunsystems, welche sich im Epithelgewebe der Haut befinden. Langerhanszellen
(LC) und CD8α+ konventionelle dendritische Zellen (cDC) gehören zu der Familie der
antigenpräsentierenden Zellen des Immunsystems, welche bis zur Aktivierung in ihrem
speziellen Gewebe verbleiben. Für ihre richtige Entwicklung und Funktion müssen diese
Zellen in ihr umliegendes Gewebe verankern.
Es ist bekannt, dass der Transkriptionsfaktor Id2 wichtig für die Entwicklung von LC
und CD8α+ cDC ist. Die vorliegende Arbeit untersucht diesen Zusammenhang genauer
und beschreibt die Rolle von Id2 in der Entwicklung von DC und zeigt, dass der Tran-
skriptionsfaktor sehr wichtig für die Differenzierung und Verankerung dieser Zellen in
ihrer Nische im umliegenden Gewebe ist. Dies macht Id2 durch Unterdrückung von Zeb2
während der letzten Schritte der LC und CD8α+ cDC Differenzierung. Id2–/– LC und
CD8α+ cDC zeigen eine hohe Expression von Zeb2 und entsprechend reduzierte Mengen
an Adhäsionsmolekülen. Folglich können Id2–/– LC nicht stabil in der Epidermis verankern
und wandern in den ersten Wochen nach der Geburt aus, wodurch die Zellen im adulten
Stadion fehlen. Zeb2–/– Mäuse zeigen eine erhöhte Anzahl von LC und CD8α+ cDC und
eine verringerte Anzahl von plasmazytoiden DC (pDC). Zeb2–/– pDC wiesen stark erhöhte
Werte von Id2 auf, was auf eine gegenseitige Hemmung von Id2 und Zeb2 hinweist. Des
Weiteren induziert E47 die Expression von Zeb2 und die Deletion von E47 in Id2–/– Mäusen,
rettet zum Teil den Phänotyp und ermöglicht wieder die Verankerung von DC. Mittels der
Doppel-Knock-out Maus konnten auch wieder typische Adhäsionsmoleküle, wie E-cadherin
und EpCAM, ausgebildet werden.
Zusammengefasst zeigen die Daten dieser Arbeit, dass die stabile Verankerung von Gewebe-
residenten DC in ihrer Nische von Id2 durch die Hemmung der E47-vermittelten Zeb2
Expression reguliert wird.
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Abstract
The first line of defense against pathogens of our body is provided by cells of the immune
system that reside in epithelial tissue. Langerhans cells (LC) and CD8α+ conventional
dendritic cells (cDC) belong to the DC family that are potent antigen-presenting cells
that reside in their special environment until activation. For their proper development and
function these cells need to anchor to their surrounding tissue.
Id2 is known to be essential for the development of LC and CD8α+ cDC. The research
described herein assess the role of Id2 in DC development to demonstrate its importance in
the differentiation and anchoring of these cells in their niche. Id2 suppresses Zeb2 expression
during final steps of LC and CD8α+ cDC differentiation. Id2–/– LC and CD8α+ cDC show
high expression of Zeb2 and accordingly reduced levels of adhesion molecules. Consequently,
Id2–/– LC do not stable anchor and are lost from the epidermis during the first weeks after
birth. In agreement, Zeb2–/– mice contained increased numbers of LC and CD8α+ cDC
and reduced numbers of plasmacytoid DC (pDC). Zeb2–/– pDC express strongly elevated
levels of Id2, highlighting that Id2 and Zeb2 inhibit each other. Furthermore, E47 induces
Zeb2 expression and deletion of E47 in Id2–/– mice partly rescues anchoring of DC. Typical
adhesion molecules, such as E-cadherin and EpCAM, were restored in double knock-out
mice.
Taken together, the data of this work demonstrate that the stable anchorage of tissue-
resident DC in their niche is governed by Id2 through inhibition of E47-mediated Zeb2
expression.
ix

1 Introduction
1.1 Haematopoiesis
Haematopoiesis, the process by which the elements of the blood develop, is a well character-
ized process. The blood include three principal components: red blood cells (erythrocytes),
white blood cells (lymphocytes) and platelets. Because these differentiated cell types are
predominantly short lived, primitive undifferentiated cells are required. Those stem cells
are multipotent, self-renew and are called long-term haematopoietic stem cells (LT-HSC).
LT-HSC have the potential to develop into all types of blood cells. In general, the less differ-
entiated the cell type, the less abundant are those. While during ontogeny haematopoiesis
occurs in the yolk sack and then occurs in the liver, during adulthood, the bone marrow is
the side of production for all blood cell types (Orkin and Zon, 2008).
The haematopoietic development is often shown in haematopoietic trees (Figure 1.1).
LT-HSC are on top of the hierarchy and differentiate into multipotent progenitor cells
(MPP) that show short-term repopulating activity. MPP develop into common myeloid
progenitor cells (CMP) and common lymphoid progenitor cells (CLP), which give rise
to the myeloid lineage and lymphoid lineage, respectively. CMP differentiate into the
megakaryocyte/erythrocyte progenitors (MEP), granulocyte-monocyte progenitors (GMP)
and macrophage-dendritic cell progenitors (MDP). MEP can give rise to erythrocytes
and platelets. GMP differentiate into granulocytes and monocytes. Monocytes can further
diverge into macrophages and inflammatory dendritic cells (DC). DC can derive from CMP
as well as CLP (Shortman and Naik, 2007). MDP that derive from CMP or maybe direct
from lymphoid-primed multipotent progenitors (LMPP), differentiate into the common DC
progenitor (CDP) that give rise to pre-pDC and pre-cDC precursors that are already primed
for the DC subsets accordingly (Guilliams et al., 2014 and Schlitzer et al., 2015). Pre-
pDC differentiate to plamsacytoid DC (pDC). Pre-cDC differentiate over the intermediate
precursors pre-cDC1 and pre-cDC2 into the cDC1 and cDC2 subsets, including CD8α+
cDC and CD11b+ cDC, respectively.
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Figure 1.1. Haematopoietic hierarchy.
Hierarchical representation of the haematopoietic development. The multipotent haematopoietic
stem cells (HSC) can give rise to all haematopoietic cell types, via intermediate progenitors. LT-
HSC, long-term HSC; ST-HSC, short-term HSC. Through multipotent progenitors (MPP) or also
lymphoid-primed multipotent progenitors (LMPP), two lineage-restricted progenitors are developed,
common myeloid progenitors (CMP) and common lymphoid progenitors (CLP). The myeloid lineage
can give rise to specialized mature cell types, like erythrocytes, platelets, granulocytes (Gran.),
monocytes, macrophages and dendritic cells (DC). MEP, megakaryocyte/erythrocyte progenitors;
GMP, granulocyte-monocyte progenitors; MDP, macrophage-DC progenitors; CDP, common DC
progenitor; pre-cDC, cDC precursors; cDC, classical DC; pDC, plasmacytoid DC. The lymphoid
lineage can give rise to T cells, B cells, natural killer (NK) cells and also to DC. Pro-T, T cell
progenitors; pro-B, B cell progenitors, Pro-NK, NK cell progenitors. Dashed lines are predicted
pathways that needs to be proven, while solid lines represent proofed pathways. This figure was
adapted from Schmid et al., 2010, Hieronymus et al., 2014 and Guilliams et al., 2014.
From CLP the lymphoid cells, like T cells, B cells and natural killer (NK) cells, are produced
via specified intermediate progenitors. The haematopoietic development is an highly
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conserved mechanism that is controlled by intrinsic and extrinsic cues, like transcription
factors, growth factors and cytokines (Orkin and Zon, 2008).
1.2 The Subset Specification of DC
Antigen-presenting cells were first described by Ralph Steinmann and Zanvil Cohn in 1973
that analysed spleens of mice and termed the lymphoid cells ’dendritic cells’ according
to their stellate shape (Steinman and Cohn, 1973). That DC exhibit a unique feature of
the immune system, especially in adaptive immunity, became evident only in the next
decade.
DC are distributed throughout the body where they act as immune sentinels. The hetero-
geneity of DC, according to different anatomic locations, distinct surface and intracellular
markers and immunological function, leads to the distinction of subpopulations (Figure
1.2; Belz and Nutt, 2012). DC can be divided into two main types: classical DC (cDC)
and plasmacytoid DC (pDC). cDC can be further divided into lymphoid tissue-resident
DC and migratory DC according to their anatomic location. Langerhans cells (LC) share
several immunogenic properties with DC and can be assigned into the class of migratory
DC (Merad et al., 2013).
1.2.1 Plasmacytoid Dendritic Cells
pDC were named according to their characteristic plasma cell-like morphology, lacking
dendrites (Liu, 2005 and Reizis et al., 2011). This type of cell is rather rare in the body, which
comprise less than 1% of total peripheral blood mononuclear cells, and resides primarly
in lymphoid organs and in the blood (McKenna et al., 2005; Merad et al., 2013). After
encountering and recognition of viral products, like single-stranded RNA and unmethylated
CpG-containing DNA by toll-like receptors, pDC become activated and produce large
amounts of interferon-α. By this they efficiently prime and activate T cells. pDC express
characteristic surface markers, such as Siglec-H and PDCA-1, and are positive for the B
cell marker B220 (CD45R; Reizis et al., 2011). Murine pDC can be further characterised
by low expression of CD11c, Gr1 and the absence of CD11b.
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Figure 1.2. The development and migration of DC subsets.
In bone marrow HSC differentiate into lineage-restricted progenitors, including CDP. CDP give rise
over pre-pDC to pDC that fulfil their tasks in lymphoid tissue and to pre-cDC (here termed pre-DC).
This pre-DC circulates in blood and differentiate into different DC subsets in non-lymphoid and
lymphoid tissue. HSC, haematopoietic stem cells; MPP, multipotent progenitor cells; CDP, common
DC progenitors; cDC, classical DC; pDC, plasmacytoid DC. Obtained from Belz and Nutt, 2012.
1.2.2 Classical Dendritic Cells
cDC form the link between the innate and adaptive immune response by sampling local
antigens, process those and migrate to the draining lymph nodes to initiate proper immune
response of T cells (Förster et al., 2012; Merad et al., 2013). They are short lived cells with
a half-life of 5 - 7 days. cDC are found in lymphoid tissue as well as non-lymphoid tissue
and are characterised by the expression of the integrin CD11c and intermediate to high
levels of MHC class II (MHC-II; Schmid et al., 2010).
cDC derive from local precursors, the pre-cDC that develop from CDP in the bone marrow
and then migrate to peripheral organs where they give rise over the intermediated precursors,
pre-cDC1 and pre-cDC2, to the different cDC subsets (Guilliams et al., 2014). cDC can be
subdivided according to their surface marker expression and also tissue location. By the
4
1.3 Skin Immunity
expression of the surface markers CD11b and CD8α, cDC are distinguished into CD8α+
cDC (cDC1) and CD11b+ cDC (cDC2; Vremec et al., 2000). CD8α+ cDC are unique
in that they are potent cross-presenting DC (den Haan et al., 2000). CD8α+ cDC and
CD11b+ cDC are found in major lymphoid organs, such as spleen, thymus and lymph
nodes. However, also in non-lymphoid tissue, such as the skin, their counterparts can be
found and are knwon as migratory DC, like CD103+ DC and CD11b+ DC (also reffered to
as dermal or interstitial DC; Henri et al., 2010).
1.3 Skin Immunity
The skin represents the first immunological barrier of our body to the environment by
separating the inner body mechanically from commensals and pathogens. Beside LC also
other cells line the epidermal tissue in the skin.
The skin can be divided into three layers, the epidermis (cuticle), the dermis (connective tis-
sue) and the subcutaneous layer (adipose tissue) that is connected to the dermis (Figure 1.3).
These compartments in turn consist of a network of different, partially highly specialized
cell types that can influence each other (Pasparakis et al., 2014).
The outermost part of the skin, the epidermis, consists of around 90% keratinocytes.
Keratinocytes undergo a process of differentiation. They are build from stem cells that
reside in the basal membrane of the epidermis and transmigrate through the epidermis until
they undergo apoptosis. Depending on the stage of differentiation of the keratinocytes, the
epidermis can be further divided into four layers: basal layer, stratum spinosum, stratum
granulosum and stratum corneum. The nourishment of the epidermis is ensured by diffusion
of the vascularized dermis. To build the skin tissue, keratinocytes are anchored to the
dermis through connections called hemidesmosomes, while inter-connections are build
through desmosomes. Keratinocytes serve as the skin structure and are further important
to take over immunological functions through the secretion of various cytokines. LC reside
in the spinous cell layer in the epidermis and build the first immunological barrier (Heath
and Carbone, 2013).
In skin epidermis LC comprise only 2-3% of all epidermal cells (Romani et al., 2003;
Kissenpfennig and Malissen, 2006). Beside LC, dendritic epidermal T cells (DETC) are the
5
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Figure 1.3. The skin.
The skin is composed of three different layers. The epidermis, which is the outer layer, the dermis
and the subcutaneous layer made up of adipose tissue. The epidermis can be further separated in
to four layers, but only the spinous cell layer is bearing haematopoietic cells. Adapted from Chong
et al., 2013 and Pasparakis et al., 2014.
only haematopoietic cell types that reside as well in unchallenged epidermis. Steady-state LC
are sessile and express adhesion molecules that allows them to anchor to their neighbouring
keratinocytes. The functional adhesion between LC and keratinocytes is mediated by the
calcium-dependent binding of the molecule E-cadherin. If LC also communicate with DETC
is not known so far. Further, in the basal cell layer of the epidermis around 5% melanocytes
are responsible for the production of the pigment melanin, which gives the skin its colour
(Chorro and Geissmann, 2010).
The dermis, in contrast, bears additional immune effector cells, including dermal DC, T cells,
innate lymphoid cells, macrophages, eosinophils, neutrophils and mast cells. These cells are
connected through cells, known as fibroblasts that secrete elastin and collagen fibres forming
a dense extracellular matrix. Blood capillaries supply the dermis with nutrients. Lymph
fluid is drained through lymphatic vessels that enables the lymphocytes to migrate to lymph
nodes, a specialized immune structure (Pasparakis et al., 2014).
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1.3.1 Langerhans Cells
LC were first discovered in 1868 by Paul Langerhans who observed dendritically shaped cells
in human epidermis, although they were assumed to be a type of nerve cell (Langerhans,
1868; Romani et al., 2012). Only one century later and with the discovery of birbeck
granules (Figure 1.4B) and the detection of the expression of ATPase, LC were regarded
as leucocytes (Romani et al., 2003). LC are specialized haematopoietic cells that reside in
all epidermal tissue of mice and men, such as skin, mucosa, lung and intestine, and build a
network as defence (Figure 1.4A). As a subset of DC, LC are critical mediators of both
cutaneous tolerance and adaptive immunity. LC are, compared to other DC, exceptionally
long-lived cells (Hieronymus et al., 2014).
Figure 1.4. Haematopoietic network in skin epidermis.
(A) Immunofluorescent microscopy of LC (red) and DETC (green) in tissue context of mouse
epidermis. LC, Langerhans cells; DETC, dendritic epidermal T cells. Scale bar, 50 µm. (B) Electron
microscopy of the rod-shaped birbeck granules of a human LC that contain the receptor langerin.
Obtained from Romani et al., 2006.
Although LC share common DC markers, such as MHC-II and CD11c, they can be
characterised nowadays by the expression of EpCAM, the adhesion molecule E-cadherin
and the C-type lectin CD207, also called langerin (Tang et al., 1993; Romani et al., 2010).
Langerin is expressed extracellular on LC as well as intracellular in the main molecular
components, the birbeck granules (Figure 1.4B; Valladeau et al., 2000; Valladeau et al.,
2003).
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Langerin is known to bind carbohydrates, such as mannose and fucose (Galustian et al.,
2004). The precise mechanism how langerin takes up antigens and its role in antigen
presentation is not understood so far. Interestingly, in contrast to MHC-II, which is
expressed already in late embryogenesis on LC, langerin expression is upregulated only
upon postnatal day three (P3; Tripp et al., 2004). It is assumed that there is a correlation
of the developmental pathway of the expression of langerin with the appearance of birbeck
granules one day later, at P4. Birbeck granules are part of the endosomal recycling network
and can internalize extracellular langerin very fast. Although langerin is not exclusively
expressed on LC (also expressed in a subset of dermal DC), this hallmark can be used to
identify LC, including their anatomical location.
These highly specialized LC produce antimicrobial peptides, which can kill bacteria directly
through secretion of inflammatory mediators, such as interleukin-1 (IL-1) that activate
other DC. On the other hand, after encountering antigens or toxins, LC become activated,
change their morphology and start to migrate to the dermis, where they enter lymphatics
to present the antigens in lymph nodes to T-cells. This process is also called maturation of
LC (Kissenpfennig and Malissen, 2006).
Although a lot of research has been done on LC, their concrete immunological role in
epithelium is not unrevealed so far.
1.3.1.1 LC Development in Steady-State
LC development represents a special pathway compared to other DC. LC originate from
embryonic fetal liver monocytes with minor contribution of yolk sac-derived macrophages
that seed the developing skin from embryonic day 14.5 (E14.5) during mouse development
(Figure 1.5; Chorro and Geissmann, 2010; Hoeffel et al., 2012). At that time point the
epidermis is not yet developed. The differentiation of the stratum corneum into the mature
epidermis is established around E16.5. Then LC precursors are recruited in the epidermis. LC
precursors are defined by the expression of CD45, CX3CR1, CD11b, CD115 and the lack of
c-kit, Flt3 and all mature LC markers (Chorro and Geissmann, 2010).
8
1.3 Skin Immunity
Figure 1.5. Development and homeostasis of epidermal LC.
(A) Between E9.5 and E10.5 of embryogenesis yolk sac (YS) derived macrophages start to migrate
to the skin. At E12.5 haematopoiesis occur in the fetal liver that replace most YS-derived precursors
at late embryogenesis and give predominantly rise to LC precursors. Between E16.5 and E18.5
the epidermis is fully matured and LC precursors migrate to it. Shortly after birth LC precursors
differentiate into LC, proliferate and form a dense network. This network is sustained throughout
steady-state and inflammation in adulthood. Only in certain occasions LC can be renewed by bone
marrow derived precursors. (B) Schematic representation of mouse LC development based on (A).
Taken from Chorro and Geissmann, 2010 and adapted with Hoeffel et al., 2012.
Shortly after birth, LC precursors start to differentiate by downregulation of typical
progenitor markers, CX3CR1 and CD115, and expression of specific DC/LC surface
markers, such as MHC-II, langerin, EpCAM and CD11c. At P3, LC start to proliferate
to increase in number and form a network in skin epidermis, which is established at P7
9
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(Chorro and Geissmann, 2010). It is assumed that LC are maintained during life by a self-
renewing local precursor, although this precursor is not yet identified. Note, LC precursors
are radio-resistant because they stay of host origin after bone marrow transplantation
(Seré et al., 2012). As LC are long-lived their turn-over is very slow. However, in case
of inflammation bone marrow cells can give rise to LC in skin epidermis (Seré et al.,
2012).
1.3.1.2 LC Development during Inflammation
While in steady-state a skin-residing LC precursor was not yet discovered, in the last years
the understanding of LC development during inflammation progressed. In adult mice it
was shown that LC precursors exist in bone marrow that can repopulate the skin after
injury (Figure 1.6; Seré et al., 2012). Shortly after inflammation, Gr1hi monocytes with
bone marrow origin can give rise to short-term LC (Ginhoux et al., 2006; Seré et al., 2012).
Like the name implies, these cells occur transiently and have to be replaced by LC that
reconstitute the LC network long lasting. Therefore, in a second wave of recovery long-term
LC migrate into the skin (Figure 1.6). However, it is not known if long-term LC derive
from precursors originating from bone marrow or skin. Interestingly, short-term LC do not
depend on the transcription factor inhibitor of DNA-binding 2 (Id2), while long-term LC
do. Further hallmark of short-term LC is the low expression of langerin and EpCAM (Seré
et al., 2012).
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Figure 1.6. Schematic representation of LC development in steady-state and inflam-
mation.
(A) Haematopoietic stem cells (HSC) that reside in the bone marrow or a local precursor in skin
give rise to LC in steady-state, referred to as long-term LC. During inflammation Gr1hi monocytes,
developed from HSC, give rise to short-term LC that seed the epidermis independent of Id2 and are
transient. (B) The two waves of LC development after inflammation. In a first wave short-term LC
migrate in the epidermis, independent of the transcription factor Id2. In the second wave long-term
LC replace the short-term LC and establish the normal LC network. Obtained from Seré et al.,
2012.
1.3.2 Dendritic Epidermal T cells
DETC are specialized T cells that are found in the mucosa and skin epidermis of mice. They
are reported to sense skin injury by recognizing antigens that are expressed on damaged or
transformed keratinocytes (Jameson et al., 2004). In contrast to the majority of T cells
found in other organs expressing α/β receptors, DETC bearing γ/δ T-cell receptors. DETC
develop from embryonic precursors arising at P14 (Prinz et al., 2013). The aryl hydrocarbon
receptor (Ahr) plays an important role in the postnatal maintenance of DETC. Ahr induces
expression of c-kit, a receptor tyrosine kinase that controls proliferation and expansion of
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DETC (Hao and Whitelaw, 2013). DETC are the major source of GM-CSF in skin that is
required for LC maturation (Hao and Whitelaw, 2013). Therefore, Ahr deficiency leads also
to impaired LC maturation (Hao and Whitelaw, 2013). The transcription factor Runx3
(Runt-related transcription factor 3) regulates DETC development and the expression of
the integrin-αE (CD103), which is responsible for migration and retention of DETC (Woolf
et al., 2007). Furthermore, Runx3 regulates the expression of IL-2β receptor on DETC,
which mediates cell proliferation in response to IL-2 and IL-15 signalling (Woolf et al.,
2007). Similar to LC, DETC are also dependent on Id2 and it was reported that DETC
precursors express Id2 already from P14 onwards (Tokuriki et al., 2009; Prinz et al., 2013).
Although DETC and LC form a close network in skin epidermis (Figure 1.4A), the function
and interplay between these two cell types is still not known.
1.4 Molecular Mechanisms in DC Development
The lineage commitment from stem cells to the differentiation of DC subsets and specific
to LC is accompanied by the expression of growth factors, cytokines and their receptors,
and of transcription factors (Figure 1.7).
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Figure 1.7. Cytokines and transcription factors that are important for the lineage
commitment and cell fate decision in the haematopoietic system discussed in this
study.
In the haematopoietic hierarchy specific cytokines and transcription factors are important in the
indicated lineage commitments (for abbreviations see Figure 1.1). Extended from Orkin and Zon,
2008; for references read in the following sections.
1.4.1 Cytokines and Growth Factors
Cytokines and growth factors are typically secreted molecules that interact with other
molecules or bind to receptors to influence cellular behaviour, both through alternating
transcription and other molecular messengers.
The transforming growth factor β (TGF-β), belonging to the transforming growth factor
superfamily, is a cytokine that plays an important role in a variety of biological processes,
such as development, differentiation and apoptosis (Li et al., 2006). TGF-β binds TGF-β
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receptor type II (TGF-βRII) that recruits and phosphorylates TGF-β receptor type I
(TGF-βRI, also known as ALK5). This in turn activates downstream Smad signalling
pathways by phosphorylation of Smad2 and Smad3 that cross-talk with G-protein coupled
receptors (Xu et al., 2012; Massague, 2012). TGF-β signalling is crucial for preserving
quiescence of HSC and maintain their self-renewal capacity (Figure 1.7; Karlsson et al.,
2007).
TGF-β comprises three isoforms, TGF-β1, TGF-β2 and TGF-β3. TGF-β1 is essential for
embryonic development and newborn growth and as a transcriptional regulator important
for many downstream targets in the cell (Kulkarni et al., 1993). Moreover, TGF-β1 is
essential for LC development and differentiation because LC are absent in mice deficient
for TGF-β1 and showed reduced LC numbers in TGF-βRII deficient mice (Figure 1.7;
Borkowski, 1996; Kaplan et al., 2007). However, cell types that are responsible for secreting
TGF-β1 and whether TGF-β1 acts directly or via intermediate stages on LC is unresolved
(Kaplan et al., 2007). TGF-β1 is produced by LC and keratinocytes, which make the skin
a rich TGF-β1 environment. Autocrine and paracrine secretion of TGF-β1 is important for
LC homeostasis, while development and seeding of LC in skin epidermis occurs independent
of TGF-β1 signalling (Bobr et al., 2012; Hieronymus et al., 2014). The deficiency of TGF-β1
or TGF-βRI results in the downregulation of E-cadherin that mediates interactions between
LC and keratinocytes (Kel et al., 2010). Riedl and co-workers showed that E-cadherin is
induced by TGF-β1 during differentiation of CD34+ human haematopoietic progenitor
cells (Riedl et al., 2000).
Interestingly, another TGF-β family member, the BMP7 (a bone morphogenetic protein)
promotes LC biology (Yasmin et al., 2013a). It was shown to be important for LC differenti-
ation by using the BMP7/ALK3 signalling pathway (Yasmin et al., 2013a). Further, TGF-β1
induces β-catenin expression, which was shown to promote LC differentiation (Yasmin et al.,
2013b). β-catenin is a transcriptional regulator of the Wnt signalling pathway that can
promote the expression of multiple epithelial genes by LC. Due to the fact that β-catenin is a
ligand-dependent coactivator of vitamin D receptor, vitamin D enhances TGF-β1 mediated
β-catenin induction. Furthermore, β-catenin is responsible for the anchoring of LC in the
epidermis by interaction with the intracellular tail of cadherins, such as E-cadherin, to
the cytoskeleton (Yasmin et al., 2013b). Furthermore, TGF-β1 plays important role in DC
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development by priming MPP to CDP and into the cDC lineage by blocking pDC-specific
gene expression (Felker et al., 2010; Seré et al., 2012).
Axl ia also a downstream effector of TGF-β1 during LC differentiation and epidermal
homeostasis (Figure 1.7; Bauer et al., 2012). It belongs to the TAM (Tyro3, Axl, Mer)
receptor tyrosine kinase family. The expression of Axl is induced early during LC precursor
differentiation and is further induced during steady-state LC ontogeny. The downregulation
of Axl signalling is crucial for LC maturation during emigration from skin (Bauer et al.,
2012).
The microenvironment of LC is believed to play a critical role in the control of LC
homeostasis. For example the surrounding keratinocytes produce cytokines and growth
factors that are crucial for LC development. Keratinocytes produce M-CSF/Csf1, IL-34
and TGF-β1, which are required for development of the LC network (Borkowski, 1996;
Ginhoux et al., 2006; Kaplan et al., 2007). The expression of Csf1r on LC is mandatory for
their proliferation. It was shown that another ligand for Csf1r, interleukin-34 (IL-34), is
crucial for LC survival (Wang et al., 2012; Greter et al., 2012).
1.4.2 Transcription Factors
Transcription factors are proteins that bind specific to DNA sequences and control thereby
the amount of transcription of the specific genetic information. Either transcription factors
act alone or they perform their function together with other proteins in a complex. They
can act as activators or repressors of transcribing the DNA into RNA.
The transcription factor PU.1 is encoded by the Sfpi1 gene and based on findings with PU.1
deficient mice, PU.1 is considered to be a master regulator of haematopoiesis (Satpathy
et al., 2011). Here it takes part in the maintenance of HSC and differentiation to B
cells, T cells and DC (Figure 1.7; Carotta et al., 2010). Further, PU.1 is essential in the
differentiation of CDP to cDC and pDC (Carotta et al., 2010).
The transcription factor Runx3 is also expressed by LC and regulates their develop-
ment. Chopin and colleagues showed that Runx3 is regulated by the binding of PU.1
to regulatory elements in response to TGF-β1 dependent signalling (Chopin et al.,
2013).
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The growth factor independent 1 (Gfi1) is in general expressed during haematopoiesis
(Satpathy et al., 2011). Gfi1 was shown to be important for the maintenance and quiescence
of stem and progenitor cells to the lymphoid and myeloid compartment (Figure 1.7; Zeng
et al., 2004; van der Meer et al., 2010). Gfi1 is especially required for B cell, T cell and
neutrophil development (Figure 1.7; Li et al., 2010). Gfi1 and the highly homologous Gfi1b
act as transcriptional repressors (Chow et al., 2013). Gfi1 deficient mice lack neutrophils
and show defective DC maturation and an overabundance of macrophages (Karsunky et al.,
2002; Hock et al., 2003; Horman et al., 2009). Furthermore, while DC subsets are impaired,
Gfi1–/– mice showed a significant enhancement of LC (Rathinam et al., 2005; Moore and
Anderson, 2013).
1.4.2.1 Helix-Loop-Helix Transcription Factors
The basic helix-loop-helix (bHLH) proteins are a large family of dimeric transcription factors
that are found in almost all eukaryotes. They are critical regulators during developmental
processes, like neurogenesis and haematopoiesis (Jones, 2004). bHLH members contain two
highly conserved domains, which are functionally distinct and are made up by two α-helices
that are connected by a loop. Together this makes up a region of around 60 amino-acid
residues. At the amino-terminal end is the basic domain, containing the DNA binding
domain, which is known to bind to E box consensus sequences on DNA. Different E box
consensus sequences, existing of six nucleotides, are recognized by different members of
bHLH family. The carboxy-terminal end of the region is responsible for the interaction with
other proteins. Hereby, homo- or heterodimeric complexes can be facilitated. bHLH proteins
are divided into six major groups, bHLH A to F (Jones, 2004).
1.4.2.1.1 Inhibitor of DNA Binding/Differentiation 2
Id proteins belong to the inhibitor of DNA binding/differentiation (Id) family (Man-
tani et al., 1998). Four subtypes have been identified, Id1 to 4. Id proteins belong the
bHLH group D that contain the interaction domain responsible for binding with other
proteins but lack the basic domain that is required for DNA binding (Figure 1.8A). By
binding to other bHLH proteins they suppress the binding of activating bHLH factors to
DNA.
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Inhibitor of DNA-binding 2 (Id2) is the lineage determining factor for cDC and is involved
in haematopoiesis and interacts with E proteins (Hacker et al., 2003; Belz and Nutt, 2012).
Previous work showed that the bHLH transcription factor Id2 is a critical regulator of LC
biology and adult Id2–/– mice lack LC (Hacker et al., 2003). Furthermore, mice deficient for
Id2 have severe reduction in splenic CD8α+ cDC, dermal DC and increased pDC frequencies
(Figure 1.7; Jackson et al., 2011; Hacker et al., 2003).
Id2 is a target of TGF-β1 and TGF-βRI–/– mice lack LC as well (Kowanetz et al., 2004;
Kel et al., 2010). Further, Id2 proteins are known to inhibit the action of E proteins by
heterodimerization and are therefore referred as antagonising transcription factors in DC
development (Figure 1.8A; Hacker et al., 2003; Kee, 2009). Id2 is of major interest in this
project due to its predicted binding to E2A. Boos and colleagues showed already the direct
interaction between Id2 and E2A in the context of NK cell development (Boos et al., 2007).
Id2 deficient mice lack lymph nodes and NK cells as well and these could be restored by
additional knock-out of E2A.
Figure 1.8. The Id2 and E2A antagonism.
(A) E2A is antagonized by other classes of bHLH proteins, like the Id protein family. Upon binding
to e.g. Id2, E2A proteins become DNA-binding incompetent heterodimers resulting in inhibition
of transcription. (B) The bHLH transcription factor E2A forms homo- or heterodimer with other
bHLH factors of the E-family. Following binding to E box consensus sequences in target DNA E2A
acts as transcriptional activator.
1.4.2.1.2 E2A Immunoglobulin Enhancer Binding Factors E12/E47
Four different E proteins are identified in mammals: HEB, E2-2, E12 and E47 together
known as E2A immunoglobulin enhancer binding factors E12/E47, short E2A (Kee, 2009).
E2A is encoded by the Tcfe2a gene, also known as Tcf3, and transcripts of this gene can give
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rise by alternative splicing to the two E2A isoforms, E12 and E47 (Kwon et al., 2008). These
isoforms differ only in their bHLH domain and recognize different E boxes. E2A proteins
can bind to the E-box domain as homo- or heterodimer. However, E2A predominantly
exist as homodimers in the B lymphoid lineage and function as transcriptional activators,
while heterodimers most likely act as transcriptional repressors (Figure 1.8A and B; Kwon
et al., 2008).
E2A is indispensable during early B cell development (Kwon et al., 2008). Also the T
cell lineage is dependent on the expression of E2A (Figure 1.7; Kee, 2009; Welinder
et al., 2011). For the development of DC another E protein, E2-2, was shown to be
important for pDC development but not for cDC (Cisse et al., 2008). E2A is known to
repress E-cadherin (Perez-Moreno et al., 2001). However, for LC development expression
of the epithelial marker E-cadherin is essential (Tang et al., 1993; Takahashi et al., 2013;
Mayumi et al., 2013) and therefore an impact of E2A expression in LC development is
predicted.
1.4.2.1.3 Musculin (Msc)
Musculin, also known as the bHLH protein activated B cell factor 1 (Abf-1 or MyoR
for myogenic repressor) has been identified as a dimerization partner of E-proteins in B
cells (Figure 1.7; Massari et al., 1998; Wong et al., 2001; Mathas et al., 2006; Janz et al.,
2006; Debuisson et al., 2013). This protein is able to form homo- and heterodimers and
contains a transcriptional repression domain, which inhibits the transcriptional activity
of E47 (Massari et al., 1998; Mathas et al., 2006). The overexpression of the Msc pro-
tein, as well as Id2 protein, was shown to disrupt B cell differentiation (Mathas et al.,
2006).
The physiological role of Msc during mouse heamatopoiesis is not known so far. Because
Msc exhibits a similar role than Id2 and its upregulation during DC differentiation, it might
be of interest for further downstream subset specification in DC development (Hacker et al.,
2003).
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1.5 The Epithelial to Mesenchymal Transition
Epithelial cells show an apical-basolateral polarisation and attach to other cells by special-
ized junctions, such as tight junctions, adherens junctions, gap junctions and desmosomes.
Therefore their motility is limited. In contrast, mesenchymal cells have a fibroblast-like
morphology and contact their neighbouring cells only focally without building organised
cellular junctions. By exhibiting a different structural organisation mesenchymal cells have
the potential to be highly migratory. While mesenchymal cells build intermediate filaments
composed of vimentin, the predominant component of intermediate filaments in epithelial
cells are cytokeratins (Thiery and Sleeman, 2006).
The transformation of epithelial cells to mesenchymal cells is known as the epithelial to
mesenchymal transition (EMT) and is a highly conserved cellular program. The conversion
of a cell from an epithelial to mesenchymal state is accompanied by changes in gene
expression pattern, which include downregulation of epithelial markers and upregulation
of mesenchymal markers. Typical epithelial markers on LC are E-cadherin, occludins
and desmoplakin. Typical mesenchymal markers include vimentin, smooth muscle actin,
fibronectin and collagen (Hieronymus et al., 2014).
EMT was first described as a feature during embryogenesis, where constant morphogenetic
events occur, such as gastrulation and organogenesis (Wu and Zhou, 2008). EMT is also
important in pathological events during life, such as tissue repair. However, if EMT signals
persist during this process, tissue fibrosis may occur. Further, it can be associated with
carcinoma and metastasis, as it allows motility of these cells to secondary organs. The process
by which mesenchymal markers are upregulated and epithelial markers downregulated is
well studied during tumour progression towards metastasis. The transition of a cell from
one state to the other is transient and can occur in different states of their life (De Craene
and Berx, 2013).
The hallmark of EMT is the functional downregulation of the cell-cell adhesion protein
E-cadherin (Wu and Zhou, 2008). E-cadherin (encoded by the Cdh1 gene) is a calcium
(Ca2+)-dependent transmembrane glycoprotein and is found on the surface of epithelial cells.
E-cadherin allows homophilic binding to neighbouring cells by the interaction with members
of the catenin family, including α-catenin and β-catenin. β-catenin can directly bind to
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E-cadherin in adherens junctions, whereas the association with α-catenin occurs indirect
via β-catenin (Peinado et al., 2004). The interaction of E-cadherin to actin cytoskeleton
is supported through interaction of α-catenin with actin-binding proteins, like α-actinin
and vinculin. The homologue of β-catenin, the γ-catenin, may substitute for binding to
E-cadherin.
Figure 1.9. The promoter region of the human and mouse E-cadherin gene.
Several functional cis-elements, such as E-boxes, CCAAT-box and GC-rich region, are located in
the promoter region of human and mouse E-cadherin. The replicative E-box sequence, known as an
E-pal element, is only present in the mouse promoter. Adapted from Peinado et al., 2004.
The promoter region of E-cadherin is well preserved throughout various mammals and
contain the positive regulatory CCAAT-box element located near the GC-rich region
(Figure 1.9). The murine E-cadherin contains, in contrast to the human locus, two E-box
domains (5’ -CANNTG- 3’) known as E-pal element. It has been reported that binding of
zinc finger transcription factors to E-boxes within the promoter region of E-cadherin leads
to the suppression of E-cadherin expression. This causes the disruption of cell-cell contacts
and EMT (Peinado et al., 2004).
The downregulation of adherens and tight junctions is further promoted by suppression of
EpCAM, Jam1, claudins (e.g. claudin1), cytokeratins (e.g. cytokeratin 8 and 18), occludins,
and zonula occludens (ZO) proteins (e.g. ZO-1 and ZO-3). In contrast, typical mesenchymal
markers are the expression of N-cadherin, integrins, vimentin and matrix metalloproteinases
(MMP) that reorganize the cytoskeleton (Hieronymus et al., 2014).
1.5.1 EMT Regulators
The EMT processes are regulated by transcriptional regulators that drive the corresponding
phenotype. Different signalling pathways are involved in the control of EMT, including TGF-
β1, Notch and Wnt (Garg, 2013). These signals activate several transcriptional repressors.
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Transcriptional repressors of epithelial markers include the ZEB family (zink-finger-E-box-
binding protein 1 [Zeb1] and zink-finger-E-box-binding protein 2 [Zeb2]), the Snail family
(Snail homolog 1 [Snail1] and Snail homolog 2 [Snail2]) and the bHLH family (Twist-related
protein 1 [Twist1], Twist-related protein 2 [Twist2] and E2A). All these factors are known
to downregulate epithelial genes, such as E-cadherin, most of them through direct binding
to proximal E-boxes of the promoter. Of importance, E2A was already shown to be a
repressor of E-cadherin and thereby enable EMT (Perez-Moreno et al., 2001). In recent
years much progress have been achieved in understanding the function of different EMT
repressors that are implicated in cancer.
1.5.2 The Zink-Finger Homeodomain Transcription Factor Zeb2
Zeb2 (synonyms are smad interacting protein 1 [SIP1], zinc finger E box-binding homeobox
2 and deltaEF2) belongs to the zinc-finger homeodomain transcription factor family and
is closely related to its family member Zeb1 (Nelles et al., 2003). These proteins repress
transcription of genes coding for junctional proteins, such as E-cadherin, and induce
EMT (Vandewalle et al., 2005). Increased expression of Zeb2 with a reduced E-cadherin
expression is associated to multiple tumour types and has also been associated with tumour
progression and metastasis (Vandewalle et al., 2005).
The association of Zeb2 with inhibitory effects on transcription is mainly due to binding
to Smad-1, which is a classical signal protein of the BMP-4-Smad signalling pathway.
BMP-4 is essential for both the embryonic and adult haematopoiesis (Bhatia et al., 1999).
The various described functions of Zeb2 thus point to an important role of the protein
in the homeostasis of different cell types. However, how Zeb2 is regulated has still to
be revealed. Due to its important role during EMT in normal development and cancer
metastasis, a better understanding of the molecular mechanism that controls its expression
is important.
Recently, Scott and colleagues showed that Zeb2 acts as an transcription factor impor-
tant during DC commitment (Scott et al., 2016). Zeb2 regulates the development of
pDC and CD11b+ cDC by repressing the transcription factor Id2. Zeb2–/– mice had
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a reduction in these two DC subsets and an increase in CD8α+ cDC (Scott et al.,
2016).
1.5.3 The Mesenchymal to Epithelial Transition
The EMT process described before in section 1.5 can be also reversed, which is known
as mesenchymal to epithelial transition (MET). During MET, migratory cells acquire
an sessile phenotype, which is caused by upregulation of adherent molecules, such as
integrins and E-cadherin. While MET is less studied, it was shown to take place during
embryonic development and during metastatic growth (Yao et al., 2011). MET is induced
by downregulation of the transcriptional factors including zink-finger proteins, such as
Snail, Twist and E2A (see section 1.5.1).
1.6 Activation and Migration of DC
During ontogeny DC undergo several morphological changes due to their immunological
function, which is related to stationary life and mobility.
CD8α+ cDC belong to tissue-resident DC that are found in lymphoid tissues, such as the
spleen. In spleen CD8α+ cDC reside in the marginal zone, where they sense the surrounding
for antigens and only migrate to the white pulp of the spleen in case of antigen capture, to
interact with the T cells (Hey and O’Neill, 2012).
In the skin epidermis LC are anchored to surrounding keratinocytes and build the immuno-
logical barrier for invading pathogens in case of skin injury. LC are sessile until they are
activated from foreign antigens and have to undergo then several changes to acquire a
mesenchymal phenotype.
The migration of DC in general is achieved by first detaching from peripheral tissues, e.g.
LC from neighbouring keratinocytes, by Met/HGF (hepatocyte growth factor) receptor
activation and downregulation of specific cell adhesion molecules on the cell surface (Baek
et al., 2012; Mohammed et al., 2016). To migrate through the extracellular matrix and
basement membranes DC activate proteolytic enzymes, such as MMP (Alvarez and Teale,
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2008). MMP9 was shown to be a critical mediator for LC mobilization using MMP9-deficient
mice (Kobayashi et al., 1999; Ratzinger et al., 2002).
In a second wave, migratory DC, such as LC in the dermis, start to upregulate receptors
that guide them to skin-draining lymph nodes. By expression of the chemokine receptor
CCR7, LC are guided by gradients of the ligands CCL19 and CCL21 to lymphatics that
penetrate the dermis (Ohl et al., 2004).
1.7 Genetically Engineered Mouse Models
Mouse experiments correlate very well to human biology because we share around 99 %
of our genome and get similar diseases due to similar genetic abnormalities. Therefore, a
mouse with a specific genetic modification can serve as model for a disease in a human being.
In this way, scientists can carry out experiments that would be ethically impossible with
men. Such experiments provide insights into the biology of men that allows better diagnosis
and treatment of many diseases (Capecchi, 1994; Tecott, 2003).
During the last decade mouse models were established that drive LC research. Most studies
used knock-out models that show clearly the need for special factors in LC development
(Romani et al., 2010). In the recent years further approaches lead to establishment of
useful tracer models. As they will be referred to throughout this manuscript, they will be
introduced in this section.
1.7.1 Knock-out Mouse Models
The genetically modification of the mouse genome represents a valuable tool to analyse
the importance of a specific factor in DC development. Besides knock-in modifications
most research is done with knock-out models. The loss of a gene activity leads often to
quantifiable changes in the phenotype, which allows conclusions of the gene function. There
are various procedures to knock-out a gene.
A constitutive/conventional knock-out is the permanently inactivation of a target gene
in every cell of the organism. This causes in certain gene knock-outs limitations due to
developmental lethality. To determine a gene function in relation to human biology it is
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often necessary to look in adult mice. This problem can be overcome by using conditional
knock-out models, which can inactivate gene expression in a specific target tissue, either
non-inducible or inducible at a specific time point. To this end, often the Cre-lox mechanism
of the P1 bacteriophage is used (Sternberg et al., 1981; Sauer and Henderson, 1988). For
genome manipulation the bacteriophage uses only two components: (i) the Cre-recombinase
(Cre) and (ii) the loxP sites. A loxP site is a specific sequence consisting of 34 bp. Cre, as
the name implies, is an enzyme that catalyses the recombination between two loxP sites
and is often introduced under the control of a tissue-specific promoter (Rawlins and Perl,
2012). To use this strategy, the Cre gene and the loxP sequences have to be introduced
into the desired host by transgenic recombination.
Knock-out mouse models used in this thesis can be assigned to both categories. Id2–/– mice,
E47–/– : Id2–/– mice, Gfi1–/– mice and Msc–/– mice are constitutive knock-out models.
In contrast, the VavCre+ : E2Af mouse model (Kwon et al., 2008) and the Gfi1KD/KD
mouse model are non-inducible conditional knock-out models because the Cre locus is
introduced under the control of a specific promoter. In VavCre+ : E2Af mice the Cre
locus is introduced under the control of the Vav promoter and Vav is expressed only in
haematopoietic cells (de Boer et al., 2003). Cre expression leads to the excision of the floxed
sequence upstream of exon 17 and downstream of exon 19 in the Tcf3 allele. Further, the
Tcf3 gene has an insertion of a GFP sequence, which is only expressed upon Cre-mediated
excision. This leads to the expression of a non-functional E2A-GFP fusion protein (Kwon
et al., 2008).
The conventional knock-out of Zeb2 resulted in embryonic lethality (Van de Putte et al.,
2003), while an inducible conditional knock-out mouse model of Zeb2 can give insights to
Zeb2 expression also during later stages (Riedt, 2014). For this end, Cre is controlled under
the Mx1 promoter, which is inactive in healthy mice and administration of interferon-α,
interferon-β or stimulation of endogenous interferon by using a synthetic double-stranded
RNA (poly(I:C)) leads to its activation (Kuhn et al., 1995). Poly(I:C) treatment results in
an endogenous interferon secretion and thus to an activation of the Mx1 promoter and Cre
expression in treated animals. Cre recognizes the loxP sites in the Zeb2 gene, which leads
to full deletion of Zeb2 (Higashi et al., 2002).
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1.7.2 Lineage Tracing of Cells
Lineage tracing is the identification of all offspring’s of a single cell. Lineage tracing and
genetic labelling technologies provide powerful tools to understand tissue development,
stem and progenitor cell fate determination, homeostasis and tissue repair. The combi-
nation of inducible recombinases, multicolour reporter constructs and live-cell imaging
provides nowadays remarkable insights into stem cell biology (Kretzschmar and Watt,
2012).
1.7.2.1 Lineage Tracing of Id2
The Id2-CreERT2+ : Rosa26R-eGFPf, short Id2-CreERT2+, mouse model is used for
lineage tracing the expression of the transcription factor Id2 (Figure 1.10). The advanced
mouse strain consists of the (1) Id2-CreERT2 knock-in allele and the (2) Rosa26R-
eGFP-f knock-in allele, which were kindly provided from Emma Rawlins (Rawlins et al.,
2009).
(1) The Cre protein is fused to the ligand-binding domain of the estrogen receptor (ER) to
allow temporal control of Cre activity (CreER). The ER domain used here is mutated and
instead binding endogenous estrogen, only 4-hydroxytamoxifen (4-OHT) can be bound.
4-OHT is the active metabolite of the synthetic steroid tamoxifen that strongly binds
to CreERT2. The CreERT2 fusion protein is knocked-in in the Id2 allele and will be
produced whenever the Id2 gene is transcribed. The CreERT2 protein is located in the
cytoplasm and translocates into the nucleus upon binding to 4-OHT, where it executes
its recombinase activity. Activated CreERT2 can then excises the loxP sites on specific
loci.
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Figure 1.10. Schematic representation of the Id2-CreERT2+ lineage tracer mouse
model.
This lineage tracer is based on the Cre-lox technology. Cre recombinase is knocked-in in the Id2
allele and will be produced whenever the Id2 gene is transcribed. The CreERT2 fusion protein
contains the hormone-binding domain of a mutated estrogen receptor (ERT2). The CreERT2
protein is cytoplasmic and translocates into the nucleus upon activation by 4-hydroxytamoxifen
(4-OHT). 4-OHT is the active metabolite of the synthetic steroid tamoxifen. Activated CreERT2
excises the loxP sites in the Rosa26 locus and removes the STOP cassette and membrane-targeted
(farnesylated) eGFP-f is expressed. This leads to eGFP expression in Id2 dependent cells (Rawlins
et al., 2009).
(2) The loxP sites in this mouse model are introduced into the Rosa26 locus and flanking
a STOP codon. The Rosa26 locus is constantly and ubiquitously expressed in all cells.
After CreERT2 has recombined the loxP sites in the locus, a STOP cassette is removed
and the inserted membrane-targeted (farnesylated) eGFP-f is expressed from the CAG
promoter.
Mice, expressing both mutated alleles, serve as a tracer for Id2 expression in all cell types,
when treated with tamoxifen (in vivo) or 4-OHT (in vitro). However, to trace Id2 expression,
both events mentioned above, need to be fulfilled for GFP expression. CreERT2 has to be
present in the cytoplasm and 4-OHT has to activate its translocation to the nucleus to
excise loxP sites on the Rosa26 locus.
However, the recombination rates between each pair of loxP sites vary and are sensitive to
the levels of CreERT2 expression (Rawlins and Perl, 2012). Further, the duration CreERT2
spending in the nucleus depends on the concentration of active 4-OHT and the frequency
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of tamoxifen application. Nevertheless, tamoxifen or the active state, 4-OHT, can be toxic
to the cells in high doses and also the Cre toxicity can cause problems. The Cre toxicity is
caused by off-target effects of the Cre recombinase, which is due to endogenous cryptic
loxP sites that cause cytotoxic chromosomal rearrangements when activated. Therefore,
the dosing strategy of tamoxifen (in vivo) or 4-OHT (in vitro) has to be adjusted for each
CreERT2 mouse strain (Rawlins and Perl, 2012).
1.8 Aims and Objectives
The important role of Id2 for development of LC and CD8α+ cDC has been previously
shown in Id2–/– mice that lack these cell types in adult mice (Hacker et al., 2003). However,
its special role and molecular mechanism of action in the development of DC subsets is so
far not assessed.
Therefore, the aim of this study is to understand when Id2 is expressed during embryonic
and adult LC development and other haematopoietic subsets and how Id2 affects their
development maybe in concert with other factors. To this end, different knock-out models
are used as well as a lineage tracer mouse model to study transcription factor dependency
in DC subsets. The Id2-CreERT2+ lineage tracer mouse model allows to GFP-label Id2
expressing cells and to follow their fate during their ontogeny.
LC precursors have to migrate to the skin epidermis where they have to anchor to the
surrounding keratinocytes. So it can be speculated that the first wave on LC development
is associated with MET. Id2 is known to inhibit the repressive function of E proteins on
adhesion molecules, such as E-cadherin. Therefore, this work aims at investigating the
inhibitory function of E protein on LC homing and maintenance in target tissue. A further
aim is to show the importance of Id2 for the anchoring process and following MET of
LC and tissue resident CD8α+ cDC in their niche. In this context the study investigates
the deletion of the mesenchymal marker Zeb2 in DC subsets, to show that it exhibit
opposite effects on DC development compared to Id2–/– mice. Due to its importance for
DC development, Zeb2 might play a role also during LC development, not only as a factor
that is important for commitment but also important for EMT.
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These objectives are investigated by isolating single cells from the different mouse strains
to perform flow cytometry analysis as well as cell sorting to be further analysed for their
gene expression profile. To assess LC also in tissue context immunofluorescence approaches
are used. Taken together, this manuscript aims to show the stable anchorage of tissue-
resident DC in their niche to be dependent on Id2 through inhibition of E47-mediated
Zeb2 expression.
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2.1 Materials
All centrifugation steps were performed with a benchtop centrifuge from Heraeus Multifuge
3 L-R or Eppendorf centrifuge 5415D.
2.1.1 Kits
The following kits were used:
• High Capacity cDNA Transcription Kit (Life Technologies, Darmstadt, Germany)
• NucleoSpin RNA II Kit (Macherey & Nagel, Düren, Germany)
• MagMAX-96 Total RNA Isolation Kit (Thermo Fisher Scientific, Massachusetts,
USA)
2.1.2 Chemicals
All chemicals were purchased in analytical grade from Sigma-Aldrich (St Louis, USA), Merck
(Darmstadt, Germany), Thermo Fisher Scientific or AppliChem (Darmstadt, Germany) if
not stated otherwise.
2.1.3 Buffers and Solutions
Phosphate Buffered Saline (PBS) pH 7.4: 137 mM NaCl
2.7 mM KCl
1.78 mM Na2HPO4 x 2H2O
FACS buffer: PBS
5 mM EDTA
1% FCS
Sorting buffer: PBS
5 mM EDTA
0.5% FCS
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Post-Sort Solution (pH 7.2), for 50 ml: 44 ml H2O
5 ml 10x HBSS
0.5 ml Gentamycin
250 µl sodium bicarbonate pH7
0.5% FCS
Blocking Solution: PBS
1 mM MgCl2
0.1 mM CaCl2
0.1% TritonX-100
3% FCS
optional 2% mouse serum
Cytoskeleton buffer, pH 7.0: H2O
10 mM PIPES
150 mM NaCl
5 mM EGTA
5 mM MgCl2
5 mM glucose
4% (w/v) PFA, for 100 mL: heat 80 mL of cytoskeleton buffer to 60°C
add 4 g of PFA and mix for 30 min
add drops of 10 N NaOH (to clear solution)
cool to room temperature (RT)
adjust pH to 7.0 and bring volume to 100 mL
filter and store in aliquots at –20°C.
Red blood cell lysis buffer (pH 7.0): 155 mM NH4Cl
10 mM KHCO4
0.1 mM EDTA
10x HBSS and RPMI 1640 were from Gibco®(Thermo Fisher Scientific, catalogue
numbers 14180-046 and 31870-074, respectively). Minimal Essential Medium α (α–
MEM) were purchased from PAN-Biotech, Aidenbach, Germany, catalogue number P04-
21150.
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2.2.1 Mice
Id2-CreERT2+ : Rosa26R-eGFPf mice, short Id2-CreERT2+ mice, on C57BL/6 background
(Rawlins et al., 2009), Id2–/– : 129/svJ mice (Yokota et al., 1999), VavCre+ : E2Af mice,
on C57BL/6 background (Kwon et al., 2008), Id2–/– : E47–/– mice, on mixed C57BL/6 x
129/svJ background (Bain et al., 1994, Boos et al., 2007), Id2–/– : Msc–/– mice, on mixed
C57BL/6 x 129/svJ background (Lu et al., 2002) and C57BL/6 (wild-type) mice were bred
and maintained under specific pathogen-free conditions at the central animal facility of the
RWTH Aachen University Hospital, Aachen, Germany.
The genotype of mice was confirmed by DNA isolation and PCR of the respective genes
(section A.1).
Gfi1–/– and Gfi1KD/KD mice were kindly provided from colleagues in Essen (Cyrus
Khandanpour, MD, Department of Hematology, Essen University Hospital, Essen, Ger-
many).
Mx1-Cre+ : Zeb2f mice on mixed C57BL/6 x CD1 background (short Zeb2–/–) received
3 injections of 200 µg polyinosinic/polycytidylic acid (pI:pC) i.p. at 2-day intervals to
induce deletion of Zeb2. Zeb2–/– mice were kindly provided by Viktor Janzen, MD, De-
partment of Hematology/Oncology, Bonn University Hospital, Bonn, Germany (Riedt,
2014).
2.2.2 Animal Experiments
Adult mice were used for experiments between 6 -14 weeks of age. Day of birth was
counted as day 0 and newborn mice were treated or analysed at the indicated time points.
All animal experiments were approved by local authorities (Bezirksregierung Köln) in
compliance with the German animal protection law (reference numbers 11368A4 and
84-02.04.2012.A256).
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2.2.2.1 In vivo Tamoxifen Treatment
Tamoxifen, tmx, (Sigma-Aldrich, catalogue number T5648) was dissolved with 10% ethanol
in mazola corn oil to achieve a concentration of 20 mg/ml (Rawlins et al., 2009). The
solution was filtered through 0.2 µm pore filter and aliquots were stored at -20°C for up
to 3 month for further use. Id2-CreERT2+ males were mated with C57BL/6 females and
pregnant mice received a single intraperitoneal injection of 0.1 mg tmx per gram body
weight. Plug positive females are referred to as E0.5. Neonates received a single injection
of tmx into nuchal fold. Day of birth is referred to as day P0. Injection regimen depended
on age: from P0 – P6, 0.2 mg/pup (10 µl) and at P7, 0.8 mg/pup (40 µl). Id2-CreERT2+
mice, 8-14 weeks of age, received 1, 2 or 4 injections every second day of 0.25 mg tmx per
gram body weight. Id2-CreERT2– : Rosa26R-eGFPf adult mice (short Id2-CreERT2– mice)
were used as controls.
2.2.3 Isolation of Mouse Primary Haematopoietic Cells
Mice were sacrificed by cervical dislocation and different organs were obtained for the
isolation of haematopoietic cells. Cell numbers were determined with an electronic cell
counter device (CASY, Roche Innovatis, Reutlingen, Germany).
2.2.3.1 Bone Marrow Cells
Single cell suspensions from femur and tibia were obtained for the isolation and cultivation
by rinsing bones with a 23 gauge needle with RPMI 1640 medium or FACS buffer. The cell
solution was homogenised by flushing the medium several times through the syringe and
let stand for 5 min for sedimentation of any remaining clumps and debris. The supernatant
was transferred into a new tube. Cell number was determined for further processing by an
electronic cell counter device (CASY, Roche Innovatis).
2.2.3.2 Splenocytes
Splenocytes were obtained by cutting the spleen into small pieces and the tissue was
squeezed through a 40 µm cell strainer (BD Biosciences, Franklin Lakes, USA) with the
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help of a plunger of a syringe. Cell strainer was washed with FACS buffer to flush remaining
single cells into the tube. The total cell number was determined using an electronic cell
counter device (CASY, Roche Innovatis).
2.2.3.3 Lymph Node Cells
Inguinal, axillary and brachial lymph nodes were obtained according to anatomical location.
Lymph nodes were cut into small pieces and squeezed with the help of a plunger of a
syringe through a 40 µm cell strainer (BD Biosciences). Remaining cells on top of cell
strainer were flushed with FACS buffer into the tube. The total cell number was determined
by an electronic cell counter device (CASY, Roche Innovatis).
2.2.3.4 Epidermal and Dermal Cells of Newborn and Adult Skin
Newborn mice from one litter were analysed together at one time point. Epidermal sheets
of newborn skin were prepared as previously described (Chorro et al., 2009). Briefly, ventral
skin of mice between P3 to P10 (ears are at these time points very small and do not
provide enough material for analysis) was dissected and cut into pieces of two cm x two cm
size and incubated in PBS/0.02 M EDTA (Invitrogen, Thermo Fisher Scientific). Ears of
newborns (P14 – P26) and adult mice were obtained by dissection, hair was mechanically
removed by employing hair depilation creme (5 min) and scratching. Ears were washed
with PBS and separated with forceps into dorsal and ventral sheets. Sheets were incubated
in PBS/0.02 M EDTA for 1.5 hours at 37°C. The separation of epidermis and dermis was
done under a binocular with thin tweezers. Dorsal epidermis was used for immunostaining.
Ventral epidermis and dermis were digested with 2 mg/ml Collagenase D (100 mg/ml stock
solution in HBSS frozen at -20°C, from Clostridium hystolyticum, Sigma-Aldrich) in RPMI
1640 medium for 45 min at 37°C and used for flow cytometry. Single cell suspensions were
obtained by passing 10-15 times through a 23 G needle and filtration over a cell strainer
(40 µm, BD Biosciences) to remove cell clumps.
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Table 2.1. Cytokines and growth factors for cell culture.
Supplement Stock Final Supplier
concentration concentration
SCF, murine 3000 U/ml 30 U/ml produced by stably
transfected CHO KLS C6 cells
hyper-IL-6 25 µg/µl 25 ng/µl kindly gift from
Dr. S. Rose-John, University Kiel
(Fischer et al., 1997)
Flt3L, human 25 µg/ul 25 ng/µl PeproTech (Hamburg, Germany)
(DC progenitors)
Flt3L, human 25 µg/µl 50 ng/µl PeproTech
(one-step DC)
IGF-1, 40 µg/µl 40 ng/µl Sigma-Aldrich
long range, human
2.2.4 Cell Culture
Cells were incubated at 37°C with a CO2 level of 5% in a humidified incubator (Hera Cell
240 Incubator, Thermo Fisher Scientific). Cell numbers were determined with an electronic
cell counter device (CASY, Roche Innovatis).
2.2.4.1 DC Growth Medium
RPMI 1640 medium was supplemented with 10% heat-inactivated fetal calf serum (FCS,
inactivation for 30 min at 56°C, lot 41Q1307K), 2 mM L-glutamine, 100 U/ml peni-
cillin/streptomycin and 50 µM beta-mercaptoethanol (all purchased from Gibco®, Thermo
Fisher Scientific) and is called further DC growth medium. For culture of bone marrow
cells, cytokines and growth factors were added as listed in Table 2.1.
2.2.4.2 Culture of DC Progenitors
For culture of bone marrow cells to DC precursors, cells were generated according to
the protocol developed by Piritta Felker (Felker et al., 2010). The bone marrow cells
were prepared as described above (section 2.2.3.1). Cells were centrifuged at 1400 rpm
for 4 min. Cell concentration was adjusted to 2x106 cells/ml in DC growth medium and
supplemented with SCF, hyper-IL-6, Flt3L and IGF-1 (Table 2.1). After three days of
culture, density gradient centrifugation using Ficoll-Hypaque (LSM 1.077 g/ml, PAA
Laboratories, Pasching, Austria) was used to remove dead cells and debris. For this, cells
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were centrifuged for 4 min at 1400 rpm and resuspended in 20 ml of DC growth medium
and carefully overlaid on 15 ml Ficoll. After centrifugation at 2000 rpm for 16 min at
brake setting slow (Heraeus Multifuge 3L, Thermo Fisher Scientific), the middle layer
containing progenitor cells, was taken off with a plastic Pastuer pipette. Progenitor cells
were washed with DC medium and adjusted to a cell density of 1.5x106 cells/ml. Medium
and cytokines were refreshed every second day to keep cells at a density of 1.5x106 cells/ml.
At day 7 of culture DC progenitor cells, MPP and CDP, were harvested and used for
analysis.
2.2.4.3 One-Step Amplification of DC Subsets
DC subsets were generated in vitro by a one-step culture system as previously described by
Naik et al., 2005. Briefly, bone marrow were isolated as described in section 2.2.3.1. Cells
were applied to red blood cell lysis by quickly adding water to the cells and directly fill
up with DC growth medium. After two washing steps with PBS, cells were cultured in a
6-well plate at a concentration of 1x106 cells/ml by adding 50 ng/ml Flt3L (Table 2.1).
Medium change is performed partially at day 5 and 8. DC subsets can be analysed at day
10 of differentiation.
2.2.4.4 TGF-β1 Treatment
Cultured DC progenitors at day 5 or cultured one-step DC subsets at day 9 were treated
with TGF-β1 (R & D Systems, Wiesbaden-Nordenstadt, Germany) for 24 hours prior to
analysis by adding a total concentration of 5 ng/ml or 10 ng/ml, respectively, to the culture
medium. Cells were harvested for final analysis.
2.2.4.5 OP9 Co-Culture
Mitotically inactivated OP9 cells were kindly provided by Stephanie Sontag, M.Sc., Institute
for Biomedical Engineering, Department of Cell Biology, RWTH Aachen University, Aachen,
Germany. Briefly, murine bone marrow derived OP9 cells were pre-cultured with OP9 cell
medium containing α–MEM supplemented with 20% FCS , 100 U/ml Penicillin/Strepto-
mycin and 1 mM L-Glutamine. OP9 stromal cells were harvested and irradiated with 30 Gy
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(Transfusion Medicine, RWTH Aachen University Hospital, Aachen, Germany). Inactivated
OP9 cells were frozen in 90% FCS and 10% DMSO at a density of 2x106 cells/ml and
cryopreserved.
Inactivated 1.2 x 106 OP9 stromal cells were thawed and transferred to OP9 cell medium
1 day prior to usage. Cells were recovered by centrifugation and plated in wells of a 6
well plate with OP9 medium in a density to achieve 12000 cells/cm2. Plates were gently
moved to distribute the cells evenly. The next day, medium was taken off and stromal cells
were washed with PBS. Then bone marrow-derived DC were added to the cells in DC
medium.
2.2.4.6 In vitro Tamoxifen Treatment
The active form of tamoxifen, 4-OHT (Sigma-Aldrich, catalogue number H7904), was
dissolved in ethanol (1 mM) and stored in aliquots at -20°C. 4-OHT was used at a
concentration of 1 µM and added during culture of Id2-CreERT+ bone marrow cells
after Ficoll treatment at day 3. 4-OHT was refreshed during culture after each medium
change.
2.2.5 Flow Cytometry
Flow cytometry was performed as described before (Felker et al., 2010). Single cell sus-
pensions of spleen, bone marrow, lymph nodes, dermis and epidermis were incubated with
combinations of monoclonal antibodies listed in Table 2.2 in FACS buffer according to
cell subsets listed in Table C.1 for 30 min at 4°C. Unbound antibodies were removed by
washing cells with 4 ml FACS buffer and centrifugation by 1400 rpm for 4 min. In the case
of not directly labelled primary antibodies, a labelled Streptavidin was diluted in FACS
buffer 1:400 and added to the cells for further 30 min at 4°C (see Table 2.3). After staining,
cells were washed once with 4 ml FACS buffer and resuspended in 200 µl FACS buffer.
Corresponding isotype controls were obtained from eBioscience. For intracellular staining
with langerin, cells were stained first with extracellular antibodies as described above,
cells were fixed with 4% PFA (paraformaldehyde) for 15 min, washed twice with PBS
and permeabilised in Blocking Solution for 30 min at 4°C. Cells were taken up in FACS
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buffer and flow cytometry was performed using the FACSCantoTM II (BD Biosiences,
Franklin Lakes, USA) and data were analysed with FlowJoTM software (Tree Star, Ashland,
USA).
2.2.5.1 Apoptosis Assay
Apoptosis was assessed using the FITC Annexin V detection kit in combination with PI
from BD Biosciences. Procedure was performed according to manufactures’ protocol. Short,
after flow cytometry staining for other markers, cells were washed twice with PBS. Cells
were taken up in 100 µl 1x Annexin binding buffer. Then 5 µl FITC Annexing V and 5
µl PI were added. Solution was gently vortexed and incubated for 15 min at RT in the
dark. 100 µl 1x Annexin binding buffer was added and analysed by flow cytometry within
1 hour.
2.2.6 Cell Sorting
For cell sorting, single cell suspensions were stained with specific antibodies (listed in Table
2.2) as described above. Briefly, cell suspensions were passed through a 40 µm cell strainer,
reacted with antibodies and sorted. Either cultured progenitor cells, one step DC subsets,
ex vivo LC or splenic DC subsets were sorted. Epidermal cells were directly sorted into 100
µl lysis buffer in 1.5 ml Eppendorf tubes for RNA isolation.
Splenic single cell suspensions were applied to red blood cell lysis by using red blood
cell lysis buffer for 5 min at RT. After two washing steps with sorting buffer pellet was
dissolved in a concentration of 109 cells/1.5 ml sorting buffer and depleted for CD3+ and
CD19+ cells by immunomagnetic bead selection (LS columns, Miltenyi Biotec, Bergisch
Gladbach, Germany). Briefly, anti-CD3-biotin and anti-CD19-biotin antibodies (both
1/100) were added to the cell suspension and incubated for 30 min at 4°C. Cells were
again taken up in the same concentration in sorting buffer and anti-biotin microbeads
(200 µl beads/1.5 ml sorting buffer, Miltenyi Biotec) were added for 30 min at 4°C.
Immunomagnetic bead selection was performed using QuadroMACS Separator (Miltenyi
Biotec) and depleted cells were stained with specific antibodies (Table 2.2). Sorting was
done into FACS tubes containing 3 ml post-sort solution. Before, FACS tubes were coated
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Table 2.2. Antibodies used for flow cytometry analysis.
Antigen Alternative Name Fluorochrome Clone Company
B220 CD45R APC RA3-6B2 eBioscience
B220 CD45R Biotin RA3-6B2 Invitrogen
B220 CD45R PE-Cy5.5 RA3-6B2 eBioscience
CD3 APC 145-2C11 eBioscience
CD3 Biotin 145-2C11 eBioscience
CD3 PE 145-2C11 eBioscience
CD4 APC GK1.5 Miltenyi
CD4 PE GK1.5 eBioscience
CD8 Ly-2 Biotin 53-6.7 eBioscience
CD8 Ly-2 PE-Cy7 53-6.7 eBioscience
CD11b Mac-1 APC M1/70 eBioscience
CD11b Mac-1 Biotin M1/70 eBioscience
CD11b Mac-1 FITC M1/70 eBioscience
CD11b Mac-1 eFluor450 M1/70 eBioscience
CD11c Intergrin-α Biotin N418 eBioscience
CD11c Intergrin-α FITC N418 eBioscience
CD11c Intergrin-α PE N418 eBioscience
CD11c Intergrin-α PE-Cy7 N418 eBioscience
CD16 FITC 93 eBioscience
CD16 PE-Cy5.5 93 eBiocscience
CD19 B4 Biotin 1D3 eBioscience
CD19 B4 PE-Cy5.5 1D3 eBioscience
CD19 B4 eFluor450 1D3 eBioscience
CD34 AlexaFluor647 RAM34 BD Biosciences
CD34 PE MEC14.7 Invitrogen
CD45 APC-Cy7 30-F11 eBioscience
CD62L L-selectin eFluor450 MEL-14 eBioscience
CD103 PE 2 E7 eBioscience
CD115 M-CSF receptor APC AFS98 eBioscience
CD115 M-CSF receptor PE AFS98 eBioscience
CD117 c-kit PE-Cy7 ACK2 eBioscience
CD122 PerCPeFluor710 TM-beta1 eBioscience
CD127 Sirp/α AlexaFluor647 A7R34 eBioscience
CD135 Flt3 PE A2F10 eBioscience
CD172a Sirpα APC P84 BD Biosciences
CD326 EpCAM eFluor450 G8.8 eBioscience
E-cadherin PE 114420 R&D Systems
EpCAM eFluor450 G8.8 eBioscience
Gr1 Biotin RB6-8C5 BD Biosciences
Gr1 PerCP-Cy5.5 RB6-8C5 BD Biosciences
Langerin CD207 AlexaFluor488 929F3.1/DDX0362 Dendritics
Langerin CD207 FITC caa8-28H10 Miltenyi
Langerin CD207 APC 4C7 BioLegend
MHC-II Biotin M5/114.15.2 eBioscience
MHC-II PerCP-Cy5.5 M5/114.15.2 eBioscience
NK1.1 Biotin PK136 eBioscience
PDCA-1 PE eBio927 eBioscience
Sca-1 Ly6AE APC D7 Miltenyi
SiglecH AlexaFluor647 eBio440c eBioscience
Ter119 Biotin TER119 BD Biosciences
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Table 2.3. Streptavidin fluorochrome conjugates used for detection of biotinylated
primary antibodies for flow cytometry analysis.
Antigen Fluorochrome Company
Streptavidin APC Invitrogen
Streptavidin eFluor450 eBioscience
Streptavidin FITC eBioscience
Streptavidin PE eBioscience
Streptavidin PE-Cy7 eBioscience
Streptavidin PerCP-Cy5.5 BD Biosciences
with 3.5 ml sorting buffer on a rotator for 1 hour at 4°C and the solution was discarded
afterwards.
Cultured DC progenitor cells and DC subsets were harvested, washed with PBS and either
deprived of Flt3L for 1.5 hours (DC progenitors) or directly stained (DC subset). 150x106
cells/ml were taken up in sorting buffer and stained with 5 µl/ml antibody mix for 30 min
at 4°C. Cells were washed with sorting buffer and taken up in a concentration of 100x106
cells/ml and filtered through a 40 µm cell strainer. CDP were sorted by surface marker ex-
pression as CD11c-Gr1-Flt3+c-kitint. Sorting was done in 15 ml Falcon tubes. Subsequently,
cells were counted and cultured at a concentration of 1.5x106 cells/ml for further treatment.
One step DC were sorted for CD8α+ cDC (CD11c+CD11b+B220-CD24+Sirpα-), CD11b+
cDC (CD11c+CD11b+B220-CD24-Sirpα+) and pDC (CD11c+CD11b-B220+). Sorting was
done into 15 ml collection tubes. First, collection tubes were coated with 3 ml sorting
buffer for 1 hour at 4°C on a rotator. After coating sorting buffer was discared and 1.5 ml
post-sort solution was added.
Cell sorting was performed with FACSAria I instrument (BD Biosciences) using a 70 µm
nozzle, except for DC cultured with OP9 cells, a 85 µm nozzle was used. The systems was
adjusted for sorting for purity and the collection tube holder was electronically cooled
during sorting at 4°C.
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2.2.7 Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR)
RNA was isolated with MagMAX-96 for Microarrays Kit (Ambion, Life Technologies) or
using NucleoSpin RNAII Kit (Macherey & Nagel) according to manufacture’s protocol
and reverse transcribed to cDNA using High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems). cDNA from 145 LC and 200 splenic cells or 5 - 50 ng cDNA were
applied for quantitative PCR reaction with SYBR green (Fast SYBR Green Master Mix,
Applied Biosystems) using a StepOnePlus Real Time PCR system (Applied Biosystems,
Thermo Fisher Scientific) with the standard program (Tabel 2.4). Primer sequences are
listed in Table 2.5.
Table 2.4. Thermal cycling conditions for qRT-PCR.
Stage Cycle Temperature Duration
Holding 1x 95°C 20 sec
Cycling 40x 95°C 3 sec40x 60°C 60 sec
Melt Curve
1x 95°C 15 min
1x 60°C 60 sec
1x 95°C 15 min
Data were analysed with the StepOne Software v2.1 (Life Technologies) using the corre-
sponding cycle threshold (Ct) values of Glyceraldehyde 3-phosphate dehydrogenase (Gapdh)
for normalisation. Relative expression values are either represented in bar diagrams or in
heatmap format. Heatmap generation and hierarchical cluster analysis was performed with
MeV software v4.9.
Table 2.5. Sequences of primers for qRT-PCR.
Gene Primer Sequence (5’ → 3’) Reference
Gapdh
GAPDH-fw ACCTGCCAAGTATGATGACATCA
Tagoh et al., 2004
GAPDH-rv GGTCCTCAGTGTAGCCCAAGAT
Id2
mID2_for1_q AAAACAGCCTGTCGGACCAC
Saika et al., 2006
mID2_rev1_q CTGGGCACCAGTTCCTTGAG
Tcf3
m_Tcf3_tQ_F2 TGCCTTATCCCCCAACTACGA Kwon et al., 2008
m_Tcf3_tQ_R2 AAAAGCCCATGGAGATCGCT own design
Cd207
Langerin-FWD ATGTTGAAAGGTCGTGTGGAC
Seré et al., 2012
Langerin-REV GGTGGTGTTCACTATCTGCATCT
Cldn1
mCldn1_tQ_F ATTTCAGGTCTGGCGACATT
own design
mCldn1_tQ_R GCCTGGCCAAATTCATACCT
Cdh1
mCdh1-tQ-F TGACGCAGCTCAAGAATCTC
own design
mCdh1-tQ-R TTGTTCTGGTTATCCGCGAG
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Table 2.5. Sequences of primers for qRT-PCR. continued
Gene Primer Sequence (5’ → 3’) Reference
Axl
mAxl-tQ-F TGAGCCAACCGTGGAAAGAG
Bauer et al., 2012
mAxl-tQ-R AGGCCACCTTATGCCGATCTA
Jam1
mF11r_tQ_F1 AAGTCGGGGGATCTGATCTT
own design
mF11r_tQ_R1 TCATGGCTGTCCCATATCCA
Ctnnb1
mCtnnb1_tQ_F1 GTTCGCCTTCATTATGGACTGCC
Chopin et al., 2013
mCtnnb1_tQ_R1 ATAGCACCCTGTTCCCGCAAAG
Zeb1
mZeb1_tQ_F1 AGGTGACTCGAGCATTTAGAC
own design
mZeb1_tQ_R1 ATAATTTGTAACGTTATTGCGCC
Zeb2
mZeb2_tQ_F1 GGGACAGATCAGCACCAAAT
own design
mZeb2_tQ_R1 GCACTTGAACTTGCGGTTAC
Snail1
mSnai1_tQ_F1 GCGTGTGTGGAGTTCACCTTC
Smith et al., 2009
mSnai1_tQ_R1 GGTTGAGGACCTCGGGC
Snail2
mSnai2_tQ_F1 TGCAAGATCTGTGGCAAGG
Cousins et al., 2014
mSnai2_tQ_R1 CAGTGAGGGCAAGAGAAAGG
Rap1gap
mRap1gap-F1 CTCGCTCAAGTATGATGTCATCG
Niola et al., 2012
mRap1gap-R1 GGTAAAGCACGGGGTAGAATC
Rap1gap2
mRap1gap2-tQ-F2 GAGACAGCCGGACACGAT
own design
mRap1gap2-tQ-R2 TGAAGGGCTTCTCTTTGTTGG
Bax
Bax_tQ_F1 CAGGATGCGTCCACCAAGAA
Wang et al., 2015
Bax_tQ_R1 GTTGAAGTTGCCATCAGCAAACA
Bcl2
Bcl-2_tQ_F1 TGAAGCGGTCCGGTGGATA
Wang et al., 2015
Bcl-2_tQ_R1 TTCAGTCCAGCATTTGCAGAAGTC
Tjp3
mZO-3_tQ_F1 TGCACCAAAACAGCCAACG
Qiao et al., 2014
mZO-3_tQ_R1 CTCACCCCATGATCGACCT
Krt8
mCk8_tQ_F1 CCATGAAGAGGAGATCCGTG
own design
mCk8_tQ_R1 CGATTGGCAATGTCCTCGTA
Krt18
mCk18_tQ_F1 AGATGACACCAACATCACAAGG
Cousins et al., 2014
mCk18_tQ_R1 TCCAGACCTTGGACTTCCTC
Id3
mID3_for1_q AGCTTAGCCAGGTGGAAATCCT
Saika et al., 2006
mID3_rev1_q TCAGCTGTCTGGATCGGGAG
Itgae
mItgae-tQ-F CAAAGACTCAGGACCACACT
own design
mItgae-tQ-R GTGATAGCACAGACCACTGAA
Il2rb
IL2Rb_tQ_F1 CCTTTGACAACCTTCGCCT
own design
IL2Rb_tQ_R1 TACGGGCCTCAAATTCCAAG
Ahr
Ahr_tQ_F1 TGCACAAGGAGTGGACGA
Villard et al., 2007
Ahr_tQ_R1 AGGAAGCTGGTCTGGGGTA
Csf1r
mCsf1r_tQ_F1 GCAGTACCACCATCCACTTGTA
Mizuno et al., 2011
mCsf1r_tQ_R1 GTGAGACACTGTCCTTCAGTGC
Runx3
mRunx3-tQ-F CAGGTTCAACGACCTTCGATT
Chopin et al., 2013
mRunx3-tQ-R GTGGTAGGTAGCCACTTGGG
Sfpi1
PU.1_F GGAGAAGCTGATGGCTTGG
Weigelt et al., 2007
PU.1_R CAGGCGAATCTTTTTCTTGC
Spib
mSpib_for1_q CTTCCAGTTCTCCTCCAAGCACAAG
Lazorchak et al., 2006
mSpib_rev1_q TGGTAGGTGAGTTTGCGTTTGACC
Batf3
Batf3_tQ_F2 TCCACGAGGAGCACGAGAGC
own design
Batf3_tQ_R2 TTCATAGGACACAGCAGCAGCG
Irf4
mIrf4_for1_q GGCTTCACAATCTTCAAGGTGGAC
Lazorchak et al., 2006
mIrf4_rev1_q CACACTTTCCTGTCGGGCTTAGAC
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Table 2.5. Sequences of primers for qRT-PCR. continued
Gene Primer Sequence (5’ → 3’) Reference
Mmp9
Mmp9_tQ_F1 CCTGGAACTCACACGACATCTTC
Chen et al., 2005
Mmp9_tQ_R1 TGGAAACTCACACGCCAGAA
2.2.8 Immunohistochemistry
Epidermal sheets (as described in section 2.2.3.4) were straighten with hairs pointing
upwards on a glass slide and were surrounded by a border with a liquid blocker PAP pen,
which retains 200 µl solution for following staining and washing steps. Epidermal sheets
were fixed with 4% PFA for 15 min, washed with PBS and stained with anti-langerin and
anti-MHC-II antibodies in PBS over night or at least 5 hours at 4°C. For intracellular
staining epidermal sheets were fixed with 4% PFA as above, incubated with Blocking
Solution for 30 min and stained with anti-langerin, anti-CD3, anti-MHC-II or anti-eGFP
antibodies overnight at 4°C in Blocking Solution. Antibodies are listed in Table 2.6. For
secondary staining a goat anti-rabbit or goat anti-rat antibody was added in Blocking
Solution for 60 min after washing with PBS (Table 2.6). Epidermal sheets were washed
three times in PBS, stained with DAPI for 1 min (2 mg/ml stock solution is stored at -20°C;
1:1000 working stock solution is stored at 4°C and used 1:32 [0.0625 µg/µl] on epidermal
sheets, Vector Laboratories, Burlingame, CA, USA) and slides were mounted in ProLong
Gold mounting media (Molecular Probes, Thermo Fisher Scientific).
Table 2.6. Antibodies used for immunohistochemistry.
Antigen Fluorochrome Clone Dilution Company
Langerin AlexaFluor488 RMUL.2 1:150 eBioscience
Langerin AlexaFluor647 CCX0362 1:150 Dendritics
Langerin APC 4C7 1:200 BioLegend
Langerin FITC caa8-28H10 1:40 Miltenyi
MHC-II AlexaFluor488 M5/114.15.2 1:2000 BioLegend
MHC-II AlexaFluor647 M5/114.15.2 1:2000 BioLegend
MHC-II pure M5/114.15.2 1:2000 BioLegend
CD3 APC 145-2C11 1:200 eBioscience
CD3 pure 145-2C11 1:200 eBioscience
eGFP pure ab290 1:1000 abcam
goat anti-rabbit AlexaFluor488 1:500 Invitrogen
goat anti-rat AlexaFluor594 1:500 Invitrogen
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2.2.9 Imaging
Images used to determine LC density and morphology were assessed using a fluorescence
microscope (Axioplan 2, Zeiss) and a camera (Visitron Systems) operated with VisiView
Imaging software (version 2.0.3, Visitron Systems). Image processing was done with Image
J software (version 1.46r; Wayne Rasband, National Institute of Health, USA). LC numbers
per mm2 were calculated from microscopic fields.
2.2.10 Statistics
For statistical analysis a Student’s t-test (unpaired, two-tailed) was performed. P values
above 0.05 were considered to be not significant (ns), p values from 0.01 - 0.05 (∗), p values
from 0.001 - 0.01 (∗∗), p values below 0.001 (∗ ∗ ∗) and p values below 0.0001 (∗ ∗ ∗∗).
Outliers were determined with Grubbs’ test using online tool of graph pad software and
excluded for further analysis (Figure 3.6C and D at P5).
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3 Results
3.1 Lineage Tracing of Id2 Expressing Haematopoietic Cells
Recently, a mouse model was generated to lineage trace Id2-expressing cells in lung (Rawlins
et al., 2009; section 1.7.2.1). In these mice, a CreERT2 cassette is knocked-in into the Id2
locus. As lineage reporter, an eGFP cassette preceded by a loxP-flanked stop codon is
inserted into the Rosa26 locus. Administration of tmx to Id2-CreERT2+ : Rosa26R-eGFPf
mice (short Id2-CreERT2+ mice) induces excision of the stop codon in the Rosa26 locus
in Id2 expressing cells and leads to constitutive expression of eGFP (Figure 1.10). In this
study the system is used to trace Id2-expressing cells in DC lineage.
3.1.1 Tamoxifen Dose Does Not Affect Excision Rate
The manipulation of genes using the in vivo Cre-lox technology in combination with the
mutated estrogen receptor type 2 (ERT2 ), is dependent on the amount and frequency of
tmx administration but can be toxic in higher dosages (Rawlins and Perl, 2012). To verify
this in our system adult Id2-CreERT2+ and Id2-CreERT2– : Rosa26R-eGFPf control mice
(short Id2-CreERT2– mice) received once, twice or four times intraperitoneal tmx injection
every second day and were analysed 6 or 7 days after the last injection to find the optimal
conditions to lineage trace Id2 dependent DC (Figure 3.1A).
The Id2-eGFP expression was determined in skin epidermis by flow cytometric analysis for
LC and DETC of tmx treated Id2-CreERT2+ and Id2-CreERT2– mice. An example for
the gating strategy is shown in Figure 3.1B. Highest recombination rates were obtained
by an average of 25% of Id2-eGFP positive cells in LC and DETC (Figure 3.1C and
D). However, no significant differences were observed with repeated tmx administrations.
Furthermore, no eGFP+ cells were found in tmx-treated Id2-CreERT2– mice, indicating
that induction of eGFP expression is dependent on tmx-mediated Cre recombinase activity
(Figure 3.1B).
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Figure 3.1. Lineage tracing of Id2 dependent haematopoietic cells.
Adult Id2-CreERT2+ mice received either four, two or a single dose of tamoxifen. Analysis of
mice were performed 6 or 7 days after the last injection. (A) Schematic representation of the
experiment layout. (B) Gating strategy for LC (CD45+MHC-II+CD3-CD11c+EpCAM+) and
DETC (CD45+MHC-II-CD3+) from epidermal single cell suspensions from Id2-CreERT2+ mice
or Id2-CreERT2– mice that were treated with tamoxifen. For full gating strategy see Supplement
Figure B.2. (C and D) Percentage of labelled Id2-eGFP+ (C) LC and (D) DETC determined by flow
cytometry. 4x tmx, N=4; 2x tmx, N=2; 1x tmx, N=3. (E) Splenic cell subsets from Id2-CreERT2+
and Id2-CreERT2– mice treated with tamoxifen. For gating strategy see Supplement Figure B.3
and Supplement Figure B.4. (F) Percentage of Id2-eGFP+ splenic cell subsets determined of
Id2-CreERT2+ mice by flow cytometry analysis. For gating strategy see Supplement Figure B.3
and Supplement Figure B.4. (G) Percentage of labelled Id2-eGFP+ cell types in lymph nodes of
Id2-CreERT2+ mice determined by flow cytometry. For gating strategy see Supplement Figure B.5
and Supplement Figure B.6. 4x tmx, N=5; 2x tmx, N=2; 1x tmx, N=3.
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The time course of labelling other cell types in spleen and lymph node was also assessed
(Figure 3.1E-G). No increase in eGFP expressing cells was obtained with repeated injections.
While NK cells and CD8α+ cDC showed a high number of Id2-eGFP expressing cells, T
cells and other DC subsets in spleen and lymph nodes revealed lower percentages of eGFP
expressing cells. This reflects their dependency on the expression of Id2 (Hacker et al.,
2003; Jackson et al., 2011; Li et al., 2012; Masson et al., 2013).
It is noteworthy that one single dose injection is sufficient to label the Id2 dependent cell
types in skin and that no increase with repeated injections could be obtained. Because LC,
CD8α+ cDC and DETC are highly dependent on Id2, we wondered why these cells do not
achieve more Id2-eGFP expressing cells. This is, however, in agreement to communication
with Emma Rawlins. No higher efficiency rates than 30% of Id2-eGFP+ cells were achieved
before.
Figure 3.2. Lineage tracing of Id2 dependent skin haematopoietic cells.
Adult Id2-CreERT2+ mice received either four, two or a single dose of tamoxifen. Analysis of mice
were performed 6 or 7 days after the last injection in epidermis (LC and DETC) and spleen (CD8α+
cDC, CD11b+ cDC and NK cells) by flow cytometry and immunofluorescence. For schematic
representation of the experiment layout see Figure 3.1A. (A) Summary of the percentage of Id2-
eGFP positive cells within the indicated cell types analysed 6 or 7 days after tmx injection by flow
cytometry. N=9-10. (B) Epidermal ear sheets were fixed and permeabilised, stained with antibodies
specific for MHC-II and eGFP and analysed by immunofluorescence microscopy. One example is
shown for analysis 7 days after injection. Scale bar, 50 µm.
Therefore, the results of the Id2-CreERT2+ mice were combined to compare the dependency
of Id2 in the cell subsets of interest (Figure 3.2). While LC and DETC showed on average
25% eGFP+ cells, CD8α+ cDC and NK cells showed on average 15% of eGFP+ cells (Figure
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3.2A). Concomitantly, very few eGFP+ CD11b+ cDC were found, which is in agreement
with their low Id2 dependency (Figure 3.2A; Hacker et al., 2003).
Further, immunostaining of the epidermis was performed to observe Id2-eGFP expression in
the tissue context. However, the endogenous GFP expression was too weak for fluorescence
microscopy and thus we stained with an anti-GFP antibody for visualization. As shown
in Figure 3.2B, patches of Id2-eGFP expressing cells were observed in which both LC
(overlay of red and green appears yellow) and DETC (only green) were positive for eGFP.
In contrast, areas were found that showed no eGFP expression, which might indicate a
synchronized Id2 expression in the tissue. In this area, DETC seem to be activated, which
is seen by the rounded shape of the cells and might be explained due to the experimental
procedure.
3.1.2 Id2 Expression in Haematopoietic Progenitors and Bone Marrow
Subsets
Haematopoietic precursors residing in the bone marrow are rather short lived cells. To
catch the time point of labelling Id2 dependent precursors and cell subsets, bone marrow of
Id2-CreERT2+ mice was analysed by flow cytometry after 2, 5 and 7 days of tmx treatment
(Figure 3.3).
The bone marrow was analysed for the DC precursors, MPP, CLP, CDP and pre-cDC. Only
in CLP Id2-eGFP expression was detected, which suggest that MPP, CDP and pre-cDC are
not dependent on Id2. Around 1% CLP were Id2-eGFP+ after 2 and 5 days of treatment
(Figure 3.3B). This is surprising because the CLP lineage was so far not reported to be
dependent on Id2 (Carotta et al., 2011). The low Id2-eGFP frequency might indicate a
minor role of Id2 in these cells and it could be speculated that this portion of Id2-eGFP
expressing CLP are precursors for the NK cell lineage. Already after 7 days of treatment
this portion of Id2-eGFP CLP was no longer present. This means, CLP that were labelled
at day 1 already diverged into downstream cell types after 7 days.
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Figure 3.3. Short term lineage tracing of Id2 dependent haematopoietic precursors
and medullary subsets.
Adult Id2-CreERT2+ mice received a single injection of tamoxifen and bone marrow was analysed
at different time points after treatment. (A) Schematic representation of the experiment layout.
A=Analysis. (B - D) The percentage of eGFP+ cells within the indicated cell populations was
determined by flow cytometry for (B) DC precursors (C) NK cell precursors (D) other medullary
subsets. The gating strategy is shown in Supplement Figure B.7, Supplement Figure B.8, Supplement
Figure B.9 and Supplement Figure B.10, respectively. 2 days N=4; 5 days N=2; 7 days N=9.
Next, Id2 expression was assessed during NK cell development. The transcription factor Id2
is essential for NK cell development and Id2-/- mice lack NK cells (Yokota et al., 1999). Id2
inhibits E proteins, which is important for the cell fate decision to NK cells (Figure 1.7).
The NK precursors, NKP, have as a pre-stage the pre-pro NK cell precursors, which are
divided according to their surface marker expression into pre-pro NKa and pre-pro NKb
(Carotta et al., 2011). Although Boos and colleagues reported no influence of Id2 depletion
in NK precursors (NKP; Boos et al., 2007), more recently a group around Carotta and
colleagues showed Id2 expression within these subpopulations with the help of a reporter
mouse system (Carotta et al., 2011). Here the new definition of NK precursor subsets by
surface marker discrimination might lead to different results as well as the use of different
mouse systems. In contrast to Carotta and colleagues (Carotta et al., 2011) analysis of NK
precursors with our lineage tracer showed no eGFP+ cells within the pre-pro NKa and
pre-pro NKb populations, indicating that they do not dependent on Id2 (Figure 3.3C). This
would underline the results of Boos and colleagues, which state that Id2 is not required
for NK precursors and only for mature NK cells in the bone marrow (Boos et al., 2007).
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However, the NKP revealed about 2.5% and 5% eGFP+ cells after 2 and 5 days after
treatment, respectively (Figure 3.3C). During their maturation NK cells upregulate Id2
expression and are dependent on the transcription factor during maintenance (Boos et al.,
2007). This fact is shown in the moderate Id2-eGFP expression of about 10% of mature
NK cells in bone marrow (Boos et al., 2007).
Analysis of Gr1hi monocytes, Gr1lo monocytes and granulocytes demonstrate low Id2-eGFP
expression in steady-state by up to 1.5% of Id2-eGFP+ cells (Figure 3.3D). This result
is in line with previous data on Id2 expression in monocytes and granulocytes (Ishiguro
et al., 1996; Buitenhuis et al., 2005). The fast decline in detection time of Id2-eGFP+ cells
in these subsets (not detectable after 7 days of injection) represents their short life-span
(Figure 3.3D).
The dependency on Id2 of DC precursors were further assessed in detail by in vitro bone
marrow cultures (Felker et al., 2010). MPP and CDP were obtained from Id2-CreERT2+
bone marrow cells cultured with SCF, hyper-IL-6, Flt3L and IGF-1 (section 2.2.4.2). At
day 3, after Ficoll treatment, cells were either treated with the active form of tmx, 4-OHT,
or left untreated (section 2.2.4.6). On day 7 of culture, cells were stained for specific
surface markers to analyse MPP and CDP using flow cytometry. Within the living cell
population, Gr1+ cells were excluded to gate out granulocytes and monocytes. MPP and
CDP were defined as c-kit+Flt3- and c-kitintFlt3+, respectively. From each population the
eGFP expression was analysed (Figure 3.4). 4-OHT treated bone marrow cells showed no
Id2-eGFP expression in MPP and CDP compared to the control, where 4-OHT was not
added (-4-OHT). These results correlate with the in vivo data on CDP and MPP, indicating
that during proliferation Id2 was not expressed (Jackson et al., 2011).
Since TGF-β1 induces Id2 expression (Hacker et al., 2003), it was assumed that TGF-β1
treatment could increase the frequency of Id2-eGFP+ cells. Therefore, the experiment
was extended to treat cells with 5 ng/ml TGF-β1 plus 4-OHT for 24 hours. On day 7
eGFP expression of MPP and CDP was assessed by flow cytometry. As shown in Figure
3.4, TGF-β1 treatment plus 4-OHT yielded 1.45% eGFP+ cells within CDP, but no
eGFP+ cells (0.02%) within MPP. Therefore, TGF-β1 treatment increased the number
of eGFP+ cells in CDP but not in MPP and thus TGF-β1 induced Id2 expression in
CDP.
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Figure 3.4. Id2 expression is induced by TGF-β1 treatment in CDP.
Id2-CreERT2+ bone marrow cells were cultured with SCF, hyper-IL-6, Flt3L, and IGF-1 (section
2.2.4.2) in the presence or absence of 4-OHT (section 2.2.4.6). On day 6 of culture, cells were
treated with 5 ng/ml TGF-β1 for 24 hours. On day 7 of culture, cells were analysed using flow
cytometry by gating on living cells only. MPP were defined as Gr1-c-kit+Flt3-. CDP were defined
as Gr1-c-kitintFlt3+. Numbers indicate percentages of parent population. Representative analysis
of two experiments, which were performed and published in my master thesis.
In summary, the in vivo and in vitro data showed that the DC precursors MPP, CDP and
pre-cDC are Id2-eGFP negative. The same was observed for the pre-pro NKa and pre-pro
NKb precursors. This is in agreement with published data which report on no influence of
Id2 on these cell subsets (Hacker et al., 2003; Boos et al., 2007; Jackson et al., 2011). As
shown previously NK cells showed a high Id2 dependency, which is reflected in the lineage
tracer by a high percentage of eGFP expressing cells (Boos et al., 2007; Carotta et al.,
2011). The low frequency of eGFP expressing CLP, monocytes and granulocytes indicates
only a minor role of the transcription factor Id2 in these populations.
3.1.3 Skin LC and T cells are Long Lived and Express Id2 in
Steady-State
Next, the label-retention in LC, DETC and other haematopoietic cell types was determined,
as particularly LC and DETC are long-lived cells. Id2-CreERT2+ mice, which received a
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single dose of tmx, were analysed at various time points after injection at day 2, 5, 7, 14,
30 and day 90 (Figure 3.5).
Two days after tmx administration few eGFP+ cells were detected, except for NK cells
that showed already up to 25% eGFP+ cells (Figure 3.5B, C and D). In the following
days, however, the percentage of eGFP+ LC, DETC and their dermal counterparts, the
migrating LC and dermal T cells, increased and reached highest levels at 7 days after
injection (Figure 3.5B). eGFP+ LC, DETC, migrating LC in dermis and dermal T cells
were still present 3 months after injection, indicating that LC precursors or self-renewing
LC were labelled. This could be also the case for DETC and the dermal T cells, which
are mostly tissue-resident memory αβ-T cells but also γδ-T cells can be found (Heath and
Carbone, 2013). Analysis of the skin epidermis by immunofluorescence staining after 30
days of tmx injection showed, as observed before, patches of Id2-eGFP expressing cells in
which both LC and DETC were positive for eGFP (Figure 3.5C).
In spleen NK cells and CD8α+ cDC were labelled with eGFP, reflecting their high Id2
expression level (Figure 3.5D; Jackson et al., 2011; Carotta et al., 2011). Surprisingly, NK
cells show fast Cre activity expression showing already highest eGFP expression after 2
days. The long-lived NK cells showed an intermediate decline in Id2-eGFP expression until
they are nearly not detected anymore after 90 days (Figure 3.5D). This led to the hypothesis
that there might be a correlation between Id2 expression and proliferation. CD8α+ cDC
reached their highest frequency of eGFP+ cells after 7 days with around 15% eGFP+ cells
(Figure 3.5D). eGFP+ cells were rapidly lost from the short-lived CD8α+ cDC population
and were virtually absent by day 14 (Figure 3.5D). Very few eGFP+ CD11b+ cDC were
found, indicating with their low Id2 expression (Figure 3.5D).
The dermal DC subsets, CD103+ DC and CD11b+ DC showed a similar eGFP expression
pattern to their splenic counterparts of the CD8α+ cDC and CD11b+ cDC, respectively
(Figure 3.5E). Around 15% and 10% of eGFP+ CD103+ DC were labelled at day 5 and
7 after injection. Due to their short life expectancy, no eGFP+ cells were visible after 14
days. Also the dermal CD11b+ DC showed very few eGFP+ cells, which reflects their low
Id2 expression (Figure 3.5E).
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Figure 3.5. Long term lineage tracing of haematopoietic cells.
Id2-CreERT2+ mice were treated with a single dose of 0.25 mg tmx per gram body weight and
analysed after different time points after injection. (A) Schematic representation of the experimental
layout. A=Analysis. (B) Percentage of eGFP+ LC, migrating LC in dermis, DETC and dermal T
cells were determined. Migrating LC were defined as CD45+MHC-II+CD11bintEpCAM+. At least 3
mice per time point. (C) Epidermal ear sheets were fixed and permeabilised, stained with antibodies
specific for MHC-II and eGFP and analysed by immunofluorescence microscopy. One example is
shown for analysis 30 days after injection. Scale bar, 50 µm. (D) Percentage of splenic Id2-eGFP+
NK cells, CD8α+ cDC and CD11b+ cDC are summarised for each time point of Id2-CreERT2+ mice
by flow cytometry analysis. For gating of splenic cells see Supplement Figure B.3 and Supplement
Figure B.4. (E) Dermal cell suspension were stained for CD103+ DC and CD11b+ DC and the
percentage of Id2-eGFP+ cells within these populations were determined. For gating see Supplement
Figure B.11. Error bars are SEM of at least 2 mice per group.
Taken together, eGFP expression in Id2-CreERT2+ mice is specific for Id2-expressing cells
and is retained throughout the entire life span of these cells.
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3.1.4 Id2 Expression in LC is Induced After Birth
So far it is unclear, at which stage during LC development Id2 expression is essential.
Therefore, Id2-CreERT2+ mice were used to lineage trace Id2 expression during LC devel-
opment in newborns. To this end, wild-type females were mated with Id2-CreERT2+ males
that were homozygote for Rosa26R-eGFPf. Progeny was therefore either Id2-CreERT2+
or Id2-CreERT2–. Pregnant mice received a single tmx injection at embryonic day E18.5
whereas newborns were treated at P1, P3, P5 or P7 (Figure 3.6A). Animals were kept until
adulthood (7 weeks) and epidermis was analysed for eGFP+ cells by flow cytometry and
immunofluorescence (Figure 3.6B-E).
Offspring’s of pregnant mice treated at E18.5 showed only 2% eGFP+ LC, indicating that
at E18.5 only a minority of LC precursors expressed Id2 (Figure 3.6B). Mice treated at
P1 and P3 harboured up to 10% and 15% eGFP+ LC, respectively, thus Id2 expression
is upregulated soon after birth (Figure 3.6B and C). Id2-CreERT2– control littermates
were devoid of eGFP+ cells (Figure 3.6B). Summarised results show the increase in Id2
expression during the first week after birth (Figure 3.6C). In contrast to LC, DETC
expressed Id2 already at E18.5 and this expression remained high, about 20%, after birth
(Figure 3.6D). This fits with published data showing that DETC development depends
on Id2 from embryonic day 14 onwards (Prinz et al., 2013). Surprisingly, at P5 the mean
of Id2 expression drops to around 5% of Id2-eGFP+ LC and also to 10% of Id2-eGFP+
DETC (Figure 3.6C and D). At least three independent experiments were performed for
that time point and no higher percentages of eGFP+ cells were obtained. Therefore we can
exclude technical problems explaining this decrease. Thus, we assume that this drop in
percentage of Id2-eGFP expressing cells at P5 is real and LC and DETC downregulate Id2
shortly after arriving in the niche.
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Figure 3.6. Id2 expression during LC development.
Id2-CreERT2+ males were mated with wild-type females to obtain Id2-CreERT2+ or Id2-CreERT2–
offsprings, heterozygote for Rosa26R-eGFPf. Pregnant mice were injected with tamoxifen at E18.5
or newborns received tamoxifen injections at P1, P3, P5 or P7. Offspring’s were analysed at the age
of 7 weeks. (A) Schematic representation of the experiment layout. (B) Single cell suspensions from
epidermis of ventral ear halves were prepared to perform flow cytometry analysis. Representative
FACS plots are shown. LC were defined as CD45+MHCII+CD11c+EpCAM+. Id2 expression was
determined by the percentage of Id2-eGFP+ cells within the population. (C) Percentage of Id2-
eGFP+ LC is summarised for each time point. Error bars are SEM of at least 5 mice per group.
(D) Percentage of Id2-eGFP+ DETC from Id2-CreERT2+ mice is summarised for each time point.
DETC were defined as CD45+MHC-II-CD3+. Error bars are SEM of at least 5 mice per group. (E)
Epidermal sheets of Id2-CreERT2+ mice were stained for MHC-II and eGFP. One representative
picture is shown for each time point. Scale bar, 50 µm. (F) LC (CD45+MHC-II+CD3-) were
FACS sorted at the indicated time points from 3-6 C57BL/6 wild-type mice and analysed by
qRT-PCR for Id2 expression. Values were normalized to the house keeping gene Gapdh. (G) Dermal
cell suspensions were stained for migrating LC and T cells and the percentage Id2-eGFP+ cells
within these populations were determined. For gating strategy see Supplement Figure B.12. na, not
analysed. Error bars are SEM of at least 5 mice per group.
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Immunofluorescence analysis of epidermal sheets further substantiated the presence of
eGFP+ cells (Figure 3.6E). Again, patches of eGFP+ cells were found of which only part
co-expressed MHC-II. MHC-II- cells are most likely DETC and cycling keratinocytes
(Baghdoyan et al., 2005). Thus, there appears continuous replenishment of both LC and
DETC from a cell originating and labelled shortly after birth, which show stable adhesion
in epidermis to the surrounding keratinocytes.
Next, Id2 expression was assessed in FACS sorted LC from wild-type newborn mice at P2,
P10, P14 and P18 by quantitative PCR analysis to confirm the expression on RNA level
(Figure 3.6F). Id2 expression is induced after birth and reaches highest expression at P18 and
adult, which shows the importance of this factor during later stages of LC development, like
proliferation and anchoring. Therefore, following Id2 expression in newborn with the lineage
tracer might be of interest in later stages than shown in Figure 3.6C.
As shown before, dermal T cells and LC are long lived Id2 dependent cells and could
therefore also be followed during the development in dermis. Accordingly, dermal T cells
and migrating LC were analysed by flow cytometry (Figure 3.6G). About 10% eGFP+
migrating LC were already be detected at P1, revealing a constant turnover of Id2-eGFP+
migrating LC (Figure 3.6G). T cells were found to show an Id2-eGFP labelling of around
20%, which is already present during embryonic days (Figure 3.6G). At P3 and P5 a small
decrease in eGFP+ T cells were observed, which however was not statistical significant. In
these analysis no discrimination of the different T cell subsets present in dermis were made
and both T cell types were reported to be long lived (Heath and Carbone, 2013; Hartwig
et al., 2015).
In summary, Id2 expression in embryonic LC precursors is low but is upregulated shortly
after birth. From this we hypothesised that Id2 is not a prerequisite for development of the
LC precursor but rather becomes important when these precursors differentiate, proliferate
and anchor in their niche.
3.2 Embryonic LC Precursors are Present in Id2–/– Mice
It was shown previously that Id2 is a critical regulator of LC biology as adult Id2–/– mice
lack LC (Hacker et al., 2003). To test the results obtained before and the hypothesis that
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Id2 is not important for development of LC precursors, Id2+/– and Id2–/– newborn mice
were analysed according to their development and expansion of LC in the epidermis starting
at P3.
3.2.1 Id2–/– LC are Impaired in their Surface Marker Expression
Interestingly, flow cytometry analysis revealed a prominent MHC-II+CD11c+ population
in both Id2+/– and Id2–/– mice at P3, which constituted about 20% of all CD45+ cells in
epidermis (Figure 3.7A). However, this population was not retained in Id2–/– mice and
was virtually gone 3 weeks after birth. Of note, also MHC-II-CD11c- DETC were found in
epidermis of Id2–/– newborn mice and were lost in time (Figure 3.7A).
To determine LC density, epidermal sheets of Id2–/– and Id2+/– newborns were stained for
MHC-II and langerin and analysed by immunofluorescence microscopy. On P5, epidermis
of Id2+/– animals contained a clear network of MHC-II+langerin+ LC with a density of
1000 cells/mm2, similar to what has been reported before (Figure 3.7B and C; Chorro
et al., 2009). Id2–/– epidermis also harboured MHC-II+ cells at P5, however, these cells
did not co-express langerin, a hallmark of LC (Figure 3.7B). Of importance, while langerin
expression is increased in the first days of life in Id2+/– controls, Id2–/– newborns do not
start to express this hallmark at all (Figure 3.7B). This is also demonstrated by flow
cytometry analysis (Figure 3.7E). In addition, with 600 cells/mm2 the density of Id2–/– LC
was significantly lower compared to LC in Id2+/– epidermis (Figure 3.7C). Furthermore,
whereas in Id2+/– animals LC density remained constant with age, Id2–/– mice rapidly lost
LC and at P22 Id2–/– epidermis was virtually devoid of LC (Figure 3.7B and C). The few
scattered LC found in adults seem to be increased in size, maybe due to more space available
(Figure 3.7B, indicated by arrows). This loss of LC-like cells was also observed using flow
cytometry (Figure 3.7A). In time Id2–/– mice lost almost all CD45+ cells from epidermis
until they are essentially absent in adult mice (Figure 3.7A).
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Figure 3.7. Embryonic LC precursors are present in Id2–/– newborns.
The epidermis of Id2–/– newborns was analysed postnatal at the indicated time points. Id2+/–
littermates were used as control. (A) Single cell suspensions from the epidermis of Id2–/– mice and
Id2+/– littermates were prepared to perform flow cytometry. LC were identified as CD45+MHC-II+
singlet cells. The percentage of LC is shown in regard to CD45+ singlet cells (box). (B) Epidermal
sheets were stained for MHC-II and langerin. One representative picture is shown for each time
point. Scale bar, 50 µm. (C) MHC-II+ cells of epidermal sheets, as shown in (B) were counted. Three
different areas per mouse were counted and calculated in mm2. Error bars represent SD. P5 - P26,
N=5-9; 15w, N=2. (D and E) Epidermal single cell suspensions were stained for LC markers and the
mean fluorescence intensity (MFI) of CD45+MHC-II+ singlet LC was determined for the indicated
markers. Error bars represent SD. P3 - P26, N=5-9; 15w, N=2. Significances were determined using
a two-tailed, unpaired Student’s t-test; (∗∗)p<0.01; (∗ ∗ ∗)p<0.001; (∗ ∗ ∗∗)p<0.0001.
Further, the lack of langerin expression in Id2–/– in comparison to Id2+/– MHC-II+ cells at
different time points after birth was confirmed by determination of the mean fluorescence
intensity (MFI) by flow cytometry (Figure 3.7D and E). Importantly, MHC-II expression
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is not affected in Id2–/– newborn LC (Figure 3.7D), which makes it a good marker to sort
these cells (see section 3.2.2).
Taken together, embryonic LC precursors develop in Id2–/– mice. However, recruitment to
epidermis or proliferation during the first days after birth might be hampered because the
number of MHC-II+ cells in Id2–/– epidermis is reduced to around 50%. Furthermore, differ-
entiation and maintenance of Id2–/– MHC-II+ cells appears impaired.
3.2.2 Id2–/– LC Show Deficient Anchorage
Next we aimed at understanding why Id2–/– LC are not maintained in epidermis and
disappear a few weeks after birth. There might be different possibilities: (i) LC undergo
apoptosis, (ii) LC are inhibited in their differentiation potential, or (iii) Id2 might be
involved in the anchoring/adhesion mechanism of LC. These hypothesis will be addressed
in the following section.
To address the first question, if Id2–/– LC undergo apoptosis, flow cytometry analysis
and gene expression profiling of FACS sorted Id2+/– and Id2–/– LC at P2, P8, P14 and
P18 were performed (Figure 3.8). The pro- and anti-apoptotic markers, Bax and Bcl2,
respectively, were not differently expressed although both were reported to be Id2 target
genes (Figure 3.8A and B; Kel et al., 2010). Id2–/– LC at P18 showed rather an elevation of
the anti-apoptotic marker Bcl2 compared to Id2+/– LC, which might indicate that LC try
to rescue themself in skin epidermis. This fits with the observation that there is no increased
number of Annexin V+ LC in Id2–/– epidermis compared to Id2+/– LC (Figure 3.8C). Taken
together, no increased rate of apoptosis in Id2–/– cells was observed and therefore it can be
concluded that Id2–/– cells do not disappear because of cell death.
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Figure 3.8. Id2–/– LC do not undergo apoptosis.
(A and B) Epidermal single cell suspensions were obtained from Id2+/– and Id2–/– newborns.
LC were FACS sorted at P8 and P18 (CD45+MHC-II+CD3-), followed by RNA isolation, cDNA
preparation and applied for qRT-PCR analysis. The fold expression to Gapdh was calculated and
here depicted for the (A) pro-apoptotic gene Bax and (B) anti-apoptotic gene Bcl2. (C) Analysis of
Annexin V+ and propidium iodide (PI) LC at P18 did not reveal any indication for apoptosis in
Id2+/– and Id2–/– mice.
Next, genes involved in differentiation and maintenance of LC were analysed to address the
second hypothesis. Sfpi1, Csf1r and Ctnnb1 (β-catenin) did not show a consistent difference
in expression between Id2+/– and Id2–/– cells (Figure 3.9B). Only Runx3 expression showed
a decrease at P14 and P18 in Id2–/– LC compared to Id2+/– LC. Further, differences in gene
expression were found for Axl (Figure 3.9B). At P2 Id2–/– LC express Axl at higher levels
compared to Id2+/– LC, while its expression is lost at P14. This might be an indicator for
disrupted LC differentiation as Axl was shown to be required for LC maintenance (Bauer
et al., 2012).
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Figure 3.9. Gene expression in Id2–/– LC.
Epidermal single cell suspensions from Id2+/– and Id2–/– mice were FACS sorted at different
days after birth for LC (CD45+MHC-II+CD3-) and DÈTC (CD45+MHC-II-CD3+) followed by
RNA isolation, cDNA preparation and qRT-PCR analysis. For each time point sorted cells of 3-8
mice were pooled and further processed together.(A) Gating strategy is shown for P8. (B) Gene
expression of genes important for LC differentiation and maintenance was assessed by qRT-PCR.
The fold expression to Gapdh was calculated and is depicted in bar diagrams. nd, not detected.
N=1.
Interestingly, consistently increased frequencies of LC in dermis of Id2–/– mice compared
to Id2+/– mice between P3 and P14 were found, suggesting that Id2–/– LC emigrate
from epidermis to dermis (Figure 3.10A and B). During steady-state turnover LC migrate
through the dermis where they enter lymphatics (Kissenpfennig and Malissen, 2006).
Thus, it is hypothesised that Id2–/– LC do not fully anchor in epidermis and migrate
further to dermal tissue. Nevertheless, what happens to these cells after migrating to
the dermis is still unclear. LC in wild-type tissue enter lymphatics and finally lymph
nodes. Id2–/– mice, however, lack lymph nodes and thus the fate of Id2–/– LC remains
unclear.
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Figure 3.10. Id2–/– LC are more abundant in dermis than Id2+/– LC.
Dermal single cell suspensions of Id2–/– and Id2+/– newborns were prepared for flow cytometry
analysis. LC were defined as CD45+MHC-II+CD11bintEpCAM+CD24+CD103-. (A) Gating strategy
for migrating LC in dermis from P7 newborns. (B) The frequency of migrating LC in dermis of
Id2+/– mice and Id2–/– littermates in regard to MHC-II+ cells for all time points is shown. Error
bars are SD. P3 - P26, N=5-9; 15w, N=2
It was shown recently that upon maturation LC undergo EMT to acquire a motile phenotype
and leave the epidermis (Konradi et al., 2014). Therefore, next the expression of EMT
regulators Snail1, Snail2, Zeb1 and Zeb2 and of Ccr7 was analysed. Most of these genes were
not expressed (data not shown), however, there was a striking difference in Zeb2 expression
between Id2+/– and Id2–/– cells (Figure 3.11A). In Id2+/– LC Zeb2 is expressed until
P14 but becomes undetectable from P18 onwards. This expression pattern is reminiscent
of MET during differentiation of LC in the first weeks after birth (Figure 3.11A and
Figure B.1). In Id2–/– cells, however, Zeb2 expression was 5-fold higher at P2 and more
importantly even increased in time (Figure 3.11A). This suggests that Id2–/– cells do not
undergo MET and retain a motile, non-adhesive phenotype.
No detectable levels of Ccr7 in P8 Id2–/– LC were observed (data not shown). This is in
contrast to TGF-βRI deficient animals (Kel et al., 2010), yet might be in accordance with
the two-phase migration of LC, where CCR7 is dispensible for mobilization of LC from
epidermis to dermis but required for entry in lymphatic vessels (Ohl et al., 2004). Indeed,
expression of Mmp9, a typical mesenchymal marker, was 50-fold higher expressed at P14
in Id2–/– LC compared to Id2+/– LC (Figure 3.11A). Furthermore, adhesion molecules,
which allow anchorage of LC in the epithelial environment, such as Cldn1 and Cd207, were
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clearly lower expressed in Id2–/– cells compared to Id2+/– cells (Figure 3.11B). However,
Jam1 and Cdh1 were not differently expressed (Figure 3.11B). The other Id protein,
Id3 was also assessed in Id2+/– and Id2–/– LC (Figure 3.11C). In Id2+/– LC at P2 Id3
expression was absent while during development no difference was observed to Id2–/– LC.
This discrepancies cannot be explained by this single experiment. Krt8 and Krt18, which
are epithelial cell-specific intermediate filament proteins, were not expressed (data not
shown; Fortier et al., 2013).
Figure 3.11. Gene expression of EMT factors and epithelial genes in Id2–/– LC.
Epidermal single cell suspensions from Id2+/– and Id2–/– mice were FACS sorted at different days
after birth for LC (CD45+MHC-II+CD3-) and DETC (CD45+MHC-II-CD3+) followed by RNA
isolation, reverse transcription and qRT-PCR analysis. For gating strategy see Figure 3.9A. Gene
expression of various genes important for (A) EMT process, (B) epithelial marker expression on
LC and (C) transcription factor expressed in LC were assessed by qRT-PCR. The fold expression
to Gapdh was calculated and here depicted as bar diagrams. nd, not detected. N=3-8 mice were
pooled at each time point.
In steady-state, LC express epithelial markers that allows them to make contact to
surrounding cells and keeps themself in an epithelial state. Flow cytometry analysis further
showed reduced cell surface expression of the epithelial marker EpCAM and E-cadherin in
Id2–/– cells, determined by the mean fluorescence intensity (MFI, Figure 3.12A, B and C).
Interestingly, Id2+/– LC and Id2–/– LC showed similar EpCAM (P3 - P7) and E-cadherin
(P3 - P14) levels during the first days after birth (Figure 3.12B and C). However, with
time expression started to differ and from P10 and P18 onwards Id2–/– LC expressed
significantly lower levels of EpCAM and E-cadherin, respectively, compared to Id2+/– LC.
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This coincides with the time point, when in dermis a high percentage of migrating Id2–/–
LC are observed (Figure 3.10B).
Figure 3.12. Epithelial surface markers are downregulated on Id2–/– LC.
Epidermal single cell suspensions of Id2+/– and Id2–/– were stained for LC markers and the mean
fluorescence intensity (MFI) of CD45+MHC-II+ singlet LC was determined. (A) Representative
FACS plots of expression levels at P18. Summary of all time points of the MFI for (B) EpCAM
and (C) E-cadherin. Error bars represent SD. P3 - P26, N=5-9; 15w, N=2.
Taken together, these data show that Id2 is required for MET during differentiation of LC
precursors into LC in the epithelial niche. In the absence of Id2, MHC-II+ cells express high
levels of the mesenchymal markers Zeb2 and Mmp9, and low levels of adhesion molecules.
As a consequence, Id2–/– LC lack the capacity to stably anchor in their niche and leave
the epidermis.
3.3 DETC are Present in Id2–/– Newborn
Similar to LC, DETC develop from embryonic precursors at P14 (Prinz et al., 2013)
and the precursors are reported to be dependent on Id2 (Figure 3.6D; Tokuriki et al.,
2009). Id2–/– DETC migrate to the newborn epidermis, however, they disappear shortly
after birth (Figure 3.7A). It is hypothesised that DETC might also be hampered in their
expression of epithelial genes that are responsible for their anchoring in the epithelial
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niche. Therefore, gene expression of MET regulators and DETC specific genes were
analysed.
To this end, DETC from Id2–/– and Id2+/– mice were FACS sorted at P2, P8, P14 and P18.
However, after P8 only very low cell numbers were obtained and thus their analysis was
not possible. DETC from P2 and P8 were applied for RNA isolation, cDNA preparation
and analysis by qRT-PCR (Figure 3.13, for gating strategy of FACS sorting see Figure
3.9A).
Figure 3.13. Gene expression in Id2–/– DETC.
Epidermal single cell suspensions from Id2+/– and Id2–/– mice were FACS sorted at different days
after birth for DETC (CD45+MHC-II-CD3+). For sorting strategy see Figure 3.9A. Sorted cells
from 3-8 mice were pooled for each time point and applied to RNA isolation, reverse transcription
and qRT-PCR analysis. (A-F) Genes of interest in DETC development were analysed and values
normalised to the house keeping gene Gapdh and here depicted as bar diagrams. nd, not detected.
N=1.
Interestlingly, Id2 expression is upregulated in Id2+/– DETC from P2 to P8 and is, as
expected, absent in Id2–/– DETC (Figure 3.13A). Other transcription factors, like Tcf3
and Runx3, important for DETC development were also upregulated during development
in Id2+/– cells (Figure 3.13B and C). At P2 no difference in Tcf3 and Runx3 expression
was observed in Id2+/– and Id2–/– DETC, while at P8 Tcf3 and Runx3 expression was
slightly higher in Id2+/– DETC than in Id2–/– DETC. Similar to LC, Runx3 regulates the
development of DETC in general. We also analysed the expression of further genes: (1) Itgae,
encoding integrin αE, which is involved in cell migration and retention (Uchida et al., 2011),
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(2) Ahr, encoding the aryl hydrocarbon receptor that controls the postnatal maintenance
of skin-resident DETC (Hao and Whitelaw, 2013) and (3) Il2rb, encoding IL-2Rβ, which
mediates cell proliferation in response to to IL-2 and IL-15 (Woolf et al., 2007; Figure 3.13D,
E and F). For Itgae, Ahr and Il2rb no consistent difference in expression level between
Id2–/– and Id2+/– DETC was observed (Figure 3.13D, E and F).
Further, we investigated expression of EMT regulators Snail1, Snail2, Zeb1 and Zeb2
in Id2–/– and Id2+/– DETC. However, none of these genes were expressed (data not
shown).
In summary, at this stage of analysis there was no consistent pattern of DETC transcription
factors or EMT regulators that would allow conclusion on how DETC dynamics in epidermis
is regulated.
3.4 Id2 Regulates Anchorage in Tissue-Resident CD8α+
cDC
Id2 also controls development of other DC subsets, including CD8α+ cDC in lymphoid
tissue, which are reduced in number in Id2–/– mice (Hacker et al., 2003). Therefore,
the same gene repertoire that was analysed in LC were also assessed in splenic DC
subsets.
3.4.1 In vivo
To this end, splenic CD8α+ cDC , CD11b+ cDC and pDC were FACS sorted from adult
Id2–/– and Id2+/+ mice and subjected to qRT-PCR (Figure 3.14).
Zeb2 levels were high in Id2+/+ pDC and CD11b+ cDC, reflecting their motile behaviour,
and was not influenced by Id2 (Figure 3.14B; Scott et al., 2016). Zeb2 expression in
Id2+/+ CD8α+ cDC was very low but more than 10-fold increased in the few remaining
Id2–/– CD8α+ cDC, most likely representing CX3CR1+ CD8α+ cDC (Bar-On et al., 2010;
Gurka et al., 2015), and reached levels similar to the other splenic DC subsets (Figure
3.14B). Similarly, we observed clearly elevated Mmp9 expression in Id2–/– CD8α+ cDC and
CD11b+ cDC, which indicates an induced migratory behaviour of these cells, compared to
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Id2+/+ cells (Figure 3.14C). In contrast, expression of the adhesion molecule Itgae (CD103),
which is specific for CD8α+ cDC, was not detectable in Id2–/– cells (Figure 3.14D). Cdh1
(E-cadherin) is specifically expressed in Id2+/+ pDC and is also not increased in the other
Id2–/– cell subsets (Figure 3.14E). The transmembrane receptor Cd207 was remarkably
reduced in Id2–/– CD8α+ cDC compared to Id2+/+ CD8α+ cDC (Figure 3.14F). Thus, also
splenic CD8α+ cDC need Id2 to establish the sessile capacity.
Figure 3.14. Id2 and Zeb2 show opposite expression pattern in tissue resident DC.
Splenic CD8α+ cDC (Lin9-MHC-II+CD11c+CD8α+CD11b-), CD11b+ cDC (Lin9-MHC-
II+CD11c+CD8α-CD11b+) and pDC (Lin9-MHC-IIintCD11cintB220+) were FACS sorted from
Id2+/+ and Id2–/– mice and applied to RNA isolation, cDNA preparation and qRT-PCR. (A)
Gating strategy for sorting of splenic DC. (B-H) Gene expression analysis by qRT-PCR was applied
for the depicted genes. Values were normalized to the house keeping gene Gapdh. nd, not detected.
Id2+/+ CD8α+ cDC and CD11b+ cDC, N=3; Id2–/– CD8α+ cDC and CD11b+ cDC, N=2; Id2+/+
pDC, N=2; Id2–/– pDC, N=1.
Further, the expression of Spib and Batf3, specific transcription factors for pDC and
CD8α+ cDC, respectively, were investigated (Figure 3.14G and H). Of note, Id2–/– CD8α+
cDC showed a more pDC phenotype, since expression of Batf3 was reduced (Figure
3.14H) and Spib was increased compared to Id2+/+ CD8α+ cDC (Figure 3.14G). The
expression of Spib was also increased in Id2–/– pDC compared to Id2+/+ pDC (Figure
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3.14G). This implies that in CD8α+ cDC Id2 exerts functions in both, cell identity and
anchoring.
In conclusion, Id2-mediated regulation of anchorage seem to be a common mechanism found
also in tissue-resident DC. One aspect is blocking pDC genes like Spib and activating CD8α+
cDC genes like Batf3. A second aspect is repressing Zeb2 and concomitantly inducing adhe-
sion. This implies that Id2 and Zeb2 have opposite effects on the epithelial and mesenchymal
phenotype of tissue-resident DC, such as LC and CD8α+ cDC.
3.4.2 In vitro
In a next step the goal was to recapitulate the in vivo data obtained on the different DC
subsets with the in vitro differentiated DC using the one step culture system (section 2.2.4.3).
This would allow using in vitro generated DC as a model system for CD8α+ cDC anchorage
by obtaining sufficient numbers of cells for further functional analysis.
3.4.2.1 Untreated in vitro Cultured DC
Bone marrow cells of Id2+/+ and Id2–/– mice were cultured with Flt3L for 10 days
(section 2.2.4.3). CD8α+ cDC, CD11b+ cDC and pDC were FACS sorted based on their
surface marker expression (Figure 3.15A and B). This model system allows to produce
and recapitulate sufficient numbers of the different DC subsets that resemble in vivo DC
(Naik et al., 2005). As known from in vivo analysis, Id2–/– mice are impaired in their
capacity to generate CD8α+ cDC. Also in vitro cultured DC from bone marrow of Id2–/–
mice, showed an impairment in CD8α+ cDC (Figure 3.15B and C). pDC seem to be
favoured in Id2 deficient cells, which might suggest that cDC development is the default
pathway (Hacker et al., 2003; Lin et al., 2015). Establishing the pDC pathway requires
the activation and downregulation of specific factors to start the pDC program (Lin et al.,
2015). This is also shown in an increased number of pDC and decreased number of CD8α+
cDC obtained by FACS sorting from Id2–/– cells compared to Id2+/+ cells (Figure 3.15B
and C).
Sorted cells were processed for RNA isolation, reverse transcribed into cDNA and used
for qRT-PCR analysis (Figure 3.15D-L). Id2 expression is specific for Id2+/+ CD8α+
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cDC and absent in pDC and Id2–/– DC (Figure 3.15D). Interestingly, Zeb2 is induced in
Id2–/– pDC compared to Id2+/+ pDC, while there is no differential expression in CD8α+
cDC and CD11b+ cDC (Figure 3.15E). This is in contrast to in vivo splenic DC (Figure
3.14B).
Figure 3.15. In vitro cultured DC show similar gene expression pattern as in vivo DC.
Bone marrow cells from Id2+/+ and Id2–/– mice were cultured for 10 days in the one step culture
system for DC subsets (section 2.2.4.3). CD8α+ cDC (CD11c+CD11b+B220-CD24+Sirpα-), CD11b+
cDC (CD11c+CD11b+B220-CD24-Sirpα+) and pDC (CD11cposCD11b-B220+) were FACS sorted.
RNA was isolated, reverse transcribed to cDNA and applied for qRT-PCR analysis. (A) Schematic
representation of the experiment layout. (B) Gating strategy of FACS sorting CD8α+ cDC, CD11b+
cDC and pDC. (C) Cell numbers that were obatained from FACS sorting cultured bone marrow
DC subsets of Id2+/+ and Id2–/– mice are depicted as percentage of all DC subsets. (D-L) FACS
sorted DC subsets were applied to qRT-PCR analysis. Values were normalized to the house keeping
gene Gapdh. nd, not detected. N=1.
Unexpected is the Cd207 expression in Id2+/+ CD11b+ cDC while Cd207 was not expressed
in Id2+/+ CD8α+ cDC (Figure 3.15F). Id2–/– CD8α+ cDC showed a reduction in gene
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expression of Cldn1 and Itgae (CD103) compared to Id2+/+ cells (Figure 3.15G and H,
respectively). Of note, Id2+/+ pDC expressed Itgae also at a moderate level that was slightly
decreased in Id2–/– pDC (Figure 3.15H). As expected Cdh1 is soley expressed in pDC with a
mild reduction in Id2–/– pDC compared to Id2+/+ cells (Figure 3.15I).
Next, cell identity was assessed by analysing the gene expression of Irf4, Batf3 and Spib
(Figure 3.15J, K and L). Irf4 is a specific transcription factor expressed in CD11b+ cDC
and its expression was reduced in Id2–/– pDC (Figure 3.15J). Irf4 expression was anyway
very low, which could lead to inaccurate analysis. Interestingly, Id2–/– CD8α+ cDC showed
a decreased expression in Batf3 and increased expression in Spib compared to Id2+/+
cells (Figure 3.15K and L). This implies also that in vitro cultured CD8α+ cDC harbour
more pDC characteristic. However, we emphasize that the changes were only small to
moderate. As expected, Spib expression was increased in Id2–/– pDC compared to Id2+/+
pDC (Figure 3.15L).
Comparing gene expression of in vitro generated Id2+/+ DC subsets (Figure 3.15D-L)
with in vivo sorted DC subsets (Figure 3.14) revealed similar expression pattern in these
cells. Surprisingly, Zeb2 expression was not absent in in vitro Id2+/+ CD8α+ cDC (Figure
3.15E). Also Cd207 expression differed in in vivo and in vitro.
Many difference between the in vitro generated DC and the in vivo sorted DC subsets
were observed. This might be due to the artificial conditions that are going along with in
vitro culture systems. It is possible that in a culture dish cells might lack signals from the
surrounding tissue and might therefore have a changed gene expression pattern. Maybe
these conditions can be optimized by recapitulating a more ’niche-like’ environment for the
in vitro cultured DC.
3.4.2.2 TGF-β1 and OP9 treated in vitro Cultured DC
To overcome these differences observed between the in vivo sorted DC subsets and the in
vitro generated DC, it was hypothesised that the experimental in vitro culture conditions
have to be adapted to induce a more ’niche-like’ environment. To this end, two different
approaches were tested. Local growth factors, such as TGF-β1, regulate differentiation
and anchorage. TGF-β1 is a factor that is important for both LC and DC (Felker et al.,
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2010; Mohammed et al., 2016). To investigate the influence of TGF-β1 signalling in DC,
the Flt3L culture system was extended by treating the cells with TGF-β1 for 24 hours
prior to sorting (Figure 3.16A). The other approach was to co-culture bone marrow
cells with OP9 stromal cells. OP9 cells support haematopoietic stem cell differentiation
without the need of exogenous growth factors or complex embryoid structures. With this,
the system provides the co-cultured cells a niche to adhere, similar to in vivo (Figure
3.16A).
While TGF-β1 treated DC differ only to some extent to the control cells for most genes,
DC that were cultured on OP9 stromal cells showed a clear trend to in vivo splenic DC
(compare Figure 3.16B-J and Figure 3.14B-H). Of note Id2 is similarly expressed in DC
subsets for all three conditions (Figure 3.16B). Interestingly, Zeb2 is not expressed in
Id2+/+ CD8α+ cDC when cultured with OP9 stromal cells compared to the other conditions
(Figure 3.16C). Analysis of Itgae and Cldn1 expression revealed a similar pattern for the
three different conditions (Figure 3.16D and E). Notice, both genes are decreased in their
expression in all DC subsets when co-cultured with OP9 cells. Cd207 is a TGF-β1 target
gene and was therefore assumed to be induced in expression. Indeed, Cd207 expression is
highly induced in CD11b+ cDC, however not in CD8α+ cDC (Figure 3.16F). Furthermore,
in the co-culture system with OP9 stromal cells Cd207 expression is soley induced in
Id2+/+ CD8α+ cDC, but not expressed in all other DC (Figure 3.16F). In accordance with
Cdh1 being a TGF-β1 target gene (Riedl et al., 2000), Cdh1 expression was induced by
TGF-β1 treatment while its expression was only low in DC cultured with OP9 stromal
cells (Figure 3.16G).
Next, CD8α+ cDC, CD11b+ cDC and pDC of Id2+/+ and Id2–/– bone marrow cultures
using the three conditions were analysed for their cell identity by looking at the transcription
factors Batf3, Irf4 and Spib, respectively (Figure 3.16H, I and J). Batf3 expression was
induced in CD11b+ cDC co-cultured with OP9 stromal cells, while no differences in
expression level was detected when comparing control cells and TGF-β1 treated cells (Figure
3.16H). As expected, Irf4 expression was observed in CD11b+ cDC and Id2 deficiency lead
not to changes in expression level (Figure 3.16I). Interestingly, when treated with TGF-β1,
Irf4 expression was induced in Id2–/– CD8α+ cDC and Id2+/+ pDC.
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Figure 3.16. Optimization of in vitro cultured DC to mimic ex vivo DC.
Bone marrow cells from Id2+/+ and Id2–/– mice were cultured for 10 days with Flt3L for DC
subsets (section 2.2.4.3). Cells were either left untreated, seeded on OP9 stromal cells or treated
with TGF-β1. To provide the cells a niche where they can anchor, cells were seeded on day 5 on
OP9 stromal cells. For TGF-β1 treatment, 10 ng/ml was added to the medium on day 9. FACS
sorting was performed on day 10, similar as shown in Figure 3.15. RNA from sorted cells were
isolated, transcribed to cDNA and applied to qRT-PCR analysis. (A) Schematic representation of
the experiment layout. (B-J) The fold expression to Gapdh was calculated for genes of interest and
depicted as bar diagrams. nd, not detected. N=1.
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In contrast, Irf4 was not detected in DC cultured on OP9 stromal cells (Figure
3.16I). Spib expression was affected by TGF-β1 treatment and OP9 co-culture (Figure
3.16J).
In summary, TGF-β1 treatment of DC and co-culture of DC with OP9 stromal cells reflects
for some genes the in vivo phenotype better than simple suspension cultures. Due to the
absence of Zeb2 expression in Id2+/+ CD8α+ cDC cultured with OP9 cells and thus the
appropriate expression of adhesion molecules, DC cultured with OP9 stromal cells resemble
in vivo DC better. This might be due to providing these cells a niche where they can
anchor and start to upregulate epithelial markers in resident DC. However, at this stage of
analysis no strong conclusion of these preliminary experiments can made due to lack of
replicates.
3.4.2.3 Id2 Deficiency has a Minor Impact on DC Precursor
Development
Id2 depletion interfered with maintenance of LC and CD8α+ cDC caused by a decreased
expression of adhesion molecules, which leads to an impaired differentiation and anchorage.
Differentiation and anchorage is instructed by local growth factors. TGF-β1 is a factor
that is important for both LC and DC (Felker et al., 2010; Mohammed et al., 2016).
Interestingly, TGF-β1 influences the expression of adhesion molecules, such as Cdh1 in
CDP, an important precursor for DC development (microarray data of sorted CDP, as
described by Felker and colleagues [Felker et al., 2010] in Abnaof et al., 2014; GEO accession
number GSE46109; data not shown). Important to note is the fact that the influence of
TGF-β1 was specific for DC committed precursors, since MPP did not show this response
(data not shown). To investigate what changes TGF-β1 signalling causes in DC precursors,
we isolated bone marrow from Id2+/– and Id2–/– mice and amplified cells in vitro using an
established protocol (section 2.2.4.2). CDP were FACS sorted at day 7 and treated with
10 ng/ml TGF-β1 for 24 hours or left untreated. Gene expression of TGF-β1 targets and
adhesion molecules was investigated by qRT-PCR, subjected to bidirectional hierarchical
clustering and depicted in heatmap format (Figure 3.17). We hypothesised a TGF-β1
mediated Id2 mechanism also in these precursors.
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Figure 3.17. Gene expression analysis of Id2–/– CDP in response to TGF-β1.
Bone marrow from Id2+/– and Id2–/– mice was isolated and CDP were amplified in vitro with
four cytokines (section 2.2.4.2). After 7 days of culture, CDP were FACS sorted and cultured
further for 24 hours with 10 ng/ml TGF-β1 or left untreated. Cells were harvested and treated for
RNA isolation, followed by reverse transcription and gene expression analysis by qRT-PCR. (A)
Schematic representation of the experiment layout. (B) Expression values were normalised to Gapdh,
depicted as x-ΔCTx100 for indicated genes and presented in heatmap format after row normalization
and subjected to bi-directional cluster analysis using MeV software (blue: below median; white:
equals median; red: above median expression). For untreated Id2+/– CDP the average of three and
for untreated Id2–/– CDP the average of two independent experiments were calculated. For TGF-β1
treatment two and one experiment was performed for Id2+/– and Id2–/– CDP, respectively.
Intriguingly, all genes showed strong induction by TGF-β1, whereas Zeb2 was clearly
repressed (Figure 3.17B). Of note, Zeb2 was, similar to CD8α+ cDC, higher expressed in
untreated Id2–/– CDP compared to Id2+/– CDP. As expected, Id2 expression was absent
in Id2–/– CDP, while strongly induced by TGF-β1 in Id2+/– CDP. All genes involved in
adhesion (Tjp3, Cdh1, Cldn1 and Axl) and the transcription factors Tcf3, Runx3 and Id3
and Smad7, the regulator of TGF-β1 signalling, were induced by TGF-β1, independent
of the presence of Id2. Although, genes were clustered together for (I) higher, (II) equal
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or (III) lower expression in Id2–/– compared to Id2+/– CDP by TGF-β1 treatment, no
correlation of function was observed and due to analysed Ct values no differences were
concluded.
Taken together, no significant differences in gene expression between Id2+/– and Id2–/–
cells were observed for both conditions, untreated and TGF-β1 treated CDP. This led to
the conclusion that Id2 might not mediate adhesion in CDP by this pathway. Further, by
using in vitro culture systems the artificial conditions have to be adapted well, such as the
concentration of TGF-β1. By using 10 ng/ml TGF-β1 the cells could be already activated
too much so that the effect of Id2 deficiency might be undetectable. Important, however, is
the reverse expression of Zeb2 and Id2 in TGF-β1 induced genes in CDP. This might imply
a more resident phenotype of CDP, which are residing in the bone marrow, differentiate
into pre-cDC and those leave the bone marrow to circulate in blood before entering tissue
(Lee et al., 2015).
3.5 Id2-Zeb2 Antagonism Determines Sessile or Motile
Phenotype of DC
Zeb2 is a DNA binding transcriptional repressor, which inhibits expression of genes
important for an epithelial cell state, like adhesion molecules. Therefore, we next investigated
if deletion of Zeb2 promotes anchorage of LC and DC, and induces an anchorage-affiliated
gene expression pattern.
To this end, Zeb2+/+ and Zeb2–/– mice were analysed at least 8 weeks after polyI:C
injection. LC numbers were calculated from immunostained ear sheets for MHC-II (Figure
3.18A). Immunofluorescence microscopy revealed significant elevated LC density in Zeb2–/–
epidermis compared to Zeb2+/+ epidermis (Figure 3.18A and B). It can be reasoned that
this accumulation reflects deficient emigration of Zeb2–/– LC (Konradi et al., 2014). The
decrease in transmigrating LC found in Zeb2–/– dermis compared to Zeb2+/+ dermis is in
support of this reasoning (Figure 3.18C).
75
3 Results
Figure 3.18. Zeb2–/– mice exhibit increased numbers of tissue resident DC.
(A) Epidermal ear sheets of Zeb2+/+ and Zeb2–/– mice were stained for MHC-II and langerin.
One representative picture is shown. Scale bar, 50 µm. (B) Determination of LC per mm2 from
MHC-II+ immunostaining as shown in (A). Three areas per mouse were counted and averaged.
Significances were determined using a two-tailed, unpaired Student’s t-test; (∗∗)p<0.01. N=5. (C)
Flow cytometry analysis of migrating LC in dermal Zeb2+/+ and Zeb2–/– mice. N=2. (D) Single
cell suspension of spleen was analysed by flow cytometry for CD8α+ cDC, CD11b+ cDC and pDC.
(E) Total cell number of DC subsets obtained from flow cytometry analysis. N=3.
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Zeb2 deficiency also impacted on splenic CD8α+ cDC and pDC as determined by flow
cytometry (Figure 3.18D and E). Whereas the number of pDC was dramatically reduced,
lymphoid tissue-resident CD8α+ cDC were strongly increased in Zeb2–/– mice compared to
Zeb2+/+ mice (Figure 3.18E). These observations are in line with recently published data
(Scott et al., 2016). The influence of Zeb2 deletion on gene expression level was analysed in
FACS sorted DC subsets by qRT-PCR (Figure 3.19).
As expected, Zeb2 deletion mostly influenced gene expression in DC subsets that express
Zeb2, i.e. CD11b+ cDC and pDC (Figure 3.19G). Interestingly, Id2 and Itgae expression was
increased, whereas Mmp9 levels were diminished in Zeb2–/– cells compared to Zeb2+/+ cells
(Figure 3.19B, C and D). Thus, Zeb2 deletion renders CD11b+ cDC and pDC, which are
motile DC subsets, a more sessile character. Cd207 (langerin) expression was only marginally
decreased in Zeb2–/– CD8α+ cDC (Figure 3.19E). In contrast, Cdh1 (E-cadherin) expression
was essentially not influenced in Zeb2–/– pDC (Figure 3.19F).
Next, DC from Zeb2+/+ and Zeb2–/– mice were assessed for their expression of specific
transcription factors that determines their cell identity (Figure 3.19H and I). Zeb2 deletion in
pDC imposed a CD8α+ cDC-like identity judged from the elevated Id2 and Batf3 expression
and reduced Spib expression (Figure 3.19B, H and I). Of note, the duplicates of Zeb2–/– pDC
for Cdh1 and Batf3 varied in their expression value, which leads to high standard deviation.
To draw strong conclusions further analyses of mice are required.
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Figure 3.19. Zeb2 deficiency impacts on gene expression in DC subsets.
(A) Single cell suspensions of spleen were FACS sorted for DC subsets. CD8α+ cDC as
Lin10-CD11c+MHC-II+B220-CD8α+, CD11b+ cDC as Lin10-CD11c+MHC-II+B220-CD11b+ and
pDC as Lin10-CD11c+MHC-IIintB220+.(B-I) RNA was isolated from sorted cells, subjected to
cDNA synthesis and analysed by qRT-PCR. Values were normalized to the house keeping gene
Gapdh. nd, not detected. Zeb2+/+ DC subsets, N=3; Zeb2–/– DC subsets, N=2.
In conclusion, Zeb2 deficiency shows the opposite effect than Id2 deficiency, which leads to
an inversed correlation of these transcription factors in DC subset specification. Moreover,
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to induce a sessile or motile phenotype, respectively, Id2 and Zeb2 inhibit each other’s
expression.
3.6 The Important Balance Between Id2 and E Proteins in
LC Development
The interaction of Id2 with proteins of the E family is known to regulate haematopoiesis
(Kee, 2009). The Tcf3 gene encodes the transcription factor E2A with the two different
splice variants called E12 and E47 (for further information see section 1.4.2.1.2). E2A is
known to play an important role in B cell and pDC development (Kwon et al., 2008). An
interesting aspect is the inhibitory function of Id2 on E proteins, also in LC development,
which is the focus in this section. Many studies showed the interaction of Id2 proteins with
members of the E2A family (Kee, 2009).
Id2 lacks a DNA binding domain and by interacting with E proteins Id2 inhibits their
binding to E-boxes. E47 is an Id2 target, moreover, E47 inhibits expression of adhesion
molecules, such as E-cadherin (Perez-Moreno et al., 2001). It has been previously shown
that deletion of E47 in Id2–/– mice could overcome NK cell development (Boos et al.,
2007). Therefore, we asked if the same is true for LC. It is hypothesised that Id2-mediated
inhibition of E47 is needed to induce expression of adhesion molecules and by double
deficiency LC could anchor in their niche. However, the interplay of the transcription
factor E47, one isoform of the E2A gene, with Id2 was not shown so far in the context of
LC.
3.6.1 Id2 Inhibits E47 Binding to Activate Expression of Adhesion
Molecules
To unravel the importance of the balanced expression of E47 and Id2 for LC development
and anchoring, a double knock-out mouse system was analysed. To this end, Id2+/+, Id2+/–
and Id2–/– mice with varying levels of E47 were examined for the presence of LC (Figure
3.20 and Figure B.13).
79
3 Results
Figure 3.20. The double-deficiency of Id2 and E47 restore the Id2+/+ phenotype in
epidermal LC.
(A) Single cell suspensions from epidermis of ventral ear halves of Id2–/– : E47–/– mice, with
varying genotypes, were applied to flow cytometry analysis. Representative FACS plots are
shown with the percentages of CD45+ single cells in skin epidermis. LC were defined as
CD45+MHCII+CD3-CD11c+EpCAM+. See also Figure B.13. (B) Epidermal ear sheets of Id2–/–
: E47–/– mice were stained for MHC-II and langerin. One representative picture is shown for
the indicated genotype. Scale bar, 100 µm. (C) Determination of LC per mm2 from MHC-II+
immunostaining as shown in (B). Three areas per mouse were counted and averaged. N=3-9. (D)
The frequency of LC to CD45+ cells determined by flow cytometry analysis. (E-G) Epidermal
single cell suspensions were stained for LC markers and the mean fluorescence intensity (MFI) of
CD45+MHC-II+ singlet LC was determined for the indicated markers. Error bars represent SD. na,
not analysed. N=3-9.
Flow cytometry analysis of epidermal single cell suspensions showed that deletion of E47
in Id2+/+ mice did not have an effect on LC development (Figure 3.20C and D and
Figure B.13). Strikingly, deletion of E47 in Id2–/– mice restored the presence of LC and
DETC in epidermis (Figure 3.20A - D and Figure B.13). Quantification of LC density by
immunofluorescence microscopy and flow cytometry showed that restoration was partial
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(Figure 3.20A - D). LC density in Id2–/– : E47–/– epidermis was on average 500 LC/mm2,
which is around half of the density found in Id2+/+ : E47+/+ epidermis. Moreover, there
was a dose effect of E47 activity as Id2–/– : E47+/– mice had intermediate LC frequency
with around 25%. Furthermore, it was found that langerin expression in Id2–/– : E47–/–
LC reached similar levels as in Id2+/+ : E47+/+ LC (Figure 3.20E). Most importantly,
expression levels of the epithelial adhesion molecules E-cadherin and EpCAM were also
partially restored in Id2–/– : E47–/– LC (Figure 3.20F and G).
In conclusion, when Id2 is absent the excess of E47 activity inhibits establishment of
an adhesive phenotype. As a result, LC are not retained in epidermis and emigrate
soon after birth. In contrast, when E47 is under the control of Id2, Id2 can promote
the epithelial phenotype and LC stay in epidermis. By deleting E47 in addition to Id2,
the need for Id2 activity is eliminated and the epithelial phenotype is at least partly
re-established.
3.6.2 E2A Expression in Epidermal Cells
In the previous section the deletion of only one E2A product, E47, was investigated. To
study E2A expression and the influence of full E2A deletion on epidermal cells the VavCre+
: E2Af mouse model was used (Kwon et al., 2008). Kwon and colleagues generated this
sophisticated mouse model by introducing loxP sites upstream of exon 17 and downstream
of exon 19 into the Tcf3 gene. E12 and E47 are encoded by exon 18 and are both specifically
deleted in haematopoietic cells due to Cre expression under the Vav promoter. The Tcf3
gene carries further an insertion of a GFP sequence, which is not expressed before Cre-
mediated excision. This leads to the expression of a non-functional E2A-GFP fusion protein
(Kwon et al., 2008).
Therefore, this mouse model can be used as a full knock-out model to investigate E2A
dependent cell types and also used as a reporter for E2A expression due to the expression
of a non-functional E2A-GFP fusion protein. If only one Tcf3 allele carries the mutation
(VavCre+ : E2A+/f), mice can be used as an reporter by using the E2A-GFP fusion protein
as an indicator for E2A expression in nearly unaffected cell subsets because deletion
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of only one allele has only minor impact on E2A dependent cell types (Kwon et al.,
2008).
In the work presented here VavCre+ mice were crossed to E2Af mice to generate E2A+/–
and E2A–/– genotypes. Wild-type mice crossed with E2Af mice are referred to as E2A+/+
mice.
3.6.2.1 E2A Expression during Steady-State
E2A expression in LC during steady-state of adult E2A+/+, E2A+/– and E2A–/– mice was
analysed by immunofluorescence and flow cytometry (Figure 3.21).
First, the influence of E2A deletion was assessed in adult epidermal LC by quantification of
MHC-II+ cells in epidermal ear sheets by immunofluorescence. The frequency of about 700
LC/mm2 in E2A+/+ mice were not influenced by the deletion of E2A (Figure 3.21A). Note,
the frequency of LC in skin epidermis is also dependent on the genetic background of mice
and might therefore differ compared to Id2+/+ : E47+/+ mice (Figure 3.20C). Furthermore,
no expression of the E2A-GFP fusion protein could be detected by microscopy in E2A+/–
mice (Figure 3.21B).
Second, to verify the low expression of E2A-GFP fusion protein in E2A+/– LC, the MFI
was determined by flow cytometry in these mice and compared to DETC and B cells
(Figure 3.21C, D and E). Interestingly, expression of E2A-GFP was high in E2A+/+ LC,
while as expected absent in DETC and B cells (Figure 3.21E). The GFP signal in wild-type
LC was rather high, which might be due to auto fluorescence.
82
3.6 The Important Balance Between Id2 and E Proteins in LC Development
Figure 3.21. E2A deletion has no influence on adult LC.
VavCre+ mice were crossed to E2Af mice to generate E2A+/– and E2A–/– genotypes. E2Af mice
crossed with wild-type mice are referred to as E2A+/+. Epidermis and spleen of adult mice
were analysed by immunofluorescence and flow cytometry. (A) Ear sheets were stained for MHC-
II. LC were counted from MHC-II+ cells and depicted as cells per mm2. (B) Representative
immunofluorescent analysis of adult E2A+/– epidermis. Expression of E2A-GFP fusion protein was
not detectable. Scale bar, 100µm. (C) Representative flow cytometry analysis of E2A+/– epidermis
for LC and DETC. (D) Representative flow cytometry analysis of splenic cells of E2A+/– mice for B
cells. E2A+/+, white histogram; E2A+/–, squared histogram; E2A–/–, striped histogram. (E) Mean
fluorescence intensity (MFI) of internal GFP expression for LC, DETC and B cells was calculated
by flow cytometry analysis. (F) MFI of LC for the according surface markers was assessed by flow
cytometry. N=3.
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Although a significant increase in the expression of E2A-GFP in E2A+/– LC by 1.4-fold
and E2A–/– LC by 1.8-fold was detected, the differences are very small when looking at
the FACS plots (Figure 3.21C). Further, there was an increase of E2A-GFP expression in
DETC, which however was not statistical significant (Figure 3.21E). Only B cells showed
a three-fold increase in E2A-GFP expression in E2A+/– mice compared to E2A+/+ mice
(Figure 3.21E; in agreement with Kwon et al., 2008). As B cells are lacking in E2A–/– mice,
the E2A-GFP expression is again decreased due to low cell numbers. Next, intensities
of surface marker expression on LC by E2A deletion were analysed by flow cytometry
(Figure 3.21F). No significant influence of E2A deletion was observed on the expression of
E-cadherin, EpCAM, langerin and MHC-II in LC (Figure 3.21F).
In summary, the VavCre+ : E2Af mouse model is a weak reporter system to follow E2A
expression in E2A dependent cell types. Although, Tcf3 might be expressed at moderate
levels in LC, expression of the E2A-GFP fusion protein could not be detected in tissue
context by immunofluorescence. Further, a three-fold increase in E2A-GFP expression
in E2A+/– B cells compared to E2A+/+ B cells is not very strong. However, during
development E2A might be stronger induced and following expression of the E2A-GFP
fusion protein might be detectable with the reporter mouse.
3.6.2.2 E2A Expression during LC Development
To determine the E2A dependency during LC development, P10 old newborn epidermis
was analysed by immunofluorescence and flow cytometry (Figure 3.22). Interestingly,
the number of 700 LC/mm2 was significantly decreased by 1.3-fold in E2A–/– newborns
compared to control (Figure 3.22A). However, expression of the E2A-GFP fusion protein
was not visible by microscopic analysis in E2A+/– and E2A–/– newborns (Figure 3.22B).
This is in agreement with flow cytometry analysis, where no significant increase in the MFI
of E2A-GFP in LC was detected (Figure 3.22C). In contrast, DETC showed an increase of
the MFI of E2A-GFP in E2A+/– and E2A–/– newborns, yet with large variation in E2A+/–
DETC (Figure 3.22C). Determination of the expression level of important LC surface
markers by E2A deletion showed a clear reduction of langerin expression in E2A–/– LC.
E-cadherin, EpCAM and MHC-II were not affected (Figure 3.22D).
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Figure 3.22. E2A deletion in newborn LC lead to decreased langerin expression.
Epidermal skin was analysed from P10 old E2A+/+, E2A+/– and E2A–/– mice. (A) LC count
from MHC-II+ LC of immunofluorescent stained epidermis. (B) Representative immunofluorescence
analysis of E2A+/– epidermis. Expression of E2A-GFP fusion protein was not detectable. Scale bar,
100 µm. (C) The mean fluorescence intensity (MFI) of the expression of E2A-GFP protein in LC
and DETC was calculated by flow cytometry analysis. (D) Representation of the mean fluorescence
intensity (MFI) of different surface markers on LC. E2A+/+, N=4; E2A+/–, N=4; E2A–/–, N=2.
(E and F) Epidermal single cell suspensions of (E) C57BL/6 wild-type newborns or (F) Id2+/–
and Id2–/– newborns were FACS sorted for LC, followed by RNA isolation, cDNA preparation and
qRT-PCR analysis for Tcf3. Values were normalised to the house keeping gene Gapdh. For sorting
strategy see Figure B.1A and Figure 3.9A.
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Next, Tcf3 expression was assessed during LC development in epidermal LC. To this end,
epidermal single cell suspensions from wild-type newborns were FACS sorted for LC and
applied to qRT-PCR analysis for Tcf3 (Figure 3.22E). Tcf3 is induced in LC at P2 and
increased in expression level in time. The drop of Tcf3 expression at P14 most probably
represents the switch from the tissue from ventral skin to ears (see section 2.2.3.4). Further,
LC from Id2+/– and Id2–/– newborns were analysed for the expression of Tcf3 (Figure
3.22F). Interestingly, the strong induction of Tcf3 expression in time could not be detected
in here (Figure 3.22E and F). Furthermore, deletion of Id2 in newborn LC had no impact
on the expression level of Tcf3 (Figure 3.22F).
Summarised, the transcription factor E2A might play a role in LC development as its
expression increases with differentiation in LC and E2A–/– newborn skin showed reduced
numbers of LC. Furthermore, these E2A–/– LC showed a clear reduction in langerin
expression, which is important for proper LC differentiation. The experiments performed
so far do not provide explanations why LC might be impaired during development in E2A
deficient mice. However, adult E2A–/– mice showed no abnormalities in LC frequency and LC
surface marker expression compared to E2A+/+ mice. Therefore, it can be only hypothesised
that LC differentiation might be slower in E2A–/– mice compared to control mice and that
these deficiencies are somehow compensated until adulthood. Nevertheless, due to the weak
expression level of the E2A-GFP fusion protein, this reporter mouse seem not to be suitable
to trace E2A activity in tissue context during DC development.
3.7 Investigating the Potential Impact of Rap1GAP on LC
Development
The Ras-related protein 1 (Rap1)-GTPase activating protein (Rap1GAP) is ubiquitously
expressed and is known to be a master regulator of cell adhesion, cell polarity, cytoskeleton
dynamics and cell motility (Lin et al., 2010). With its specific target, the small guanine-
triphosphatase Ras-related or Ras proximal protein 1 (Rap1), GAP promotes the change
of the active, GTP-bound form to the inactive, the GDP-bound form by hydrolysis of the
GTP. This reaction can be reversed by guanine nucleotide exchange factors (GEF) that
lead to the dissociation of GDP to allow binding of GTP.
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Rap1 is a major activator of integrins and dysregulation of Rap1 activation is responsible
for the development of malignancies. The distribution of adherens junctions, required for
tumour growth, is an active process that requires the small guanine-triphosphatase Rap1
(Knox and Brown, 2002). The family of Ras small GTPase superfamily of proteins include
Rap1A and Rap1B.
Figure 3.23. Predicted Rap1GAP interaction with Id2 in LC.
(A) During steady-state Id2 inhibits Rap1GAP activity. LC can anchor in the epidermis when there
is an equilibrium of Rap1-GTP and Rap1-GDP. (B) In Id2–/– mice LC leave epidermis due to an
increase of Rap1-GDP that inhibits integrin activation. Adapted from Potla et al., 2014 and Niola
et al., 2012.
Niola and co-workers showed the interaction of Id proteins with Rap1 activity (Niola
et al., 2012). Through Id deficiency Rap1GAP is upregulated, which leads to the de-
phosphorylation of GTP to GDP. In turn, Id proteins repress Rap1GAP expression,
which favours the sustained Rap1 activity and therefore adhesion of neural stem cells
to the extracellular matrix molecules and attachment to the niche (Lathia and Rich,
2012). Following, a potential role of Rap1GAP was predicted in the anchorage process of
LC in skin epidermis. This process might be disrupted by the deficiency of Id2 (Figure
3.23).
There are two types of Rap1GAP proteins, Rap1GAP and Rap1GAP2. The Rap1gap gene
encodes a type of GAP that downregulates Rap1 activity and promotes the hydrolysis of
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bound GTP to the inactive state GDP. The Rap1gap2 gene encodes a GAP that activates
Rap1 e.g. in human platelets (Schultess et al., 2005).
3.7.1 Rap1GAP is not Expressed while Rap1GAP2 Expression is
Induced in Id2–/– LC
For determining a possible influence of the Rap1GAP proteins in LC anchorage, LC were
analysed for the expression of Rap1gap and Rap1gap2. To this end, sorted LC from wild-type
mice at P14 and adult and from Id2+/– and Id2–/– mice at P8 and P18 were applied to
RNA isolation, cDNA preparation and qRT-PCR.
Rap1GAP was shown to downregulate the activity of Rap1 proteins. However, Rap1gap
expression was not detected in FACS sorted LC from wild-type mice at P14 and adult mice
and also not in LC from Id2–/– newborns at P8 and P18 compared to Id2+/– newborns
(data not shown; detection limit was set to a Ct value 5 32).
Next, the expression of Rap1gap2 in LC was assessed.
Figure 3.24. Rap1gap2 is low expressed in Id2–/– LC.
(A and B) LC were sorted from C57BL/6 wild-type mice at P14 and adult (A) and from Id2+/– and
Id2–/– mice at P8 and P18 (B) and applied to qRT-PCR analysis for Rap1gap2. The fold Gapdh
expression of Rap1gap2 is shown. Detection limit was below a Ct value of 32 and is indicated by the
red line. (C and D) Relative expression of Rap1gap2 in TGF-β1 treated CDP (C) and MPP (D) of
in vitro cultured C57BL/6 wild-type bone marrow for 0, 2, 4, 8, 12 or 24 hours. Cells were applied
to microarray analysis and are from Abnaof et al., 2014 (GEO accession number GSE46109).
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Rap1gap2 was not detected in wild-type LC sorted at P14 and adult mice (Ct vlaue
= 32, Figure 3.24A). Notably, in FACS sorted LC from Id2+/– and Id2–/– newborns
at P8 Rap1gap2 expression was detected (Figure 3.24B). Expression decreased during
development and at P18 Rap1gap2 was no longer detectable in Id2+/– LC but still in Id2–/–
LC (Figure 3.24B).
TGF-β1 is a local growth factor that impacts on DC and LC differentiation and anchorage
(Felker et al., 2010; Mohammed et al., 2016). To investigate the changes in gene expression
induced by TGF-β1 signalling in DC precursors, we inspected our previously published
microarray data in Abnaof et al. (GEO accession number GSE46109; Abnaof et al., 2014).
Briefly, MPP and CDP from in vitro cultured bone marrow cells of wild-type mice were
treated with TGF-β1 for different periods of time and processed for microarray analysis.
These data were kindly provided by Kristin Serè, PhD, Institute for Biomedical Engineering,
Department of Cell Biology, RWTH Aachen University, Aachen, Germany (Figure 3.24C
and D). Of note, Rap1gap was not expressed in both MPP and CDP (data not shown). In
contrast, Rap1gap2 was expressed and was repressed in its expression by TGF-β1 treatment
in CDP (Figure 3.24C) but only moderately in MPP (Figure 3.24D). To this end, a possible
influence in DC and LC anchorage by Rap1GAP2 through repression by Id2 can be inferred
because Id2 is a TGF-β1 target gene.
Thus, these data are in support of the hypothesis where Rap1GAP2 might be involved in
anchorage of LC. Rap1GAP2 promotes Rap1 activity, which leads to integrin activation and
thus anchorage of cells in their niche. In Id2 deficiency an induction of Rap1GAP2 activity
could result in integrin inactivation and thus LC emigration (Figure 3.23). Nevertheless, due
to the low expression levels of Rap1gap2 no strong conclusions can be drawn and further
studies are needed to provide more evidence for the interplay between Id2 and Rap1GAP2.
Further, steady-state LC expressed Rap1gap2 at low level (which could be due to the low
amount of material). Thus further studies are required to substantiate the hypothesis on
Rap1GAP2 being involved in LC anchorage in their niche.
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3.8 Gfi1 Transcription Factor has a Minor Impact on LC
Ontogeny
Growth factor independence 1 (Gfi1) is one of the key regulators of haematopoiesis
(van der Meer et al., 2010; section 1.4.2). It is required to hold stemness of HSC (Zeng
et al., 2004; van der Meer et al., 2010). Gfi1–/– mice are impaired in DC and show a
significant enhancement of LC (Rathinam et al., 2005). Furthermore, Gfi1 is required
for the development of B cells, T cells and neutrophils (Li et al., 2010). Recently Li and
colleagues showed that Id2 is a transcriptional target of Gfi1 and that B cell and myeloid
development require Gfi1 mediated repression of Id2 (Li et al., 2010).
We hypothesised that Gfi1 represses Id2 also in LC and when Gfi1 is deleted Id2 can lead
to more effective anchoring of LC in skin epidermis, which leads to increased LC frequen-
cies. To this end, the epidermis from Gfi1–/– (conventional knock-out mice), Gfi1KD/KD
(conditional knock-out; mice, which express only 20% of the normal level of Gfi1), Gfi1+/–
and Gfi1+/+ (wild-type, control) mice were assessed by immunostaining and flow cy-
tometry analysis (Figure 3.25). Gfi1–/– and Gfi1KD/KD mice were kindly provided by
Cyrus Khandanpour, MD, Department of Hematology, Essen University Hospital, Essen,
Germany.
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Figure 3.25. Gfi1 deletion has only a minor impact on LC ontogeny.
(A) Epidermal ear sheets of adult mice were stained by immunohistochemistry for MHC-II and
langerin. Scale bar, 100 µm. (B) The number of MHC-II+ cells were determined and are shown
as cells/mm2. Three different areas were counted per genotype. (C) Single cell suspensions from
epidermal ear sheets were stained for flow cytometry analysis and the frequency of LC (CD45+MHC-
II+CD11c+CD3-CD24+EpCAM+) were calculated. (D) Single cell suspensions from epidermal
ear sheets were stained for flow cytometry analysis and the frequency of DETC (CD45+MHC-
II-CD11c-CD3+) were calculated. N=1; Replicates were performed by treating ventral epidermis of
left and right ears separate during experimental procedure.
MHC-II+ cells in epidermal ear sheets were elevated 1.3-fold in Gfi1–/– mice compared
to Gfi1+/+ mice (Figure 3.25A and B). Gfi1KD/KD mice, however, showed no elevation of
LC numbers in epidermal skin. Gfi1+/– mice showed a similar trend as Gfi1–/– mice, the
results were, however, not statistical significant. Frequencies of LC and DETC determined
by flow cytometry showed also no influence of Gfi1 deletion on both cell subsets (Figure
3.25C and D).
We emphasize that these preliminary results need to be verified by the analysis of further
mice. In summary, the Gfi1 - Id2 axis in LC represents an attractive hypothesis, however, an
increase of LC frequency by Gfi1 deletion as stated by Rathinam and co-workers (Rathinam
et al., 2005) could not be reproduced here.
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3.9 Influence of Msc on Haematopoietic Cell
Development
Musculin (Msc) has been identified as a dimerization partner of E2A during B cell differen-
tiation (Massari et al., 1998; Janz et al., 2006) and overexpression of Msc was shown to
disrupt B cell differentiation (Mathas et al., 2006). Most of these studies were performed
in human. Msc was also shown to be an important factor expressed in mouse embryonic
skeletal muscle (Lu et al., 2002). Other physiological functions of Msc are not known so far.
Msc is assumed to exhibit a similar role as Id2 in DC development and was reported to be
upregulated during DC differentiation (Hacker et al., 2003). Therefore, a possible impact
on DC subsets was predicted, including Msc dependent interactions of E2A proteins in the
absence of Id2.
3.9.1 Msc Deletion in Epidermal Cells
To analyse a potential influence of Msc and a possible compensation for Id2 in skin epidermal
cell subsets, Id2–/– mice with varying Msc genotypes were analysed by immunofluorescent
staining and flow cytometry (Figure 3.26). Quantification of LC numbers from epidermal
stainings for MHC-II (Figure 3.26A) showed no significant influence of Msc deletion on
LC numbers (Figure 3.26B). Further, Msc could not restore the LC phenotype in skin
epidermis in Id2 deficient mice (Figure 3.26B). These findings were confirmed by flow
cytometry analysis (Figure 3.26C).
Next, the analysis of Msc deletion in DETC were analysed by flow cytometry (Figure
3.26D). However, also DETC did not show significant influences of Msc deletion (Figure
3.26D).
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Figure 3.26. Msc deletion has no impact on LC ontogeny.
(A) Epidermal ear sheets of adult mice were stained by immunohistochemistry for LC by MHC-II
and langerin. Representative pictures for MHC-II are shown for the indicated genotypes. Scale
bar, 100 µm. (B) The number of MHC-II+ cells were calculated per mm2 from immunostained ear
sheets shown in (A). The average of three areas for each mouse was calculated. Id2+/– : Msc+/+,
N=5; Id2+/– : Msc+/–, N=4; Id2+/– : Msc–/–, N=5; Id2–/– : Msc+/+, N=1; Id2–/– : Msc+/–, N=1;
Id2–/– : Msc–/–, N=2. (C and D) Cell suspensions from epidermal ear sheets were analysed by
flow cytometry and the number of LC, CD45+MHC-II+CD3-CD11c+EpCAM+ (C) and DETC,
CD45+MHC-II-CD3+ (D) was calculated. nd, not detected. Id2+/– : Msc+/+, N=3; Id2+/– : Msc+/–,
N=3; Id2+/– : Msc–/–, N=3; Id2–/– : Msc+/+, N=1; Id2–/– : Msc+/–, N=1; Id2–/– : Msc–/–, N=1.
Taken together, Msc deficiency showed no influence on LC and DETC development, and
thus we conclude that Msc is dispensable for these cell subsets and does not compensate
for Id2 deficiency. However, more experiments have to be performed and maybe other tools
have to be used to draw strong conclusions from these results.
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3.9.2 Splenic Cells are Not Affected by Msc Deletion
Next we analysed splenic cell subsets in Id2–/– : Msc–/– mice with various genotypes. No
effect of Msc deletion was observed for CD8α+ T cells, CD4+ T cells, B cells (Figure 3.27A),
CD8α+ cDC, CD11b+ cDC and pDC (Figure 3.27B). The decrease in CD8α+ T cells,
CD8α+ cDC and increase in B cells in Id2–/– mice is not an effect of the Msc deletion, rather
it is the phenotype of Id2 deficiency (Figure 3.27B, upper panel).
Figure 3.27. Msc deletion has no impact on splenic lymphoid cells.
Cell suspensions from spleen of Id2–/– : Msc–/– mice were stained for flow cytometry analysis. The
percentage of CD45+ cells and the total cellularity was determined. (A) Splenic T cell subsets and B
cells. For marker discrimination see section C.1. (B) Splenic DC subsets. For marker discrimination
see section C.1. na, not analysed. N=1-2.
In summary we conclude that Msc does not play a role in the development of splenic DC
subsets and other haematopoietic cell types analysed here. The assumption that Msc might
play a similar role as Id2 in specific cell subsets is disproved.
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3.9.3 Myeloid Progenitors are Affected by Msc Deficiency
So far no influence of Msc was observed in differentiated haematopoietic subsets, yet a
possible role for Msc in the precursors still need to be investigated.
To this end, flow cytometry analysis of haematopoietic stem cells and DC precursors in
bone marrow was performed (Figure 3.28). LT-HSC, ST-HSC, LSK and MPP revealed no
significant impact of Msc deletion (Figure 3.28A).
Figure 3.28. Msc deletion impacts on haematopoietic precursors.
Cell suspensions from bone marrow of Id2–/– : Msc–/– mice were stained for flow cytometry analysis.
The percentage of CD45+ cells as well as the total cellularity was determined. Results are shown
for (A) LT-HSC, ST-HSC, LSK and MPP, (B) CMP, GMP and MEP, and (C) CLP and CDP. For
gating strategy see section C.1. N=3-4. Significances were determined using a two-tailed, unpaired
Student’s t-test; (∗)p<0.05; (∗∗)p<0.01.
Interestingly, the myeloid lineage with the precursors CMP, GMP and MEP showed a trend
or a significant decrease in population size upon Msc deletion, regardless of Id2 deletion
(Figure 3.28B). In CMP this effect was lost when Id2 was deleted in addition. The same
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result was obtained for CLP, where Msc deletion lead to a reduction of population size in
Id2+/– mice but not in Id2–/– mice (Figure 3.28C).
CDP were decreased in cell numbers upon progressive deletion of Msc, however, the results
were not significant. Of note, a significant decrease in CDP frequency was observed in Id2–/–
: Msc+/– mice compared to double deficient mice and Id2–/– : Msc+/+ mice. However, this
effect cannot be explained at this stage of analysis.
To conclude, the cell types analysed in here showed that Msc might be an important factor
for haematopoietic cell differentiation, however, due to high standard deviations, more
mice have to be analysed to draw a clear picture for Msc depletion in haematopoietic
precursors.
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Transcription factors, growth factors and cytokines play essential roles during DC develop-
ment. HSC mature into DC via specific intermediate progenitors. During this process, the
ongoing loss of developmental potential of the intermediate cell types and the activation of
a lineage-specific gene expression profile defines the character of the mature cell. Id2 is a
member of the inhibitory bHLH transcription factor family that antagonize the action of
activating bHLH transcription factors. It is well established that Id2 plays an important
role in the development in LC and CD8α+ cDC (Hacker et al., 2003). However, the targets
of Id2 are largely unknown, although the interaction with one or more E proteins is very
likely (Boos et al., 2007).
4.1 MET in the Development of Tissue-Resident DC
We showed that Id2–/– LC and CD8α+ cDC show strongly increased expression of Zeb2,
a critical regulator of cell migration. Concomitantly, Id2–/– DC express reduced levels of
adhesion molecules, which prohibit their stable anchoring to surrounding cells and increased
expression of the enzyme MMP-9 to degrade the contact to extracellular matrix. Vice
versa, Zeb2–/– mice show less migratory function and an increase in LC and CD8α+ cDC
by concomitant reduction in pDC. Thus, we conclude that antagonistic expression pattern
of Id2 and Zeb2 determines the resident (epithelial) or migratory (mesenchymal) phenotype
of DC precursors and DC. This implies for the first time that Id2 and Zeb2 are not only
transcription factors responsible for lineage commitment, but are rather important for the
epithelial and mesenchymal phenotype of DC subsets.
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Figure 4.1. Id2 dependent LC development.
Schematic representation of the amount of LC in skin epidermis in Id2+/+ mice compared to Id2 –/–
mice. Id2 expression in LC development is depicted from the Id2-CreERT2+ lineage tracer mouse
model. Further, schematic representation of Zeb2 expression and expression of adhesion molecules
in Id2+/+ and Id2–/– mice. It is postulated that LC execute MET between P5 and P18. Kindly
provided by Kristin Serè, PhD, Institute for Biomedical Engineering, Department of Cell Biology,
RWTH Aachen University, Aachen, Germany.
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Konradi and colleagues postulated that Zeb2 and N-cadherin are inducers for LC migration
and that EMT drives the mobilization of LC (Konradi et al., 2014). In this regard we showed
that already during embryonic development the reverse process, the MET, is important for
LC development. Zeb2 is needed for LC precursor migration and subsequent downregulation
of Zeb2 and upregulation of Id2 facilitates the MET process (Figure 4.1). Furthermore,
tight junction proteins like E-cadherin are direct targets of transcriptional repressors, such
as Zeb2, which is a key driver of EMT (Huang et al., 2012; Vandewalle et al., 2005). We
could show that the epithelial proteins needed for anchoring are downregulated in Id2–/–
newborns in LC by concomitantly upregulation of Zeb2 (Figure 4.1).
In this study we used the Id2-CreERT2+ mouse model, which allows the analysis of time
point specific Id2 expression in DC development. The Id2-CreERT2+ mouse model has
been already used to label well-defined cell populations during mouse lung development
(Rawlins et al., 2009), yet this model has not been investigated for other cell types. We
showed that this model is a convenient tool for lineage tracing the Id2 expression during DC
development. Although many publications show the importance of Id2 for cell differentiation
and cell cycle progression (Yokota and Mori, 2002), Seillet and colleagues postulated that
Id2 is not essential for the induction of the generation of CD8α+ cDC (Seillet et al., 2013).
This underlines our findings, where LC and CD8α+ cDC are generated in Id2–/– mice,
however they leave their niche again, due to impaired adhesion and following impaired fully
immunological differentiation (Figure 4.1). During LC and DETC proliferation we found a
drop of Id2-eGFP expressing cells at P5, which might be of importance for controlling cell
density in skin epidermis. We hypothesise that Id2 might control the amount of cells that
settle in skin epidermis.
Id proteins inhibit DNA binding of E proteins like E47 via heterodimer formation. E47 is
particularly important for lymphoid lineage development, but is also expressed in HSC,
DC progenitors and DC (van Galen et al., 2014; Niola et al., 2012). In the DC lineage,
E47 activity favours the pDC program and needs to be blocked to enable differentiation of
cDC. Accordingly, Id2–/– mice show increased number of pDC (this manuscript and Hacker
et al., 2003). Our data show that there are two aspects on Id2 mediated E47 inhibition in
DC subset development. One aspect is blocking pDC genes like Spib and activating CD8α+
cDC genes like Batf3. Id2–/– CD8α+ cDC show increased Spib expression and reduced
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Batf3 expression. A second aspect is repressing Zeb2 and concomitantly inducing adhesion.
E47 has been implicated in repression of adhesion molecules and thus preservation of a
mesenchymal phenotype. This second aspect of Id2 activity is shared by LC and CD8α+
cDC and deletion of E47 in Id2–/– mice partly rescues anchoring.
Epidermal LC and lymphoid tissue CD8α+ cDC are DC subsets, which differ in location,
origin, life span and function. Yet, they have a few features in common. Both subsets are
tissue-resident DC that have to adhere to their surrounding environment. Furthermore,
both subsets develop from precursors that immigrate in the tissue of destination and locally
undergo the final steps of differentiation.
CD8α+ cDC derive from pre-cDC, which are generated in bone marrow. Pre-cDC leave bone
marrow and migrate towards lymphoid or non-lymphoid tissue where they differentiate in
response to local growth factors (Guilliams et al., 2014; Schlitzer et al., 2015). Therefore, pre-
cDC preserve a mesenchymal phenotype until they arrive at their destination, where they
become resident, downregulate mesenchymal regulators and acquire an adherent/epithelial
state when differentiating into CD8α+ cDC. A similar series of events occurs during LC
development. When the embryonic epidermis develops (between E16.5 and E18.5) LC
precursors immigrate and start to differentiate (Chorro and Geissmann, 2010). Once LC
precursors arrive in epidermis they should acquire an epithelial phenotype (by undergoing
MET) and downregulate mesenchymal genes. In line with this, we observed in Id2 lineage
tracer mice that Id2 expression only reaches high levels at a post-precursor stage (Figure
4.1). Indeed, we do not find eGFP+ pre-cDC or eGFP+ CD11b+ cDC. Similarly, we only
find eGFP+ LC when mice are treated with tmx after birth, the time that LC start to
differentiate. When Id2 lacks, the switch from a migratory to a stationary phenotype during
these final steps of differentiation does not happen and CD8α+ cDC and LC are not able
to stably adhere in their niche (Figure 4.2). Like the skin epidermis for LC, CD8α+ cDC
are tissue-resident DC found in their niche of lymphoid tissue, such as the spleen. In spleen
they reside in the white pulp next to the T cell zone, where they can activate those. In
contrast, CD11b+ cDC remain in the marginal zone and do not anchor to their niche
(Figure 4.2; Hey and O’Neill, 2012).
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Figure 4.2. Id2 dependent MET in LC and CD8α+ cDC in their niche.
Id2 induces an epithelial-like phenotype in LC and CD8α+ cDC, which induce fully differentiation
and immunological function of these cells. Embryonic LC precursors and bone marrow derived
pre-cDC precursor travel to their tissue of choice independent of Id2, while Id2 is needed for their
anchoring. In case of Id2 deficiency, cells cannot undergo MET and leave the tissue again without
fully differentiation. Spleen is composed of capsule (black), red pulp (red) and white pulp (white).
In the white pulp the CD8α+ cDC reside in the T cell zone (dashed lines), whereas CD11b+ cDC
remain in the marginal zone (yellow) of the white pulp (Hey and O’Neill, 2012).
pDC fully differentiate in bone marrow, immigrate and travel through blood. pDC should
therefore retain expression of mesenchymal genes and indeed show high Zeb2 expression. If
they do not, pDC might lack the capacity to leave the bone marrow and might accumulate
there. This assumption could be followed in bone marrow of Zeb2–/– mice, which revealed
an reduction of splenic pDC and an elevation in CD8α+ cDC (in accordance to Scott
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et al., 2016). Scott et al., 2016 demonstrated that Zeb2 regulates commitment to cDC
and pDC lineages through repression of Id2. We further showed that deletion of Zeb2
gives pDC a CD8α+-like gene expression pattern, with elevated Id2 and reduced Spib
expression levels. Thus pDC need Zeb2 to acquire a proper pDC identity, which requires
E47 activity and thus inhibition of Id2. Further, Scott et al., 2016 speak about Zeb2 only
as an transcription factor responsible for lineage commitment. We would conclude further
from data demonstrated here that Zeb2 gives DC a mesenchymal phenotype, while when
repressed by Id2, DC anchor in their niche (Figure 4.3). In newborn LC, Zeb2 was the
only mesenchymal marker to be upregulated.
It is tempting to speculate that in other Id2-expressing haematopoietic cells, Id2 might
promote anchorage as well. A recent study showed that HSC express Id2 and that over-
expression of Id2 and Id3 in HSC affected their interaction with the niche and thus their
differentiation (van Galen et al., 2014). Also NK cells are dependent on Id2 for development.
Interestingly, Boos and colleagues reported that NK cell development is restored when E47
is deleted in addition to Id2 (Boos et al., 2007). However, E47–/– Id2–/– NK cells did not
accumulate in spleen and the authors suggested that they fail to immigrate from bone
marrow. This would fit in a model where E47 is needed to promote motility of cells (Figure
4.3). Mature NK cells reside in secondary lymphoid organs and tissues and recirculate not
only in the blood but also in the lymph. DETC development is also dependent on the
transcription factor Id2. Although they express Id2 during embryonic stages, Id2 might be
important postnatal for their anchoring in epidermis. In Id2–/– mice, DETC immigrate
from epidermis already around P10. We showed that genes important for differentiation of
DETC (Prinz et al., 2013; Hao and Whitelaw, 2013; Woolf et al., 2007) were not affected
in Id2–/– mice, therefore a disrupted MET in these cells could also apply. However, we
could not determine the mesenchymal marker that is active in Id2–/– DETC and leads to
migration out of their niche. This leads to the hypothesis that other mesenchymal markers
might be involved in the migration of DETC.
The importance of TGF-β1 signalling in LC biology is long known (Borkowski, 1996).
TGF-β1 signalling in epidermis is critical for LC maturation. Studies with TGF-βRI–/–
mice showed a gradual loss of LC during the first week (Kel et al., 2010). As a downstream
target of TGF-β1, Id2 may have similar influences on the development on LC in newborn
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Figure 4.3. Predicted transcriptional signalling during LC development and the down-
stream influence of Id2 on E47 and Zeb2.
Schematic representation of gene network in LC to maintain epithelial requirements.
as shown with our experiments. In a recent study the importance of TGF-β1 signalling for
LC maintenance was reported (Mohammed et al., 2016). It is likely that the TGF-β1-rich
environment in skin induces differentiation but also anchoring of LC shortly after birth
(Figure 4.3); Hacker et al., 2003). In addition, it was shown that TGF-β1 inhibits pDC
generation by upregulating the cDC program (Felker et al., 2010). Thus, also in lymphoid
tissue DC, upregulation of Id2 in response to local growth factor production regulates
differentiation and anchoring.
4.2 Immunity in Skin
The skin is composed of the epidermis and the dermis that are connected through the
basement membrane (Heath and Carbone, 2013). Through the variety of cell types and
structures, each layer is highly complex (section 1.3). The main cell types in the epidermis,
LC, DETC and keratinocytes, build a dense network to fulfil the first immunological
barrier against invading pathogens. To maintain this immunological network it might
be of importance that both, LC and DETC, have to differentiate properly to provide
each other the appropriate niche. If one cell type is absent, the other cannot differentiate
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properly. Here, the paracrine signalling of certain cytokines and growth factors might be of
importance. For example, DETC are an important source for GM-CSF that is needed for
LC maturation (Hao and Whitelaw, 2013). Although many chemokines and cytokines are
known to be released from the different cell types, not all factors are are known to unravel
the communication between them (Figure 4.4). With the Id2-CreERT2+ lineage tracer
model it was shown that Id2 expression in the epidermis is locally restricted. These patches
of Id2-eGFP+ cells include LC and DETC and often also patches of cycling keratinocytes
were labelled. This implies that cells of the epidermis might be synchronized in segments.
This would allow the immune cells to react fast and simultaneous in response to local
changes detected by one or the other cell type, such as skin lesion or infections. Furthermore,
as an epithelial factor deciphered in this manuscript, Id2 expression might be responsible
in these patches for the establishment of the constant cell network. The assembly of LC
and DETC in between the keratinocytes is very regular and if there would be too much
anchorage of LC and DETC, downregulation of Id2 expression would lead to immigration
or EMT of these cells (Figure 4.4; section 4.1). This result is in line with findings of Chorro
and colleagues, which showed a decline in the proliferation marker Ki67 from P4 to P7
(Chorro et al., 2009).
Figure 4.4. MET and EMT in LC life cycle.
Schematic representation of the skin epidermal network. LC, DETC and keratinocytes release
different factors that influence the behaviour and maturation of each other and themselves. LC
precursors undergo MET in epidermis. Different factors are responsible for LC maturation and
anchoring of LC to acquire the epithelial phenotype. Inducer of EMT, like hepatocyte growth factor
(HGF), are involved in the immigration of LC.
Recently, our group reported that upon local skin inflammation a wave of monocyte-derived
short-term LC transiently populates epidermis (Seré et al., 2012). In time, they are replaced
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by steady state long-term LC. These inflammatory short-term LC express much lower levels
of TGF-β1 target genes Smad7, Id2 and Cd207 (langerin), compared to long-term LC (Seré
et al., 2012). In the context of our current observations, we hypothesise that these monocyte-
derived inflammatory LC do not undergo MET when entering epidermis. Therefore, they
do not have the capacity to anchor. Three weeks after induction of inflammation, virtually
no short-term LC are left in the epidermis, a very similar kinetics of disappearance as
observed here for Id2–/– LC in newborns. Id2–/– LC do not upregulate langerin, similar to
short-term LC. Short-term LC were devoid of birbeck granules, the factory to produce the
langerin receptor. Following, it can be speculated that Id2–/– LC might also be devoid of
birbeck granules, which needs to be proven in further studies.
4.3 Conclusions
In summary, this work defined a novel mechanism for Id2 as an inhibitor for Zeb2 expression,
mediated by dimerization with E47, which leads to anchoring of tissue-resident DC. We
showed that Id2 and Zeb2 act not only as lineage commitment transcription factors, but
additionally convert the migratory/mesenchymal or stationary/epithelial phenotype of DC
subsets. The MET is a necessary step for cell subset specification to anchor in their niche.
As a mesenchymal marker, Zeb2 is important of LC and CD8α+ cDC migration to their
niche, and Id2 is an important regulator for suppressing Zeb2 expression and following
anchoring in the niche.
4.4 Future Perspective
Several interesting aspects were shown in this study by analysing the important role of the
transcription factor Id2 in the anchoring process of DC in their respective niche. These
observations might be a common anchoring mechanism not only specific for DC subsets
but also for other sessile cells. Yet, this thesis focused only on the development of DC even
though it is well known that this transcription factor regulates also other cell types, such
as NK cells. Therefore, NK cells would be another interesting cell type to be investigated
in future studies regarding their anchoring factors.
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The skin epidermis is a niche for two important immune cell types, LC and DETC.
Determining also the mesenchymal marker responsible for DETC immigration in Id2–/–
newborns would be a further attempt. Importantly, DETC express Id2 already early
during embryonic development. This have to be taken into account when also Id2–/– DETC
leave the epidermis in neonates. Further, keratinocytes are also dependent on Id2 during
cell cycling. This interplay between the skin immune cells and the communication with
keratinocytes might be of further interest to understand skin immunity in future. Here the
auto- and paracrine secretion of TGF-β1 might be an interesting aspect to be analysed in
the regulation of the different epidermal cell types.
During embryonic development and also during steady-state haematopoiesis the conversion
of a migratory precursor to often a sessile mature cell type is very important. To this
end, it might be interesting to analyse also other haematopoietic cells for important MET
factors.
To stress the findings shown in this study, in future the direct binding of the transcription
factor E47 to the proximity of the Zeb2 promoter would be of interest. This would imply the
interaction of the factors responsible for anchoring in and migration out of the respective
niche. Also unrevealing enzymes, such as Mmp9, and cytokine gradients that are needed to
overcome adhesion to the surrounding cells and makes migration possible are interesting
aspects to be analysed.
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A.1 Genotyping of Used Mouse Strains
DNA Isolation
Routinely, genomic DNA from tissue (tail cuts) was isolated using the NucleoSpin® Tissue
Kit (Macherey & Nagel) according to the manufacturer’s protocol. For Id2-CreERT2+
mice and VavCre+ : E2Af mice genomic DNA from tissue (tail cuts) was obtained by using
NaOH method. Briefly, 500 µl of 50 mM NaOH were added to the tissue and incubated
for 1-3 hours at 95 °C, cooled to 4 °C, centrifuged for 1 min at 13,2 rpm and then further
processed by polymerase chain reaction (PCR).
Polymerase Chain Reaction
The reagents used for PCR were obtained in the concentrations and from suppliers
as stated in Table A.1. PCR was run in a Thermocycler from Eppendorf (Mastercy-
cler).
Table A.1. Reagents used for PCR.
Reagent Concentration Supplier
Primer 10 µM Eurofins
Taq Polymerase buffer NH4, w/o MgCl2 Fermentas
MgCl2 25 mM Fermentas
dNTPs 10 mM Fermentas
Taq Polymerase home-made
PCR for Id2-CreERT2+ mice
For genotyping of Id2-CreERT2+ mice the following primers (Table A.2) were used in
the PCR reaction (Table A.3) with stated conditions (Table A.4). The expected band
size of the PCR products are in Table A.5 and were visualized on a agarose gel (see
below).
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Table A.2. Primer sequences for genotyping Id2-CreERT2+ mice.
No. Id2-CreERT2 Rosa26-eGFP
P1 WT-fw CTTCCTCCTACGAGCAGCAT 01F CACTTGCTCTCCCAAAGTCG
P2 Cre-fw GCTCCTGGACAGGAATCAAG 02B TAGTCTAACTCGCGACACTG
P3 WT-rv CTCACCTGCAAGGACAGGAT CAG-02B GTTATGTAACGCGGAACTCC
Table A.3. PCR reaction mix for Id2-CreERT2+ mice.
Volume [µl] Reagent
2.5 Taq buffer
2.5 MgCl2
1 P1
1 P2
1 P3
0.5 dNTPs
1 Taq Polymerase
14.5 H2O
1 DNA
Table A.4. PCR reaction scheme for Id2-CreERT2+ mice.
Step Temperature [°C] Time
Initiation 94 5 min
Denaturation 94 30 sec
Annealing 60 30 sec
Extension 72 1 min
Final extension 72 8 min
Termination 4 ∞
Step 2 - 4 are repeated for 35 cycles.
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Table A.5. Product size of Id2-CreERT2+ PCR.
Product Size [bp]
Id2-CreERT2 Rosa26-eGFP
wild-type band 371 560
mutant band 600 300
PCR for Id2–/– mice
For genotyping of Id2–/– mice two different protocols were used. The initial protocol is
described in the PhD thesis of Juliane Ober-Blöbaum (Ober-Blöbaum, 2009) and the
current protocol is presented here: The following primers (Table A.6) were used in the
PCR reaction (Table A.7) with the stated conditions (Table A.8). The expected band
size of the PCR products are in Table A.9 and were visualized on a agarose gel (see
below).
Table A.6. Primer sequences for genotyping Id2–/– mice.
Primer Sequence
Id2-c-R1 TGTTCTCCTGGTGAAATGGCTG
Id2-WT-F1 TGCTCAGGACTACAGAACAGTTGC
Id2-neo-F1 GCTTCCTCGTGCTTTACGGTATC
Table A.7. PCR reaction mix for Id2–/– mice.
Volume [µl] Reagent
2.5 Taq buffer
1.5 MgCl2
1 Id2-c-R1
1 Id2-WT-F1
1 Id2-neo-F1
0.5 dNTPs
1 Taq Polymerase
1 DMSO
15 H2O
1 DNA
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Table A.8. PCR reaction scheme for Id2–/– mice.
Step Temperature [°C] Time
Initiation 95 5 min
Denaturation 95 45 sec
Annealing 62 30 sec
Extension 72 1 min 30 sec
Final extension 72 5 min
Termination 4 ∞
Step 2 - 4 are repeated for 40 cycles.
Table A.9. Product size of Id2–/– PCR.
Product Size [bp]
wild-type band 700
mutant band 500
PCR for VavCre+ : E2Af mice
For genotyping of VavCre+ : E2Af mice the following primers (Table A.10) were used in the
PCR reaction (Table A.11) with stated conditions (Table A.12 and A.13). The expected
band size of the PCR products are in Table A.14 and were visualized on a agarose gel (see
below). PCR reaction mix of E2A with P1 and P3 generate a GFP band (319 bp) only
when at least one floxed allele is present and VavCre is present.
Table A.10. Primer sequences for genotyping VavCre+ : E2Af mice.
No. VavCre E2A
P1 fw GCCTGCCCTCCCTGTGGATGCCACCT WT-fw GTGCTACCAGTGGACAGCTGT
P2 rv GTGGCAGAAGGGGCAGCCACACCATT KO-rv TGGATGGCTGCCCTCAACTGG
P3 GFP-rv AGCAAGGGGAAGGGTGGTTAG
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Table A.11. PCR reaction mix for VavCre+ : E2Af mice.
Volume [µl] Reagent
2.5 Taq buffer
2.5 MgCl2
1 P1
1 P2 or P3
0.5 dNTPs
1 Taq Polymerase
15.5 H2O
1 DNA
Table A.12. PCR reaction scheme for VavCre primers.
Step Temperature [°C] Time
Initiation 95 4 min 30 sec
Denaturation 95 30 sec
Annealing 65 45 sec
Extension 72 30 sec
Final extension 72 10 min
Termination 4 ∞
Step 2 - 4 are repeated for 36 cycles.
Table A.13. PCR reaction scheme for E2A primers.
Step Temperature [°C] Time
Initiation 94 3 min
Denaturation 94 30 sec
Annealing 62.7 30 sec
Extension 72 45 sec
Final extension 72 5 min
Termination 4 ∞
Step 2 - 4 are repeated for 35 cycles.
Table A.14. Product size of VavCre+ : E2Af PCR.
Product Size [bp]
VavCre E2A
wild-type band - 201
mutant band 700 235
GFP band - 319
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PCR for E47–/– mice
For genotyping of E47–/– mice two different protocols were used. The initial protocol is
described in the PhD thesis of Juliane Ober-Blöbaum (Ober-Blöbaum, 2009) and the
current protocol is presented here: The following primers (Table A.15) were used in the
PCR reaction (Table A.16) with the stated conditions (Table A.17). The expected band
size of the PCR products are in Table A.18 and were visualized on a agarose gel (see below).
With this primer set a second wild-type band is obtained in E47–/– DNA at around 1500
bp. However, due to improved primer conditions amplification of this PCR product is not
favoured.
Table A.15. Primer sequences for genotyping E47–/– mice.
Primer Sequence
E47-c-F1 GCACCTCAAGTCGGATAAGGC
E47-WT-R1 AGAGCAGTGGGAGACGGTCC
E47-neo-R1 GAACACGGCGGCATCAGAG
Table A.16. PCR reaction mix for E47–/– mice.
Volume [µl] Reagent
2.5 Taq buffer
1.5 MgCl2
1.5 E47-c-F1
0.5 E47-WT-R1
1 E47-neo-R1
0.5 dNTPs
1 Taq Polymerase
1 DMSO
15 H2O
1 DNA
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Table A.17. PCR reaction scheme for E47–/– mice.
Step Temperature [°C] Time
Initiation 94 4 min
Denaturation 94 22 sec
Annealing 62 22 sec
Extension 68 30 sec
Final extension 68 5 min
Termination 4 ∞
Step 2 - 4 are repeated for 38 cycles.
Table A.18. Product size of E47–/– PCR.
Product Size [bp]
wild-type band 200
mutant band 450
PCR for Msc–/– mice
For genotyping of Msc–/– mice the following primers (Table A.19) were used in the
PCR reaction (Table A.20) with stated conditions (Table A.21). The expected band
size of the PCR products are in Table A.22 and were visualized on a agarose gel (see
below).
Table A.19. Primer sequences for genotyping Msc–/– mice.
Primer Sequence
moIMR6817r (C) CAGCAGCAGATCGCGCCCACT
moIMR6818 (WT) AGCCGCTTCCTCTTGCATCCT
oIMR6819 (M) GCGCATCGCCTTCTATCGCCT
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Table A.20. PCR reaction mix for Msc–/– mice.
Volume [µl] Reagent
2.5 Taq buffer
2.0 MgCl2
1 Id2-c-R1
2.5 C
2.5 WT
2.5 M
0.5 dNTPs
1 Taq Polymerase
1 DMSO
8.5 H2O
2 DNA
Table A.21. PCR reaction scheme for Msc–/– mice.
Step Temperature [°C] Time
Initiation 94 3 min
Denaturation 94 30 sec
Annealing 64 1 min
Extension 72 1 min
Final extension 72 2 min
Termination 4 ∞
Step 2 - 4 are repeated for 35 cycles.
Table A.22. Product size of Msc–/– PCR.
Product Size [bp]
wild-type band 400
mutant band 550
Agarose Gel Electrophoresis
PCR products were analysed in 1.5% agarose gels containing ethidium bromide. Therefore,
6x loading dye was added to the PCR product and 10 µl of PCR product were subjected to
gel electrophoresis. DNA size marker was 10 kb plus ladder (Gene ruler, Fermentas, Thermo
Fisher Scientific). Gel electrophoresis was performed at 100 volt, 120 milliampere and 50
watts for 50 min. Visualisation of the gel was done with the GelDocX gel documentation
system (Bio-Rad Laboratories, Hercules, USA).
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B.1 LC Upregulate Specific LC Marker Shortly After Birth
LC differentiation starts directly after birth and with this gene expression pattern change
from LC precursors to mature LC. Monitoring changes in gene expression pattern in
developing LC was made possible by FACS sorting LC of skin epidermis from P2 onwards
(example for P10 is shown in Figure B.1A), followed by RNA isolation and cDNA synthesis
to perform qRT-PCR analysis for several genes (Figure B.1).
Figure B.1. Gene expression pattern during LC development.
Epidermal single cell suspensions of 3-6 wild-type mice were FACS sorted at different days after birth
for LC (CD45+MHC-II+CD3-), followed by RNA isolation, reverse cDNA preparation and qRT-
PCR analysis. (A) Gating strategy is shown for FACS forting of epidermal single cell suspensions
from P10 mice. (B-J) The fold expression to Gapdh was calculated and is depicted as bar diagrams.
N=1.
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As expected from flow cytometry analysis of Id2+/– newborns (Figure 3.7E and Figure
3.12C), Cd207 (langerin) and Cdh1 (E-cadherin) are upregulated during LC development
also in wild-type mice (Figure B.1B). Also other LC genes, such as Cldn1 (claudin1),
Ctnnb (β-catenin), Jam1 and Csf1r, are expressed from P2 onwards and their expression
is upregulated during development. Highest expression was observed around P18, while
a slightly lower expression was detected during adulthood for some genes (Figure B.1B).
Interestingly, Zeb2 expression was only detected shortly after birth at P2, while it was
absent during development and adulthood (Figure B.1B).
B.2 Gating Example of Haematopoietic Subsets by Flow
Cytometry Analysis
Figure B.2. Lineage tracing of Id2 expression in epidermis.
Epidermal single cell suspensions were stained for LC and DETC. For marker discrimination see
Table C.1. One representative gating strategy for flow cytometry analysis is shown for tmx treated
Id2-CreERT2+ mice and Id2-CreERT2– mice after 7 days.
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Figure B.3. Lineage tracing of Id2 expression during adulthood in splenic cells.
Splenic single cell suspensions were stained for DC and T cell subsets. For marker discrimination
see Table C.1. One representative gating strategy for flow cytometry analysis is shown for tmx
treated Id2-CreERT2+ mice and Id2-CreERT2– mice after 7 days.
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Figure B.4. Lineage tracing of Id2 expression in splenic NK cells.
Splenic single cell suspensions were stained for NK cells. For marker discrimination see Table
C.1. One representative gating strategy for flow cytometry analysis is shown for tmx treated
Id2-CreERT2+ mice and Id2-CreERT2– mice after 7 days.
Figure B.5. Lineage tracing of Id2 expression during adulthood in skin draining lymph
nodes.
Single cell suspensions from skin draining lymph nodes were stained for DC and T cell subsets. For
marker discrimination see Table C.1. One representative gating strategy for flow cytometry analysis
is shown for Id2-CreERT2+ mice treated with tmx (+tmx) and without tmx (-tmx) after 7 days.
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Figure B.6. Lineage tracing of Id2 expression in NK cells obtained from lymph nodes.
Single cell suspensions from skin draining lymph nodes of Id2-CreERT2+ mice were stained for
NK cells. For marker discrimination see Table C.1. One representative gating strategy for flow
cytometry analysis is shown for Id2-CreERT2+ mice treated with tmx (+tmx) and without tmx
(-tmx) after 7 days.
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Figure B.7. Lineage tracing of Id2 expression in DC precursors.
Single cell suspensions from Id2-CreERT2+ bone marrow were stained for DC precursor subsets.
For marker discrimination see Table C.1. One representative gating strategy for flow cytometry
analysis is shown for Id2-CreERT2+ mice treated with tmx (+tmx) and without tmx (-tmx) after
7 days.
Figure B.8. Lineage tracing of Id2 expression in preDC.
Single cell suspensions from Id2-CreERT2+ bone marrow were stained for preDC. For marker
discrimination see Table C.1. One representative gating strategy for flow cytometry analysis is
shown for Id2-CreERT2+ mice treated with tmx (+tmx) and without tmx (-tmx) after 7 days.
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Figure B.9. Lineage tracing of Id2 expression in NK precursors in bone marrow.
Single cell suspensions from Id2-CreERT2+ bone marrow were stained for NK precursor subsets.
For marker discrimination see Table C.1. One representative gating strategy for flow cytometry
analysis is shown for Id2-CreERT2+ mice treated with tmx (+tmx) and without tmx (-tmx) after
7 days.
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Figure B.10. Lineage tracing of Id2 expression in monocytes and granulocytes.
Single cell suspensions from Id2-CreERT2+ bone marrow were stained for monocytes and gran-
ulocytes. For marker discrimination see Table C.1. One representative gating strategy for flow
cytometry analysis is shown for Id2-CreERT2+ mice treated with tmx (+tmx) and without tmx
(-tmx) after 7 days.
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Figure B.11. Lineage tracing of Id2 expression during adulthood in dermis.
Single cell suspensions from Id2-CreERT2+ dermis were stained for DC and T cell markers. For
marker discrimination see Table C.1. One representative gating strategy for flow cytometry analysis
is shown for Id2-CreERT2+ mice treated with tmx (+tmx) and without tmx (-tmx) after 5 days.
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Figure B.12. Lineage tracing of Id2 expression during development in dermis.
Pregnant mice or newborn mice recieved a single dose of tamoxifen and were analysed at the age of
7 weeks. Single cell suspensions from dermis were stained for DC and T cell markers. For marker
discrimination see Table C.1. One representative gating strategy for flow cytometry analysis is
shown for tmx treated Id2-CreERT2+ mice and Id2-CreERT2– mice at P1.
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Figure B.13. The double-deficiency of Id2 and E47 restore the Id2–/– phenotype in
epidermal LC.
Epidermal single cell suspensions were stained for CD45, MHC-II, CD3, CD11c and EpCAM. One
representative gating strategy of each genotype for LC (CD45+MHC-II+CD3-CD11c+EpCAM+)
and DETC (CD45+MHC-II-CD3+) in skin epidermis is shown.
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Table C.1. Marker profile of heamatopoietic subsets for analysis by flow ctometry.
Cell Population Tissue Markers
LT-HSC bone marrow CD45+Lin1-c-kitposSca-1+CD34-Flt3-
ST-HSC bone marrow CD45+Lin1-c-kit+Sca-1+CD34+Flt3-
LSK bone marrow CD45+Lin1-c-kit+Sca-1+
MPP bone marrow CD45+Lin1-c-kit+Sca-1+CD34+Flt3+
CMP bone marrow CD45+Lin2-c-kit+CD34-CD16-
GMP bone marrow CD45+Lin2-c-kit+CD34-CD16+
MEP bone marrow CD45+Lin2-c-kit+CD34-CD16/CD32-
MDP bone marrow CD45+Lin3-c-kit+Flt3+CD115+
CDP bone marrow CD45+Lin3-c-kit+Flt3+CD115+CD127-
preDC bone marrow CD45+Lin4-CD11c+MHC-II-Flt3intCD172α+
CLP bone marrow CD45+Lin3-c-kitintFlt3+CD115-CD127+
Gr1lo Monocytes bone marrow CD45+Lin5-Gr1-CD62L-CD115+CD11b+
spleen
Gr1hi Monocytes bone marrow CD45+Lin5-Gr1+CD62L-CD115+CD11b+
spleen
Granulocytes bone marrow CD45+Lin5-Gr1+CD62L+CD115-
spleen
B cells bone marrow CD45+Lin6-CD19+B220+
spleen
CD8α+ T cells spleen CD45+Lin7-CD3+CD8+
CD8α- T cells spleen CD45+Lin7-CD3+CD8-
pDC spleen CD45+Lin6-CD19-B220+CD11c+SiglecH+
cDC spleen CD45+Lin6-CD19-B220-CD11c+
CD8α+ cDC spleen CD45+Lin7-CD3-CD11c+MHC-II+CD8α+CD11b-
CD11b+ cDC spleen CD45+Lin7-CD3-CD11c+MHC-II+CD8α-CD11b+
NK cells spleen CD45+CD3-B220-CD122+NK1.1+
lymph nodes
NKP bone marrow Lin8-NK1.1-CD135-CD122+
pre-pro NKa bone marrow Lin8-NK1.1-CD135-CD122-CD117+
pre-pro NKb bone marrow Lin8-NK1.1-CD135-CD122-CD117-
CD11b+ DC dermis CD45+CD3-CD11c+MHC-II+CD11b+EpCAM-
CD103+ DC dermis CD45+CD3-CD11c+MHC-II+CD103+
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Table C.1. Marker profile of heamatopoietic subsets for analysis by flow ctometry.
Cell Population Tissue Markers
LC epidermis CD45+CD3-MHC-II+CD11c+EpCAM+
dermis CD45+CD3-MHC-II+EpCAM+CD11bint
DETC epidermis CD45+CD3+MHC-II-
Lineage marker cocktails
Lin1 B220,CD3,CD8,Ter119,CD11c,CD11b,NK1.1,Gr1,MHC-II,CD127,CD19
Lin2 B220,CD3,CD8,Ter119,CD11c,NK1.1,Gr1,MHC-II,CD127,CD19,Sca1
Lin3 B220,CD3,CD8,Ter119,CD11c,CD11b,NK1.1,Gr1,MHC-II, CD19
Lin4 B220,CD3,Ter119,NK1.1,Gr1,CD19
Lin5 B220,CD3,Ter119,NK1.1,MHC-II,CD19
Lin6 CD3,Ter119,CD11b,NK1.1
Lin7 B220,Ter119,NK1.1,CD19
Lin8 CD3,CD8,CD11b,CD19,Ter119,Gr1
Lin9 CD3,Ter119,NK1.1,CD19
Lin10 CD3,NK1.1,CD19
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β-ME β-mercaptoethanol
4-OHT 4-hydroxy-tamoxifen
APC Allophycocyanin
bp Base pair
bHLH Basic helix loop helix
cDC Classical dendritic cells
cDNA Complementary deoxyribonucleic acid
CDP Common DC progenitors
CLP Common lymphoid progenitors
CMP Common myeloid progenitors
Cre Cre-recombinase
Ct Cycle threshold
Ctrl Control
d Days
DC Dendritic cells
DMEM Dulbecco’s modified Eagle’s medium
DNA Deoxyribonucleic acid
e.g. For example
EDTA Ethylene diamine tetraacetic acid
EGTA Ethylene glycol tetraacetic acid
ERT2 Estrogen receptor T2
ESC Embryonic stem cells
FACS Fluorescence-activated cell sorting
FCS Fetal calf serum
FITC Fluorescein isothiocyanate isomer
Flt3 FMS-like tyrosine kinase 3
Flt3L Flt3 ligand
g Earth’s gravitational acceleration
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GAPDH Glyceraldehyde 3-phosphate dehydrogenase
GEF Guanine nucleotide exchange factor
Gfi1 Growth factor independent 1
GFP Green fluorescent protein
GM-CSF Granulocyte-macrophage colony-stimulating factor
GM-DC GM-CSF-derived bone marrow dendritic cells
GMP Granulocyte/macrophage progenitors
Gr–1 Granulocyte differentiation antigen –1
Gy Grey
HGF Hepatocyte growth factor
hIGF-1 Human insulin-like growth factor-1
HSC Hematopoietic stem cells
hyper-IL-6 IL-6/IL-6R fusion protein
Id Inhibitor of differentiation \DNA binding
IgG Immunoglobulin G
IL Interleukin
IRF Interferon regulatory factor
kb Kilobase
LC Langerhans cells
M-CSFR Macrophage colony-stimulating factor receptor
MDP Macrophage-DC progenitors
MEP Megakaryocyte/erythrocyte progenitors
MHC Major histocompatibility complex
min Minutes
MMP Matrix metalloproteinases
MPP Multipotent progenitors
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